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OUTLINE OF THE THESIS 
 
PART I comprises the background of this thesis and the description of the main 
objectives of this study.  
 
PART II consists of a comprehensive literature overview on Mycobacterium genus 
with special focus on methodologies for mycobacteria identification and for 
description of new species. CHAPTER 1 describes the general characteristics of 
mycobacteria and the evolution of the Mycobacterium genus taxonomy over the 
years. CHAPTER 2 describes general characteristics of nontuberculous 
mycobacteria including their habitats, the medically important species and the 
commonest human diseases caused by them. It focuses on the M. chelonae-M. 
abscessus complex including its serial taxonomic classification changes. CHAPTER 
3 summarizes the currently available phenotypic and molecular methodologies for 
identification of mycobacteria. CHAPTER 4 describes the antimicrobial susceptibility 
testing for rapidly growing mycobacteria. Finally, CHAPTER 5 provides an overview 
of the polyphasic approach used for description of new species and the minimal 
standards for assignment of new species to the Mycobacterium genus. 
 
PART III presents the experimental work performed during this thesis. CHAPTER 6 
describes the isolates and type strains included in this study. CHAPTER 7 describes 
the preliminary identification of the isolates included in this study. CHAPTERS 8 and 
9 includes the description of Mycobacterium franklinii and Mycobacterium 
saopaulense, respectively, as novel species of the M. chelonae-M. abscessus 
complex. CHAPTER 10 describes analysis of the remaining isolates by whole 
genome sequencing and the genome comparison of the isolates and type strain 
included in this study. 
 
PART IV presents a general discussion of the results of this study. CHAPTER 11 
includes a general summary justifying the performance of each part of this study. 
CHAPTER 12 includes some difficulties in species identification faced in each 
methodology performed in this study and the impact of this work.  
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PART V provides the conclusions of this study and future perspectives.  
 
PART VI comprises an abstract of this thesis. 
 
PART I: BACKGROUND AND OBJECTIVES 
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Background 
 
 The Mycobacterium chelonae-Mycobacterium abscessus complex comprises 
closely related rapidly growing mycobacteria that are responsible for a wide spectrum 
of opportunistic infections in humans, especially localized skin and soft tissue 
infections. The occurrence of nosocomial outbreaks caused by M. chelonae-M. 
abscessus complex has been increasingly reported. 
 This complex has undergone several taxonomic updates over the years. When 
this investigation started the species formally accepted were M. chelonae, 
Mycobacterium immunogenum, Mycobacterium salmoniphilum, M. abscessus subsp. 
abscessus and M. abscessus subsp. bolletii. However the taxonomic relations of 
these species still generate several doubts, due to important similarities in their 
phenotypic and genotypic characteristics. 
Commercial DNA strip assays for mycobacteria species identiﬁcation, as 
INNO-LiPA® (Innogenetics, Belgium), were recently developed. In this assay, isolates 
of the M. chelonae-M. abscessus complex are subdivided into four genotypic clusters 
(CHI, CHII, CHIII and CHIV). During its development, a great variability in phenotypic 
tests of the CHII cluster isolates was observed (Prof. Françoise Portaels – personal 
communication). Moreover, when other genotypic methodologies were performed, 
they showed discordant results and the identification at species level was not 
achieved. 
In previous projects of our laboratory we detected three isolates of the M. 
chelonae-M. abscessus complex that remained without conclusive identification at 
species level. Two of them were isolated from corneal specimens of patients with 
infectious crystalline keratopathy after LASIK (Laser-Assisted in Situ Keratomileusis) 
in 1999 and the last one was recovered from a lymph node biopsy in 2007. 
Genotypic analyses showed that these isolates were closely related to each other, to 
the members of M. chelonae-M. abscessus complex and to the JAN1 and JAN2 
isolates. JAN1 and JAN2 were obtained from zebrafish and were classified as 
belonging to the M. chelonae-M. abscessus complex due to their phenotypic and 
genotypic characteristics. The performance of several phenotypic and genotypic 
methodologies showed that these isolates have overlapping characteristics with 
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several members of the M. chelonae-M. abscessus complex. Nonetheless, their 
definitive identification at species level was doubtful.  
 These five isolates and a set of isolates of the CHII INNO-LiPA® cluster, 
provided by Prof. Françoise Portaels, were submitted to a polyphasic approach in 
order to investigate their taxonomic position in the M. chelonae-M. abcessus 
complex. 
This project is important because correct mycobacterial species identification 
is essential for epidemiological purposes, implementation of infection control 
measures and for therapeutic management, since some species present specific 
antimicrobial susceptibility patterns. 
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Objectives 
 
General Objective 
The main objective of the present study was to examine the taxonomic 
position of a set of isolates of M. chelonae-M. abscessus complex with inconclusive 
species classification. 
 
Specific Objectives 
In the first phase of this study, the isolates were preliminarily characterized 
using the commercial test Genotype® Mycobacterium CM and AS and the PCR 
Restriction Enzyme Analysis of the hsp65 gene (PRA-hsp65) and 16S-23S ITS 
(PRA-ITS). 
In the second phase of the project, phenotypic analyses traditionally used for 
the identification of mycobacteria, based on culture characteristics and biochemical 
features; drug susceptibility testing; and DNA sequencing of the 16S rRNA, hsp65 
and rpoB genes and the 16S-23S ITS were performed. Some isolates were 
subjected to DNA-DNA hybridization assay against the type strains of the M. 
chelonae-M. abscessus complex. With these data, two additional species of the M. 
chelonae-M. abscessus complex were fully described and validly named. 
In the third phase of this study the isolates without conclusive taxonomic 
identification after the molecular identification and the M. chelonae-M. abscessus 
complex type strains were subjected to Whole Genome Sequencing (WGS). 
Several pairwise genome comparisons, including Average Nucleotide Identity (ANI), 
Tetranucleotide frequency correlation coefficient (TETRA) analysis, genomic 
signature (delta values), Genome-to-genome distance (GGD) and digital DNA-DNA 
hybridization, were performed. 
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1 Mycobacterium sp  
 
1.1 Mycobacterium sp – General characteristics 
 
The Mycobacterium genus includes saprophytes, intermediate forms and 
obligate, facultative or opportunistic parasites. The majority of the species is 
widespread in the environment and can cause a wide range of diseases in both 
humans and animals. Diseases caused by mycobacteria differ in severity and have 
different impact in public health (Shamputa, Rigouts et al. 2004). 
Mycobacteria are aerobic or microaerophilic, slightly curved and rod-shaped 
bacilli. They are non-motile and non-sporulating organisms and do not contain 
endospores or capsules. They have high G+C content (61-71 mol%), except for 
Mycobacterium leprae with 57.8 mol% G+C content, and a thick, hydrophobic and 
lipid-rich cell wall, mainly constituted by long-chain fatty acids containing 60-90 
carbon atoms, the mycolic acids. Mycolic acids are responsible for the characteristic 
resistance to decolorization by acid-alcohol during the Ziehl-Neelsen staining 
procedure. Because of this, mycobacteria are known as Acid-Fast Bacilli (AFB) 
(Levy-Frebault and Portaels 1992, Rastogi, Legrand et al. 2001). Moreover, the 
thickness and composition of the cell wall render mycobacteria impermeable to 
hydrophilic nutrients and resistant to heavy metals, disinfectants, and antibiotics 
(Jarlier and Nikaido 1994). 
Different species have different optimal growth temperatures within a range of 
25°C-45°C. The generation time is usually long and varies widely in different species. 
Mycobacteria that form visible colonies to the naked eye within seven days on solid 
medium are named Rapidly Growing Mycobacteria (RGM), while those requiring 
more than 7 days are named Slowly Growing Mycobacteria (SGM) (Bergey, Harrison 
et al. 1923). This classification is supported by phylogenetic trees constructed with 
different housekeeping genes, in which RGM and SGM are clearly separated, 
forming distinct groups (Devulder, Perouse de Montclos et al. 2005, Tortoli 2012). A 
preliminary phylogenetic study using supertrees concluded that SGM evolved as a 
subgroup of RGM (Mignard and Flandrois 2008). 
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Some mycobacteria produce deep yellow to orange colonies when grown in 
light or darkness (schotochromogens). Others are non-pigmented in the light and 
dark (nonchromogens) and others produce non-pigmented colonies when grown in 
the dark and pigmented colonies after photoactivation (photochromogens) (Bergey, 
Harrison et al. 1923). 
 
1.2 Mycobacterium sp – Taxonomy 
 
The Mycobacterium genus is the single genus within family Mycobacteriaceae, 
order Actinomycetales. Taxonomically, it has undergone constant updates and the 
number of species has been increasing over the years (Rastogi, Legrand et al. 2001, 
Tortoli 2006). 
The first species described of Mycobacterium genus was M. leprae, which was 
identified by Hansen in 1874 (Skerman, Mcgowan et al. 1980). Then, in 1882, Robert 
Koch isolated bacilli tubercle from infected mammalian tissue and proved that they 
were the causal agent of tuberculosis. Subsequently, Mycobacterium tuberculosis 
and Mycobacterium bovis were described as causative agents of human and bovine 
tuberculosis, respectively (Smith 1896, Karlson and Carr 1970, Karlson and Lessel 
1970). Historically, for many years only M. tuberculosis and M. leprae were 
recognized as responsible for human infections (Moore and Frerichs 1953). 
Therefore, until 1950s, it was very common to diagnose as tuberculosis all 
lesions in which AFB were detected. However, in the following years, it was 
demonstrated that, bacteriologically, mycobacteria isolated from some infections 
were very different from the bacilli of tuberculosis and leprosy. Subsequently, other 
species of mycobacteria began to be described (Moore and Frerichs 1953). These 
mycobacteria were previously known as anonymous, atypical mycobacteria and 
Mycobacteria Other Than Tuberculosis (MOTT). However, nowadays the universally 
accepted terminology is Nontuberculous Mycobacteria (NTM). 
The increasing description of new NTM species prompted the necessity of 
suitable mycobacteria identification and classification methods. The first strategies 
employed to identify NTM species included bacilli staining characteristics, cultural 
morphology and biochemical tests. A proper classification system of mycobacteria 
started with Timpe and Runyon (Timpe and Runyon 1954). Subsequently, a 
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classification system based on growth rate and pigment production on solid medium 
was introduced by Runyon (Runyon 1958). According to this classification, 
mycobacteria were subdivided into four groups: I. Slow grower photochromogens; II. 
Slow grower scotochromogens; III. Slow grower nonchromogens; IV. Rapid growers. 
In 1967 the “International Working Group on Mycobacterial Taxonomy” was 
formed and during the following 10 years this group worked on classification using 
numerical taxonomy within Runyon groups. In numerical taxonomy a number of 
phenotypic characteristics are used for grouping bacterial strains based on statistical 
significance of the obtained results. These extensive studies provided a phenotypical 
identification scheme for NTM species (Wayne, Dietz et al. 1971, Kubica, Baess et 
al. 1972, Meissner, Schroder et al. 1974, Saito, Gordon et al. 1977, Tsukamura and 
Mizuno 1977, Wayne, Andrade et al. 1978). 
During this period just over 40 species were known and the recommended 
tests appeared suitable for identification of the clinically important species of NTM. 
However, because their low discrimination ability ambiguities in species identification 
emerged, leading to diverging opinions concerning the classification of mycobacteria. 
Moreover, phenotypic tests usually assigned isolates to the species they best 
resemble among those previously described leading to misidentifications (Butler and 
Guthertz 2001, Tortoli, Bartoloni et al. 2001). According to Tortoli et al. this was the 
reason why mycobacterial taxonomy remained unchanged during several years 
(Tortoli, Bartoloni et al. 2001).  
In the late 1970s/early 1980s other methodologies began to be used in order 
to clarify questions regarding mycobacterial taxonomy. The determination of DNA-
DNA Hybridization (DDH) percentages and the use of High-Performance Liquid 
Chromatography (HPLC) analysis of the mycolic acids became popular. The use of 
these methodologies led to different conclusions and several mycobacteria 
classifications were revised (Baess and Bentzon 1978, Butler and Guthertz 2001). 
Later, DNA sequencing of 16S rRNA and other housekeeping genes were also 
introduced, contributing for the delineation of mycobacteria species (Telenti, 
Marchesi et al. 1993, Lappayawichit, Rienthong et al. 1996, Kirschner and Bottger 
1998, Park, Jang et al. 2000, Adekambi, Berger et al. 2006). 
The introduction of these methodologies provided a continuous evolution of 
mycobacteria taxonomy. It led to an exponential increase in the number of 
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descriptions of new mycobacteria species over the last decades (Tortoli 2006, Dai, 
Chen et al. 2011) (Figure 1.1). However, even with the availability of several 
molecular methodologies, there are still diverging opinions concerning the 
classification of mycobacteria. 
Currently the Mycobacterium genus comprises more than 170 species (J. P. 
Euzéby, List of Prokaryotic Names with Standing in Nomenclature 
[http://www.bacterio.citc.fr/m/mycobacterium.html]) including the etiological agents of 
tuberculosis (M. tuberculosis complex) (Gagneux 2012), leprosy (M. leprae) and the 
large group of NTM (Dawson 2000). 
 
 
Figure 1.1. Numbers of officially accepted Mycobacterium species from 1980 to 
2015 in the List of Prokaryotic names with Standing in Nomenclature. This graphic 
was built based on the List of Prokaryotic Names with Standing in Nomenclature 
[http://www.bacterio.citc.fr/m/mycobacterium.html. 
 
2 Nontuberculous Mycobacteria (NTM) 
 
NTM is a heterogenic group that encompasses the majority of species in the 
Mycobacterium genus. Unlike M. tuberculosis complex and M. leprae, NTM are not 
obligate pathogens but are free living bacteria that are spread in the environment. 
They can be found as saprophytes, commensals and symbionts in soil and ground 
water, in sewage and dust as well as in fresh and sea water (Primm, Lucero et al. 
2004). Therefore NTM are inhabitants of several environmental habitats that are 
shared with animals and humans, including drinking water distribution systems, 
household plumbing and water systems in hospitals, hemodialysis centers, surgical 
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facilities, dental offices (Phillips and von Reyn 2001, Falkinham 2002, Falkinham 
2009, Falkinham 2013) (Table 2.1).  
 
Table 2.1. Environmental isolations of mycobacteria. Adapted from (Primm, Lucero et al. 2004) 
NTM Species Location 
M. ulcerans Natural waters, soil, insects, wild animals, fish 
M. scrofulaceum, MAC, M. szulgai,  
M. fortuitum 
Surface water 
M. gordonae, MAC City aquarium, drinking water 
MAC Residential water sources (i.e. toilet, tap, shower) 
MAC Hospital recirculating hot water system 
M. mucogenicum, M. kansasii,  
M. gordonae, MAC, M. fortuitum 
Public drinking and potable water sources, ice machines, 
water treatment plant 
MAC, M. gordonae, M. fortuitum,  
M. kansasii, M. marinum, M. chelonae 
Public swimming pools and whirlpools 
MAC Hot tubs 
M. scrofulaceum, MAC, M. szulgai,  
M. fortuitum, M. gordonae, M. simiae 
Hospital tap water 
M. fortuitum, MAC Soil 
M. fortuitum Sewage treatment plant 
M. flavescens, M. austroafricanum,  
M. chlorophenolicum and unknown* 
Petroleum-contaminated soil 
Many species Domestic and wild animals, numerous species 
M. immunogenum Biocide-treated metalworking fluid 
M. chelonae Gentian violet solution 
*Unknown, 16S ribosomal sequence did not match any known species.  
MAC, M. avium Complex. 
 
There has been an increasing awareness of a variety of opportunistic 
diseases caused by NTM, which were named mycobacterioses (Johnson and Odell 
2014, Mwikuma, Kwenda et al. 2015). Being classical opportunists, NTM 
predominantly infect patients already suffering from pulmonary diseases or 
immunodeficiency; however, the number of mycobacterioses is also increasing 
among immunocompetent persons (Primm, Lucero et al. 2004).  
NTM person-to-person transmission has not been demonstrated. 
Environmental exposure coupled with several inherent characteristics of NTM 
contributes for the occurrence of NTM opportunistic infections by aerosolization and 
inhalation, ingestion, or dermal contact with contaminated sources (Primm, Lucero et 
al. 2004, Donohue, Mistry et al. 2015). Lymphadenitis, pulmonary and skin and soft 
tissue infections are the most commonly described human infections (Johnson and 
Odell 2014). 
The hydrophobicity of mycobacteria results in preferential aerosolization from 
water during daily activities such as drinking, swimming and bathing leading to 
recurrent human exposure (Parker, Ford et al. 1983, Falkinham 2002, Primm, Lucero 
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et al. 2004, Feazel, Baumgartner et al. 2009). This is the likely route of NTM 
pulmonary infection in immunocompromised patients. Mycobacterium avium, 
Mycobacterium kansasii, and M. abscessus are the most frequently identified 
organisms causing lung disease (Johnson and Odell 2014).  
Immunocompromised patients are also affected by NTM lymphadenitis, 
however it is the most common NTM manifestation in young children. Pharyngeal 
mucosa, tonsils, conjunctiva, gingiva, and salivary glands are considered the NTM 
ports of infection, for example, during ingestion of contaminated soil or water. M. 
avium and Mycobacterium haemophilum are the most common cause of NTM 
lymphadenitis (Primm, Lucero et al. 2004, Amir 2010). 
Mycobacteria hydrophobicity has also been associated with biofilm formation 
(Schulze-Robbecke, Janning et al. 1992), contributing to disinfectant and antibiotic 
resistance (Jarlier and Nikaido 1994, Falkinham 2007). The presence of NTM in 
water associated with disinfectant resistance and consequent failure in sterilization, 
leads to NTM presence in solutions used in medical interventions and in medical 
instruments and equipments (Thomson, Carter et al. 2013, Mwikuma, Kwenda et al. 
2015). These factors associated with the increasing number of invasive (medical or 
non-medical) procedures, especially eye surgeries, laparoscopic procedures, plastic 
surgeries and cosmetic techniques (such as mesotherapy) have been identified as 
the main factors that generate NTM skin and soft tissue infections. The breaking 
down of the integrity of skin, corneal, or mucosal barriers leads to NTM inoculation 
and to the development of mycobacterial diseases and nosocomial outbreaks 
(Martinez, McAdams et al. 2007). During the last decades there has been a 
significant increase in post-traumatic and post-operative infections due to these 
organisms. Nearly every species of NTM may cause skin and soft tissue infections, 
however RGM are the most commonly involved, specially the members of M. 
chelonae-M. abscessus, Mycobacterium fortuitum and Mycobacterium smegmatis 
complexes (Griffith, Aksamit et al. 2007, Alcaide and Esteban 2010). 
 
2.1 M. chelonae-M. abscessus complex  
 
The M. chelonae-M. abscessus complex comprises closely related RGM that 
can cause several opportunistic infections in both immunocompromised and in 
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immunocompetent persons. They have been mainly involved in pulmonary, skin and 
soft tissue infections and disseminated disease (especially in immunocompromised 
patients) (Brown-Elliott and Wallace 2002, Falkinham 2013, Nunes Lde, Baethgen et 
al. 2014). A predisponsing factor frequently associated with pulmonary disease is the 
presence of cystic fibrosis (De Groote and Huitt 2006).  
This complex has been increasingly involved in both community and hospital-
acquired infections after trauma or surgery in immunocompetent persons, 
representing a serious public health problem (Koh, Jeon et al. 2011). Recent 
publications have indicated an increasing number of infections by M. chelonae-M. 
abscessus complex members associated with eye infections after laser in situ 
keratomileusis (LASIK), endocarditis, surgical wounds, post-injection, catheter and 
hemodialysis-related infections, infections after tattoos, as well as disseminated 
infections in immunosuppressed patients (Meyers, Brown-Elliott et al. 2002, Hansen 
and Sarma 2006, Sampaio, Junior et al. 2006, Del-Castillo, Palmero et al. 2009, Al-
Benwan, Ahmad et al. 2010, Shedd, Edhegard et al. 2010, Mitchell, Isenstein et al. 
2011, Stout, Gadkowski et al. 2011, Wongkitisophon, Rattanakaemakorn et al. 2011, 
Kennedy, Bedard et al. 2012, D'Ancona, Kanitz et al. 2014, Bhandari, Sriganesh et 
al. 2015, Edens, Liebich et al. 2015, Henkle and Winthrop 2015, Jung, Kim et al. 
2015, Shah, Relhan et al. 2016). Between 2004 and 2008, an epidemic of localized 
skin and soft tissue infections caused by members of this complex affecting more 
than 2,000 patients occurred in Brazil, following invasive procedures such as 
laparoscopic, arthroscopic and plastic surgeries, and cosmetic interventions 
(Cardoso, Martins de Sousa et al. 2008, Viana-Niero, Lima et al. 2008, Duarte, 
Lourenco et al. 2009, Leao, Viana-Niero et al. 2010, Nunes Lde, Baethgen et al. 
2014). 
 
2.1.1 Taxonomy of M. chelonae-M. abscessus complex 
 
Similar to what occurred with the Mycobacterium genus as a whole, several 
changes in the taxonomic classification of the members of M. chelonae-M. 
abscessus complex occurred over the years.  
Mycobacterium chelonei was described by Bergey et al. to include 
Friedmann’s (1903) turtle tubercle bacillus. The etymology of M. chelonei refers to 
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Gr. n. khelone, pertaining to tortoise (any of various terrestrial turtles) (Bergey, 
Harrison et al. 1923).  
Moore and Frerichs reported a human knee infection caused by mycobacteria 
probably after injections of streptomycin. Based on its phenotypical characteristics, a 
new species was described and named M. abscessus – L. gen. n. abscessus, of an 
abscess, referring to its ability to produce deep abscesses in human tissue (Moore 
and Frerichs 1953). 
Based on bacteriological and serological examinations, Stanford and Beck 
(Stanford and Beck 1969) found that the following strains were similar to the turtle 
tubercle bacillus: M. abscessus (Moore and Frerichs 1953), Mycobacterium runyonii 
(Bojalil, Cerbon et al. 1962) and Mycobacterium borstelense (Bonicke 1965). 
Therefore they were considered synonyms of M. chelonei. Subsequently, two 
subgroups of M. chelonei were recognized and distinguished by several biochemical 
tests included in the numerical taxonomy. Consequently, they were classified as M. 
chelonei subsp. chelonei and M. chelonei subsp. abscessus (Kubica, Baess et al. 
1972, Stanford, Pattyn et al. 1972). All other synonyms previously described for this 
species were considered invalid (Ward 1975). 
For many years the cause of chronic abscesses after injury or injection was 
attributed to M. chelonei and M. fortuitum. M. fortuitum was isolated from a post-
injection abscess in a Brazilian patient by da Costa Cruz and M. peregrinum was first 
proposed as a RGM species distinct from M. fortuitum (Da Costa Cruz 1938, Bojalil, 
Cerbon et al. 1962). Later, Stanford and Gunthorpe demonstrated that these two taxa 
belong to a single species based on serological tests (Stanford and Gunthorpe 
1969). Therefore, M. peregrinum was considered synonym of M. fortuitum (Kubica, 
Baess et al. 1972). 
Strains of M. chelonei subsp. chelonei, M. chelonei subsp. abscessus and M. 
fortuitum (M. peregrinum) were distinguished by some biochemical and colonial 
properties (Pattyn, Magnusson et al. 1974) and in vitro antibiotic sensibility studies 
(Haas, Michel et al. 1973). However, even with phenotypic characterization and 
numerical taxonomy, the differentiation of M. chelonei subsp. chelonei, M. chelonei 
subsp. abscessus and M. fortuitum remained difficult and different opinions 
concerning their species status emerged (Baess 1982). In consequence, based on 
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numerical analysis, the three taxa were reunited in the M. fortuitum complex 
(Tsukamura 1981). 
In the following years, Hill et al. corrected the name M. chelonei to M. 
chelonae, given the gender of the turtle name, Chelona corticata (Hill, Skerman et al. 
1984).  
In the 1980s, when the performance of DDH experiments became common, 
important taxonomic changes occurred in the M. fortuitum complex. Baess was the 
first author to demonstrate the low DNA relatedness between both subspecies of M. 
chelonae and M. fortuitum (M. peregrinum) (Baess 1982). These findings were 
complemented by Levy-Frebault et al., who clearly demonstrated that M. chelonae 
subsp chelonae and M. chelonae subsp. abscessus were independent species and 
both differed from M. fortuitum and M. peregrinum (Levy-Frebault, Grimont et al. 
1986). In 1992 Kusunoki and Ezaki confirmed the previous findings using different 
conditions of DDH experiments leading to the elevation of M. chelonae subsp. 
abscessus to the species status of M. abscessus and the revival of M. peregrinum as 
an independent species (Kusunoki and Ezaki 1992). Moreover, M. chelonae and M. 
abscessus were further grouped in the M. chelonae-M. abscessus complex. 
Besides DDH experiments, several molecular methodologies including DNA 
sequencing and HPLC analysis of the mycolic acid were introduced. Consequently, it 
became clear that both M. chelonae and M. abscessus were more closely related to 
each other than to M. fortuitum. Futhermore, using a polyphasic approach, new 
species closely related to both M. chelonae and M. abscessus were described and 
diverging opinions concerning their taxonomy emerged (Wilson, Steingrube et al. 
2001, Adekambi, Berger et al. 2006, Whipps, Butler et al. 2007, Leao, Tortoli et al. 
2011). 
In 2001, Wilson et al. studied a set of isolates of non-pigmented RGM from 
clinical and environmental sources that failed to match with patterns of officially 
accepted species. They showed phenotypical and HPLC profiles compatible with M. 
abscessus and M. chelonae. However, 16S rRNA gene sequencing and DDH clearly 
demonstrated that they belonged to a new species of the M. chelonae-M. abscessus 
complex. The name Mycobacterium immunogenum sp. nov. was proposed – N.L. 
neut. adj. immunogenum, refering an immune response – and validly published 
(Wilson, Steingrube et al. 2001). 
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In 2006, Adékambi et al. performed a polyphasic approach study in a 
collection of clinical RGM isolates recovered from bronchial and stomach aspirates, 
sputum and joint fluid (Adekambi, Berger et al. 2006). A new member of the M. 
chelonae-M. abscessus complex was validly published, Mycobacterium bolletii sp. 
nov. – N.L. gen. masc. n. bolletii, of Bollet, to honour Claude Bollet, a famous clinical 
microbiologist and taxonomist . 
In the same year, Mycobacterium massiliense was officially accepted as a 
new member of M. chelonae-M. abscessus complex (Adekambi, Reynaud-Gaubert et 
al. 2004a). It was isolated from sputum and bronchoalveolar fluid of a patient with 
hemoptoic pneumonia. Phenotypic and genotypic features of the isolates indicated 
that they were representative of a new species, M. massiliense – L. neut. adj. 
massiliense, refering to Massilia, the Latin name of Marseille, where the organism 
was firstly isolated. 
In 2007, Whipps et al. employed a polyphasic approach in order to clarify the 
taxonomic position of mycobacteria isolated from salmon (Whipps, Butler et al. 
2007). A M. chelonae-like species from salmon, ‘Mycobacterium salmoniphilum’, was 
described in 1960 (Ross 1960) – L. n. salmo -onis, a salmon; N.L. adj. philus -a -um 
(from Gr. adj. philos -ê -on), friend, loving; N.L. neut. adj. salmoniphilum, salmon-
loving. However, because it could not be distinguished from M. fortuitum, M. 
salmoniphilum was omitted from the 1980 Approved Lists of Bacterial Names. In the 
1980s, the mycobacteria isolated from salmon were characterized as a subspecies of 
M. chelonae, named ‘M. chelonae subsp. piscarium’. However, there were still 
doubts about the existence of this subspecies and, therefore, it was subsequently 
removed from the list of valid names. Again, in 2007, Whipps et al. examined the 
taxonomic relatedness of type strains and authentic isolates from earlier studies. The 
results supported the status as a separate taxon and M. salmoniphilum was officially 
accepted (Whipps, Butler et al. 2007). 
Leão et al. (Leao, Tortoli et al. 2009, Leao, Viana-Niero et al. 2010) studied 
isolates of an outbreak related to laparoscopic and arthroscopic surgeries. This 
outbreak started in Belém (Pará, Brazil) and then spread to different Brazilian 
geographic areas. This study showed that the outbreak was related to a single strain, 
which was initially identified as M. massiliense (Cardoso, Martins de Sousa et al. 
2008, Viana-Niero, Lima et al. 2008, Duarte, Lourenco et al. 2009, Leao, Tortoli et al. 
PART II: LITERATURE 
28 
2009). In fact, the identification results were controversial because of the high level of 
similarity of rpoB and hsp65 gene sequences with the corresponding sequences of 
both M. massiliense and M. bolletii (Viana-Niero, Lima et al. 2008, Leao, Tortoli et al. 
2009). In order to confirm the species identification, the isolates from this outbreak 
and the type strains of M.chelonae-M. abscessus complex were extensively studied 
using a polyphasic approach. The results showed that these isolates could not be 
clearly discriminated by phenotypic or molecular tests, including the gold standard 
DDH. Therefore, M. abscessus, M. massiliense and M. bolletii were reunited in a 
single species – M. abscessus – with two subspecies – M. abscessus subsp. 
abscessus and M. abscessus subsp. bolletii (Leao, Tortoli et al. 2009, Leao, Tortoli et 
al. 2011). Subspecies bolletii included those isolates identified previously as M. 
massiliense or M. bolletii. The name M. abscessus subsp. bolletii was chosen on the 
basis of the Bacteriological Code (1990 Revision) (Lapage, Sneath et al. 1992, De 
Vos and Trüper 2000). Since the name M. bolletii was validly published on 
January/2006 and the M. massiliense name on September/2006, the name M. bolletii 
had priority over the name M. massiliense. This reclassification was officially 
accepted in 2011 (Leao, Tortoli et al. 2011). 
Recently, a debate has ensued over the reclassification of M. massiliense and 
M. bolletii in a single subspecies - M. abscessus subsp. bolletii. Several recent 
studies based on genome comparisons have provided evidence that there can 
indeed be three taxonomic groups within M. abscessus: M. abscessus subsp. 
abscessus, M. abscessus subsp. massiliense, and M. abscessus subsp. bolletii 
(Bryant, Grogono et al. 2013, Heydari, Wee et al. 2013, Benwill and Wallace 2014, 
Sassi and Drancourt 2014, Tettelin, Davidson et al. 2014). Whole Genomic 
Sequencing and Single Nucleotide Polymorphisms (SNP) information contained in 
the core genomes were used to construct phylogenetic trees that show deep genetic 
divisions corresponding to three different taxa. It is important to mention that the 
number of isolates identified as M. bolletii or M. abscessus subsp. bolletii in these 
studies is extremely low (1-3) in comparison to the number of isolates identified as M. 
abscessus (M. abscessus subsp. abscessus) or M. massiliense (M. abscessus 
subsp. massiliense). This can generate bias to the conclusion that M. massiliense 
and M. bolletii are separate taxa. Moreover, there are several reports describing 
isolates of M. bolletii and M. massiliense that cannot be clearly classified by available 
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molecular methods (Kim, Kook et al. 2008, Viana-Niero, Lima et al. 2008, Zelazny, 
Root et al. 2009). However, it is not clear yet how this novel information will affect the 
2011 reclassification. 
Other species were proposed as new members of the M. chelonae-M. 
abscessus complex, but their names were not validly published. In 2011, Simmon et 
al. studied a group of clinical isolates from Pennsylvania and Northeastern United 
States that wrongly assigned as M. chelonae with an atypical antimicrobial 
susceptibility pattern (Simmon, Brown-Elliott et al. 2011). This study included the 
proposal of ‘Mycobacterium franklinii’ as a new member of M. chelonae-M. 
abscessus complex. Zhang et al. investigated clinical isolates previously identified as 
belonging to M. chelonae-M. abscessus complex (Zhang, Li et al. 2013). Their hsp65 
sequences showed more than 99% identity with the respective sequences of M. 
abscessus, however, low identity was verified in rpoB, ITS, sodA, and recA 
sequences. Therefore, a new species was proposed, ‘Mycobacterium fukienense’. 
Currently the taxonomic relations of members of the M. chelonae-M. 
abscessus complex still generate several doubts due to important similarities in 
phenotypic and genotypic characteristics hindering their identification at the species 
level. Species are biochemically inert and partial sequences of the 16S rRNA gene 
are too similar, making their identification a challenge. Nonetheless, definitive 
identification by the clinical laboratory is extremely important for outbreak detection 
and for patient management (Simmon, Brown-Elliott et al. 2011). 
 
3 Mycobacteria Identification Methods 
 
The NTM species are genetically closely related to each other making their 
identification at species level a challenge especially for clinical laboratories (Tortoli 
2003). However, the rapid identification at the species level is essential for several 
reasons. First of all, NTM species identification is needed to define the value of an 
isolate as a true pathogen or an environmental and potential contaminant (Leão, 
Martin et al. 2004). Moreover, it is important to discriminate the NTM species for 
therapeutic management since some species present characteristic antimicrobial 
patterns (Tortoli 2003). Species identification is also important for epidemiological 
purposes and consequently for implementation of infection control measures. 
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Different laboratory techniques are available for mycobacteria species 
identification, including conventional methods based on phenotypic characteristics 
and biochemical tests, mycolic acid analysis and molecular methods. 
 
3.1 Phenotypic Methods  
 
The phenotypic identification of mycobacteria is based on characteristics of 
the culture and biochemical features, and comprises a large variety of tests. They 
were extensively used for identification and classification of mycobacteria mainly in 
the era of numerical taxonomy (Butler and Guthertz 2001).  
However, as the number of species increased, these tests were shown to be 
unable to distinguish between all recognized mycobacteria species. Interspecies 
homogeneity, intraspecies variability, and the existence of species not yet described 
can lead to erroneous identification. For many NTM species, the phenotypic tests are 
poorly reproducible and for those biochemically unreactive, such as the members of 
M. chelonae-M. abscessus complex, they are really not useful for species 
discrimination. Furthermore, they are time-consuming and cause delay in the final 
species identification since the slow growth rate of mycobacteria. They are limited by 
subjectivity, low specificity and require experience in results interpretation (Butler and 
Guthertz 2001, Tortoli, Bartoloni et al. 2001, Cook, Turenne et al. 2003, Chimara, 
Ferrazoli et al. 2008, Simmon, Brown-Elliott et al. 2011). 
Because of all these disadvantages, only few phenotypic tests described for 
NTM identification are still used in clinical laboratories. In general, first of all a smear 
of the culture is stained by Ziehl-Neelsen (or other acid fast stain) to confirm the 
presence of AFB. Then, the colony morphology (smooth or rough), growth rate (SGM 
or RGM), growth temperature (25oC and 37oC), and pigment production are 
examined. Moreover, the addition of specific growth inhibitors as para-nitrobenzoic 
acid (PNB) is used for the differentiation of NTM as a group because it inhibits only 
species belonging to the M. tuberculosis complex (Tsukamura 1984, Kent and 
Kubica 1985, Leão, Martin et al. 2004). For the final identification, other methods are 
employed, especially molecular tests. 
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3.2 Mycolic acid analysis 
 
Another phenotypic characteristic that is used for mycobacteria identification is 
the mycolic acid pattern that can be determined using High-Performance Liquid 
Chromatography (HPLC) (Tortoli and Bartoloni 1996). 
HPLC analysis is based on the fact that mycobacterial cell wall mycolic acids 
differ in the number of carbon atoms, ranging from 60 to 90, and in the presence of 
different functional groups. Therefore, according to the polarity and carbon chain 
length, the mycolic acids are separated and a HPLC pattern is generated. Then 
several characteristics are analyzed such as number, position, and height of peaks, 
which are useful for differentiate species of mycobacteria (Tortoli 2003). 
The advantages of mycolic acid analysis are that it is rapid, not expensive and 
can identify several species and reveal unknown species (Tortoli, Bartoloni et al. 
2001, Leão, Martin et al. 2004). Although its performance is more rapid than 
conventional biochemical tests, HPLC also requires initial culture of isolates on solid 
medium delaying the species identification and consequently the initiation of an 
efficient antimicrobial therapy. In addition, it has been shown that HPLC is 
inadequate to differentiate between closely related species such as some members 
of M. chelonae-M. abscessus, M. avium and Mycobacterium mucogenicum 
complexes (Griffith, Aksamit et al. 2007, Adekambi 2009, Koh, Jeong et al. 2012, van 
Ingen 2013). 
 
3.3 Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass 
Spectrometry (MALDI-TOF MS) 
 
In recent years, microbiology laboratories are using Matrix-Assisted Laser 
Desorption/Ionization Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) for 
bacterial identification from culture and directly from clinical samples. Proteins, 
mainly represented by ribosomal proteins, are extracted and mixed with an organic 
matrix solution that enables protein ionization. The ionized proteins are subsequently 
separated based on their mass/charge ratio producing a spectrum named Peptide 
Mass Fingerprint (PMF). As PMF is, in general, unique for a particular 
microorganism, the PMF pattern of an unknown isolate can be compared with 
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patterns deposited in databases to define its identification (Singhal, Kumar et al. 
2015). Commercial MALDI-TOF MS systems with PMF patterns database are 
available, as MALDI BioTyper (Bruker Daltonics, Germany) and VITEK MS RUO 
(Research Use Only, bioMérieux, France) (Welker 2011, DeMarco and Ford 2013). 
 Studies have shown that MALDI-TOF MS is a rapid, accurate and reliable 
methodology for identification of medically important bacteria (Seng, Drancourt et al. 
2009, Bizzini, Durussel et al. 2010, Benagli, Rossi et al. 2011, Neville, Lecordier et al. 
2011). For mycobacteria identification, some studies have shown that MALDI-TOF 
MS correctly identified >90% of isolates recovered from solid medium (Pignone, 
Greth et al. 2006, Lotz, Ferroni et al. 2010, El Khechine, Couderc et al. 2011, Saleeb, 
Drake et al. 2011). However, for correct species identification these studies needed 
to build their own reference libraries or to complement the available commercial 
databases by addition of PMF patterns of reference strains. Moreover, several 
challenges have been faced to achieve reliable identification rates. For safety 
reasons, mycobacteria need to be inactivated; moreover, cell wall lysis protocols 
used for other microorganisms are inadequate to lyse the complex mycobacteria cell 
wall structure. Therefore, in these studies different protocols available for inactivation 
and cell lysis were tested or a particular protocol was developed. The use of different 
protocols could lead to differences in protein extraction efficiency and consequently 
in the generated PMF patterns, what could be a problem when using the available 
commercial databases. 
 Furthermore, important differences in accuracy and identification rates were 
reported with NTM isolates recovered from solid or liquid medium. Buchan et al. 
showed best results in identification when mycobacteria were analyzed directly from 
liquid culture; while Lotz et al. showed higher performance when isolates were 
analyzed directly from solid culture (Lotz, Ferroni et al. 2010, Buchan, Riebe et al. 
2014). Recently, van Eck et al. showed low percentage in NTM identification when 
using isolates directly from liquid cultures of respiratory samples; a subculture on 
solid medium was required to obtain good quality identification results (van Eck, Faro 
et al. 2016). 
 Therefore, the lack of well standardized protocols for mycobacteria inactivation 
and protein extraction, the necessity to build new database and differences in the 
quality of identification when mycobacteria are analyzed from liquid or solid cultures 
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hinder MALDI-TOF MS implementation in clinical settings as a routine mycobacteria 
identification method. 
 
3.4 Genotypic Methods 
 
To meet the necessity of more rapid and accurate mycobacteria identification 
at species level, several molecular assays have been developed and introduced in 
clinical mycobacteriology laboratories. These assays are rapid and offer high 
sensitivities and specificities, especially when using DNA from mycobacterial culture 
(Tortoli 2003).  
In general, they are based on the detection of highly conserved regions within 
the genome that harbor hypervariable sequences in which species-specific deletions, 
insertions, or single nucleotide polymorphisms are present (Leão, Martin et al. 2004). 
DNA sequencing and Polymerase Chain Reaction Restriction Enzyme Analysis 
(PRA), as well DNA strip assays are among the genotypic methods currently used for 
mycobacteria identification. 
 
3.4.1 DNA Sequencing  
 
Advances in molecular sequencing of the conserved genes 16S rRNA, rpoB, 
and hsp65 and the 16S-23S ITS enabled faster NTM species identification at species 
level. The widespread use of these methodologies led to the discovery of new 
species and the taxonomic reclassification of others. As a consequence the number 
of NTM species officially accepted increased (Joao, Cristovao et al. 2014). Moreover, 
these methods facilitate comparisons of identification between different laboratories 
since they allow public database construction (Devulder, Perouse de Montclos et al. 
2005). 
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3.4.1.1 16S rRNA 
 
The 16S rRNA gene has about 1,500 nucleotides in length. It is universally 
used for bacterial species identification since it has hypervariable regions that allow 
discrimination of many species but often lacks resolution to distinguish closely related 
species. These regions have high variability between species but relatively low 
variability within species (Tortoli 2003, Leão, Martin et al. 2004). For mycobacterial 
species identification, the sequencing of an initial region is generally sufficient. It 
corresponds to positions 130 to 210 in the Escherichia coli 16S rRNA gene (Tortoli 
2003).  
Today, the 98.65% is used as a threshold as determined by Kim et al. (Kim, 
Oh et al. 2014). In spite of this, the restriction known for many years is still valid: 
organisms that differ more than this threshold value generally represent different 
species but organisms that differ less than 1.35% in their full 16S rRNA gene 
sequences may or may not belong to a single species.  
The 16S rRNA molecule simply lacks resolution to distinguish among such 
closely related species due to little variations in their sequences, such as the 
following closely related NTM species: M. abscessus and M. chelonae; M. avium and 
Mycobacterium intracellulare; M. peregrinum and Mycobacterium septicum; M. 
kansasii and Mycobacterium gastri; Mycobacterium marinum and Mycobacterium 
ulcerans; Mycobacterium houstonense and Mycobacterium senegalense (Rogall, 
Wolters et al. 1990, Adekambi, Colson et al. 2003, Adekambi and Drancourt 2004b, 
Joao, Cristovao et al. 2014). 
Although rare, the presence of two different copies of 16S rRNA in the same 
microorganism represents another limitation of its use for taxonomic purposes. In 
Mycobacterium genus, RGM have two copies of 16S rRNA, except M. chelonae and 
M. abscessus (Tortoli 2003). Different 16S rRNA sequences in the same 
mycobacterium were identified in the Mycobacterium terrae and Mycobacterium 
celatum complexes (Ninet, Monod et al. 1996, Reischl, Feldmann et al. 1998).  
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3.4.1.2 rpoB 
 
rpoB is a single-copy gene that encodes the β-subunit of RNA polymerase 
responsible for the enzyme catalytic function (Adekambi, Colson et al. 2003). Since 
rpoB sequences of most clinically important species are available in public 
databases, this gene is considered a reasonable first approach for NTM isolated from 
clinical samples (de Zwaan, van Ingen et al. 2014). 
Five variable regions of 420 to 780 bp length were identified in rpoB 
sequences of RGM, which have >5% mean variability. The hypervariable region that 
extends from position 2581 to 3300 of the M. tuberculosis gene was identified as the 
most suitable for identification of RGM at the species and subspecies levels 
(Adekambi, Colson et al. 2003). This region was named region V and it has been 
widely used for RGM identification as well in taxonomic studies (Adekambi and 
Drancourt 2004b, Adekambi, Berger et al. 2006, Whipps, Butler et al. 2007, Tortoli 
2009). 
Nevertheless some pitfalls in the use of rpoB gene for taxonomic purposes 
have been identified. The intraspecies degree of rpoB sequence similarity was 
estimated to range from 98.2 to 100% (Adekambi, Shinnick et al. 2008). However, 
high internal variability was detected within some members of the M. abscessus-M. 
chelonae complex, which represents a challenge in species identification. (Adekambi, 
Colson et al. 2003) showed that M. abscessus isolates have >4.3% sequence 
divergence in region V of the rpoB gene.  
Another limitation of the rpoB gene is the occurrence of horizontal transfer 
between bacterial isolates as was for example demonstrated between M. abscessus 
isolates. Therefore its use as a single approach for NTM identification can be a pitfall 
(Macheras, Roux et al. 2011). 
 
3.4.1.3 16S-23S Internal Transcribed Spacer (ITS)  
 
The ITS between the 16S rRNA and 23S rRNA genes is more variable than 
the 16S rRNA gene and it is species specific in several bacteria (Park, Jang et al. 
2000). Because of the high level of ITS sequence variation and the good 
reproducibility, it is considered a suitable target for differentiating clinically relevant 
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mycobacterial species (Lappayawichit, Rienthong et al. 1996, Park, Jang et al. 2000). 
The only mycobacterial species that have identical ITS sequences are the members 
of the M. tuberculosis complex (Frothingham, Hills et al. 1994).  
In the Mycobacterium genus the ITS sequences length varies among the 
species, but in general it has 270 to 360 bp (Roth, Reischl et al. 2000). It has several 
polymorphic regions and only two conserved regions. Since the two conserved 
regions are near to each other, primers could be designed and the hypervariable 
region between them amplified. The size of this amplified region is variable. In 
general, the ITS sequences length of RGM are 75 nucleotides longer than those of 
SGM (Park, Jang et al. 2000).  
Unfortunately some drawbacks have been identified in the use of ITS for 
taxonomic purposes. It failed to discriminate some closely related species such as M. 
marinum and M. ulcerans. Furthermore, the analysis of RGM ITS can be doubtful 
since the majority of these species have multiple rRNA operons and interoperon 
heterogeneities can occur (Roth, Fischer et al. 1998). 
 
3.4.1.4 hsp65 
 
The 65-kDa heat-shock protein (hsp65) gene is highly conserved in the 
Mycobacterium genus. Nucleotide positions 624 to 664 and 683 to 725 of the M. 
tuberculosis gene are hypervariable regions, which are useful for identification 
purposes (Tortoli 2003). A 441-bp fragment of the hsp65 gene, known as the 
Telenti's fragment, is the most used for mycobacteria identification (Telenti, Marchesi 
et al. 1993).  
The hsp65 gene sequencing shows several advantages over other genes. 
Since it is present only in a single copy gene, there is no possibility of different 
nucleotide sequences in the same isolate, as observed with the 16S rRNA gene and 
the 16S-23S ITS. Another advantage of the hsp65 gene is the ability to differentiate 
between closely related species, such as M. abscessus and M. chelonae, 
Mycobacterium szulgai and Mycobacterium malmoense; M. kansasii and M. gastri 
(Joao, Cristovao et al. 2014). 
Despite these advantages, some pitfalls of hsp65 gene have been identified. 
Since intraspecies similarity is relatively high, from 98 to 100 %, a 97% identity cut-off 
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was recommended. However divergences of 4% were detected in some species 
such as in Mycobacterium gordonae. Therefore a cut-off of 96% associated with 
results of PCR-Restriction Enzyme Analysis (PRA-hsp65) was suggested for 
accurate species identification (McNabb, Eisler et al. 2004, Joao, Cristovao et al. 
2014). 
 
3.4.1.5 Multilocus Sequence Analysis (MLSA)  
 
The disadvantages of DNA sequencing of 16S rRNA, rpoB, hsp65 and ITS 
sequences in identifying mycobacteria led to analyses of other loci, including gyrB, 
dnaJ1, recA, sodA, secA1, tuf, ssrA, smpB, and the 32-kDa protein gene (Soini, 
Bottger et al. 1994, Zolg and Philippi-Schulz 1994, Blackwood, He et al. 2000, Kasai, 
Ezaki et al. 2000, Zelazny, Calhoun et al. 2005, Mignard and Flandrois 2007, 
Yamada-Noda, Ohkusu et al. 2007, Mignard and Flandrois 2008). However, some 
drawbacks were also identified in these loci. Some of them are not detected in all 
mycobacterial species and others have low discriminatory power and do not 
discriminate closely related species (Dai, Chen et al. 2011).  
Over the last decades it has been observed that the use of a single gene is 
not enough to discriminate mycobacterial species. Therefore with the report of the ad 
hoc committee for the re-evaluation of the species definition in bacteriology a new 
phylogenetic approach emerged, the Multilocus Sequence Analysis (MLSA) 
(Stackebrandt, Frederiksen et al. 2002). 
MLSA uses several sequences of housekeeping genes. In general, six to eight 
genes present in all studied taxon as a single copy and not subject to selective 
pressure are selected for MLSA analysis. The sequences of all selected genes are 
concatenated and then used to assess clustering patterns, to explore the 
relationships among strains within a genus and to assign unknown strains to species 
clusters (Macheras, Roux et al. 2011).  
This technique increases the discriminatory power of species identification 
since the low discriminatory power of individual genes for particular species groups is 
compensated by others. For example, although M. chelonae and M. abscessus have 
the same 16S rRNA gene sequence, hsp65 is useful to discriminate them. Similarly, 
M. senegalense and Mycobacterium farcinogenes have indistinguishable hsp65 
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sequences, but they have distinct 16S rRNA gene sequences (Devulder, Perouse de 
Montclos et al. 2005). 
Several studies have been using the MLSA approach to identify mycobacteria 
at species level (Devulder, Perouse de Montclos et al. 2005, Mignard and Flandrois 
2008, Dai, Chen et al. 2011, Macheras, Roux et al. 2011, Castillo-Rodal, Mazari-
Hiriart et al. 2012, Hashemi-Shahraki, Bostanabad et al. 2013). However, there is no 
well-defined scheme of MLSA and the selected housekeeping genes vary throughout 
the studies. Moreover, the value of this approach needs to be evaluated in clinical 
settings as a routine mycobacteria identification method. 
 
3.4.2 PCR (Polymerase Chain Reaction) – Restriction Enzyme Analysis 
(PRA) 
 
The PRA methodology is based on the amplification of a conserved region, 
which is subsequently subjected to restriction enzyme analysis. An isolate can be 
identified comparing its restriction fragment pattern with those generated by known 
species.  
PRA was developed to target genes that are present in all mycobacteria, such 
as hsp65 gene (Telenti, Marchesi et al. 1993) and the ITS fragment (Roth, Reischl et 
al. 2000). For PRA-hsp65, the 441-bp Telenti's fragment is amplified and the 
amplicons are digested using BstEII and HaeIII restriction enzymes. For PRA-ITS, 
the ITS fragment is amplified and amplicons are digested with HaeIII, CfoI, TaqI, 
MspI, DdeI, or AvaII restriction enzymes. The use of TaqI is enough for M. chelonae 
and M. abscessus identification. The digestion products of both PRA-hsp65 and 
PRA-ITS are visualized after electrophoresis in agarose gels and compared to the 
patterns included in the PRASITE (http://app.chuv.ch/prasite/index.html) for PRA-
hsp65 and published by Roth et al. (2000) for PRA-ITS. 
Species with overlapping patterns and multiple patterns within a single species 
have been described and species identification may be ambiguous or erroneous. 
However, the PRA method is rapid and easy to perform. Moreover the availability of 
restriction patterns of most clinically relevant mycobacteria species has led to its use 
as the main molecular method for mycobacteria species identification in reference 
laboratories of low-income countries, such as Brazil (da Silva Rocha, da Costa Leite 
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et al. 1999, Leao, Bernardelli et al. 2005, Martin, Uwizeye et al. 2007, Chimara, 
Ferrazoli et al. 2008). 
 
3.4.3 DNA strip assays 
 
Over the last years, commercial DNA strip assays based on reverse 
hybridization have been developed for the identiﬁcation of mycobacteria to the 
species level, such as the INNO-LiPA® (Innogenetics, Belgium) and GenoType® 
Mycobacterium assays (Hain, LifeScience, Germany). In these assays a PCR 
product is hybridized to oligonucleotide probes specific for different mycobacterial 
species that are immobilized in a nitrocellulose strip. The hybridization pattern of the 
isolates are then compared with those specified by the manufacturer. 
 
3.4.3.1 INNO-LiPA® 
 
The INNO-LiPA® MYCOBACTERIA (Innogenetics, Ghent, Belgium) was the 
first commercial DNA probe assay available for identification of the most frequently 
isolated species of mycobacteria (Tortoli, Mariottini et al. 2003). 
This assay was developed in the Institute of Medicine Tropical Prince Leopold, 
Belgium. Based on the ITS sequence heterogeneity, DNA probes specific for the 
clinically important mycobacterial species were selected, and a reverse hybridization 
LiPA (Line Probe Assay) was developed (Portaels, Rigouts et al. 1998). After 
amplification of the ITS fragment, the biotinylated amplified DNA product is 
hybridized with specific probes immobilized on membrane strips (Lebrun, Weill et al. 
2005). 
The second commercial version of this test contains 23 probes that react 
specifically with M. tuberculosis complex (MTB probe), M. kansasii (MKA-1, MKA-2, 
MKA-3), Mycobacterium xenopi (MXE), M. gordonae (MGO), Mycobacterium 
genevense (MGV), Mycobacterium simiae (MSI), M. marinum-M. ulcerans (MMU), 
Mycobacterium celatum (MCE), M. avium (MAV), M. intracellulare (MIN-1, MIN-2), 
Mycobacterium scrofulaceum (MSC), M malmoense (MML), M haemophilum (MHP), 
M. chelonae (MCH-1, MCH-2, MCH-3), M. fortuitum (MFO), and M. smegmatis 
(MSM). One probe is specific for the Mycobacterium genus (MYC) and one for the 
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MAIS complex (reacting with M avium, M. intracellulare, M. scrofulaceum and M. 
avium complex) (Figure 3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Strip design of INNO-LiPA
®
 
MYCOBACTERIA (Innogenetics, Ghent, Belgium) 
 
In this assay, isolates of the M. chelonae-M. abscessus complex are 
subdivided into four genotypic clusters (CHI, CHII, CHIII and CHIV) showing the 
genetic heterogeneity within these taxa. The cluster CHIII is characterized by the 
hybridization with probes MCH-1 and MCH-2, the cluster CHI with the probes MCH-1 
and MCH-3, and the cluster CHII/IV with the probe MCH-1. During the INNO-LiPA® 
development, distinct features of each genotypic cluster were observed. Cluster CHI 
isolates showed no clinical importance and were considered to be contaminants from 
fibroscopes, whereas CHIII isolates were clinically significant and encompassed the 
specie M. abscessus (Portaels, Rigouts et al. 1998, Suffys, da Silva Rocha et al. 
2001, Mijs, De Vreese et al. 2002). Strains of clusters CHII and CHIV were isolated 
from the environment; however they were also considered clinically significant 
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because some strains caused disease in immunocompromised patients or after 
dialysis or injection (Portaels, Rigouts et al. 1998). 
 Tortoli et al. evaluated this assay and reported that its sensitivity and 
specificity was 100% and 94.4%, respectively (Tortoli, Mariottini et al. 2003). 
However, the probes specific for M. fortuitum (MFO), MAIS complex (MAIS) and M. 
intracellulare (MIN-2) showed cross-reaction with several mycobacteria rarely 
isolated from clinical specimens. Moreover, Lebrun et al. reported that several 
isolates belonging to the MAIS group hybridized only with the complex-specific MAIS 
probe but not with the specific probes for the complex members (Lebrun, Weill et al. 
2005). 
 
3.4.3.2 Genotype® Mycobacterium assays 
 
The Genotype® Mycobacterium (Hain, LifeScience, Germany) is another 
available commercial test for mycobacteria identification. There are three different 
versions of Genotype: the GenoType MTBC for the differentiation of the six species 
of the M. tuberculosis Complex; the GenoType Mycobacterium CM (common 
mycobacteria) for the identification of M. tuberculosis Complex plus 13 of the most 
common NTM species; and the GenoType Mycobacterium AS (additional species), 
for the identification of 16 additional NTM species. Thus, the combined use of CM 
and AS can distinguish almost 30 different NTM (Figures 3.2 and 3.3) (Richter, 
Rusch-Gerdes et al. 2006, Russo, Tortoli et al. 2006, Neonakis, Gitti et al. 2008). The 
target of both AS and CM is the 23S rDNA and therefore only one PCR is needed to 
perform these assays (Neonakis, Gitti et al. 2008). 
Richter et al. found 92.6% and 89.9% concordant results of the CM and AS 
assays respectively, compared to DNA sequencing (Richter, Rusch-Gerdes et al. 
2006). According to Russo et al., the sensitivity and specificity of both Genotype® CM 
and AS are very high (97.9% and 92.4% for CM and 99.3% and 99.4% for AS, 
respectively) (Russo, Tortoli et al. 2006).  
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Figure 3.2. Strip design of GenoType
® 
Mycobacterium CM (Hain, Nehren, Germany) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Strip design of GenoType
®
 Mycobacterium AS (Hain, 
Nehren, Germany) 
 
The manufacturer declared seven and two ambiguous patterns on the CM and 
AS strip, respectively. However, the following species were also reported as 
undistinguishable by GenoType®: Mycobacterium parascrofulaceum from M. 
scrofulaceum; Mycobacterium chimaera and several intermediate MAC spp. from M. 
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intracellulare; M. farcinogenes, Mycobacterium porcinum, and M. senegalense from 
M. fortuitum. These overlapping patterns is indeed a disadvantage, however most of 
them are rarely isolated from clinical samples (Russo, Tortoli et al. 2006). 
Therefore, GenoType® is a reliable and suitable assay to identify the most 
frequently encountered species of mycobacteria. Moreover, it is rapid, easy-to-
perform and easy-to-interpret. Its implementation in clinical laboratories reduces the 
number of strains to be identified by mycobacteria reference centers (Richter, Rusch-
Gerdes et al. 2006, Russo, Tortoli et al. 2006, Neonakis, Gitti et al. 2008). 
Nowadays GenoType® is widely used in clinical laboratories for detection and 
identification of NTM in European countries. Because of its limitations, if necessary 
the results can be complemented by 16S rRNA and/or hsp65 gene sequencing (van 
der Werf, Kodmon et al. 2014). However, because of their high cost, DNA probe 
assays and DNA sequencing are not used in clinical laboratories of low-resource 
countries, such as Brazil. NTM identification in Brazil is still based on some 
phenotypic tests and PRA-hsp65 (Chimara, Ferrazoli et al. 2008, Wildner, Bazzo et 
al. 2014). 
 
4 Drug Susceptibility Testing (DST) for Mycobacteria  
 
Mycobacteria show variable drug susceptibility profiles between different 
species and also within species. The performance of DST in all NTM isolates 
recovered from clinical samples is essential for good patient management (Griffith, 
Aksamit et al. 2007).  
The Clinical and Laboratory Standards Institute (CLSI) has standardized 
procedures for DST performance, including breakpoints for the antimicrobials used 
for treatment of NTM infections. The antimicrobials tested differ between RGM and 
SGM. Table 4.1 shows the antimicrobials that should be evaluated for RGM and their 
respective breakpoints. 
CLSI currently recommends Mueller-Hinton broth microdilution method as the 
gold standard for determining the Minimum Inhibitory Concentration (MIC) of NTM 
(CLSI 2011). Several laboratories performed it as in-house assays. However, 
Sensititre™ (Trek Diagnostics, CA, USA), a commercial assay, is also available (van 
Ingen and Kuijper 2014). 
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The broth microdilution method is generally performed in a 96-well plate and 
small volumes of broth with a standardized inoculums are inoculated in each well. 
The bacteria growth is measured and compared with growth in drug-free control 
wells. This allows the determination of the minimal concentration of the drug that 
inhibits the mycobacterial growth (van Ingen and Kuijper 2014).  
 
Table 4.1. Broth Microdilution interpretive criteria for RGM (CLSI, 2011) 
Agent 
MIC (µg/mL) for category 
Susceptible Intermediate Resistant 
Amikacin (AMK) ≤16 32 ≥64 
Cefoxitin (FOX) ≤16 32-64 ≥128 
Ciprofloxacin (CIP) ≤1 2 ≥4 
Clarithromycin (CLA) ≤2 4 ≥8 
Doxycycline (DXT) ≤1 2-4 ≥8 
Minocycline (MIN) ≤1 2-4 ≥8 
Imipenem ≤4 8-16 ≥32 
Linezolid ≤8 16 ≥32 
Meropenem ≤4 8-16 ≥32 
Moxifloxacin (MF) ≤1 2 ≥4 
Tobramycin (TOB) ≤2 4 ≥8 
 
 
This technique is easy and reliable; however, some difficulties have been 
reported, especially with RGM (Broda, Jebbari et al. 2013). In general, the RGM 
growth in liquid medium form large clumps making the MIC determination by visual 
turbidity really difficult and subjective. Therefore, the addition of a redox indicator, 
resazurin, to the broth medium has been proposed (Ramis, Cnockaert et al. 2015). 
Resazurin is a blue non-fluorescent and non-toxic dye used for the evaluation of cell 
metabolism since viable cells reduce it into resorufin, which is pink and fluorescent. 
MIC is defined as the lowest concentration of the drug that prevents the bacterial 
growth represented by a change in color from blue to pink. Ramis et al. showed that 
resazurin improves the end-point readability of the broth microdilution method and 
decreases the incubation time from 5 to 3 days shortening the time for results 
(Ramis, Cnockaert et al. 2015).  
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5 Description of new species 
 
For several years species of mycobacteria were established according to their 
phenotypical characteristics only (Butler and Guthertz 2001, Tortoli, Bartoloni et al. 
2001). Because it usually leads to the use of the best fit criterion, NTM species were 
frequently missassigned and new species were infrequently described (Tortoli, 
Bartoloni et al. 2001). However, the development of highly discriminatory 
methodologies, such as HPLC of mycolic acids and DNA sequencing has greatly 
increased the description of new mycobacterial species. A not registered mycolic 
acid profile and/or a new DNA sequence highlights the possibility of the existence of 
a new species (Tortoli, Bartoloni et al. 2001, Tortoli 2006). 
For the description of a new species it is necessary to follow minimal 
standards used to determine whether it fulfills the requirements to be assigned to a 
novel taxon (Ramasamy, Mishra et al. 2014).  
The names of new species are considered valid only after publication in the 
“International Journal of Systematic and Evolutionary Microbiology” (IJSEM), novel 
prokaryotic taxa official journal. Moreover, before publication of the new species 
name, a viable culture of the type strain must be deposited in at least two culture 
collections (Tindall, Rossello-Mora et al. 2010). 
Furthermore, for a new species be officially accepted it is necessary to prove 
that it has not already been described, and that it is distinct from officialy accepted 
species by performing several methodologies. Moreover, these methodologies 
should provide the general characteristics of the new species enabling its 
classifications and identifications (Moore, Mihaylova et al. 2010).  
 
5.1 Polyphasic approach 
 
Prokaryote taxonomists agree that a reliable classification is achieved only 
when several phenotypic and genomic characteristics are examined. This approach 
is known as “polyphasic approach” and it is crucial for the delineation of new 
prokaryotic species. However, as many criteria used were selected empirically, the 
validity of polyphasic approach is being questioned. Moreover the methodologies 
used are labor intensive, money consuming, are not accessible to all laboratories and 
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lack reproducibility (Vandamme, Pot et al. 1996, Rossello-Mora and Amann 2001, 
Ramasamy, Mishra et al. 2014). 
 
5.1.1 Phenotypic methods 
 
In general, phenotypic analyses provide descriptive information that can be 
useful for the new taxa recognition (Vandamme, Pot et al. 1996). They include a 
broad range of methodologies that provide the main morphological, physiological and 
biochemical characteristics of an organism (Prakash, Verma et al. 2007). 
Chemotaxonomic techniques such as the pattern of cell wall lipids are also included 
(Vandamme, Pot et al. 1996, Moore, Mihaylova et al. 2010). As a general 
recommendation, type strains of the most closely related species should be included 
in all methodologies performed instead of using data from previously studies (Tindall, 
Rossello-Mora et al. 2010).  
Although the methodologies seem to be simple, the performance of 
phenotypic tests is a really tedious task. They are time consuming, lack 
reproducibility and require skill and experience to avoid erroneous observations 
(Rossello-Mora and Amann 2001, Prakash, Verma et al. 2007). Moreover, an 
organism can present distinct phenotypic traits according to the environmental 
conditions and different organisms can present overlapping phenotypic 
characteristics (Prakash, Verma et al. 2007). 
 
5.1.2 Genotypic methods 
 
Nowadays, the taxonomists agree that all taxonomic information about an 
organism is incorporated in its genome (Stackebrandt, Frederiksen et al. 2002). 
Moreover, bacteria are accurately classified when using genome comparisons 
(Rossello-Mora and Amann 2001).Therefore several genotypic methodologies have 
been widely used in bacterial taxonomy.  
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5.1.2.1 DNA G+C content 
 
The genomic DNA G+C content, defined as the proportion of cytosines and 
guanines within the overall number of nucleotides in the genome, is one of the 
classical genotypic methods used in the bacterial taxonomy. In a well-defined 
species, the variability in G+C content percent is below 3% while in a well-defined 
genus is below 10% (Prakash, Verma et al. 2007).  
Until a few years ago, the methods of choice for determining the G+C content 
were those HPLC-based that allowed direct measurement of the base composition 
(Mesbah and Whitman 1989, Tindall, Rossello-Mora et al. 2010). Nowadays, it is 
more often calculated through WGS (Meier-Kolthoff, Klenk et al. 2014). 
 
5.1.2.2 DNA–DNA Hybridization (DDH) 
 
Since DNA G+C content allows only superficial comparisons, a much more 
accurate method was required. Thus, DDH methodologies were developed 
(Rossello-Mora and Amann 2001). They have been used since the 1960s and are 
still an important criterion in bacterial species delineation (Goris, Konstantinidis et al. 
2007, Ramasamy, Mishra et al. 2014). 
A characteristic property of DNA is its ability of hybridization. Denatured 
strands of DNA can re-associate reforming native duplex structures. Similarly, DNAs 
from two distinct organisms can re-associate under standardized conditions. The 
quantification of the relatedness degree between two organisms can be calculated on 
the basis of nucleotide sequences identity (Rossello-Mora and Amann 2001). For 
species delineation, a cutoff of 70% was proposed by Wayne et al. (1987) (Wayne*, 
Brenner et al. 1987). However it is not applicable to all prokaryotic organisms (Goris, 
Konstantinidis et al. 2007, Ramasamy, Mishra et al. 2014)  
DDH can be performed using several distinct techniques, however the 
methods of choice are those that don´t require radioactive substances for DNA 
labeling (Tindall, Rossello-Mora et al. 2010). Ezaki et al. developed a fluorometric 
hybridization assay using DNA labeled with photobiotine, a nonradioactive material 
(Ezaki, Hashimoto et al. 1989). With this methodology, the biotinylated DNA is 
hybridized with single-stranded unlabeled DNA, which is immobilized on microdilution 
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plates. After hybridization, the biotinylated DNA is quantitatively detected with 
streptavidin-conjugated beta-D-galactosidase and a fluorogenic substrate, 4-
methylumbelliferyl-betaD-galactopyranoside allowing the determination of the genetic 
relatedness between two different isolates. 
Considerable amounts of high quality DNA are required in all DDH classical 
techniques, making the whole process time-consuming and labour-intensive 
(Vandamme, Pot et al. 1996, Goris, Konstantinidis et al. 2007). Moreover, since the 
comparative nature of the DDH technique, no cumulative databases could be built 
and single strains could not be analyzed (Gevers, Cohan et al. 2005). Therefore, 
alternative methods have been searched in order to replace the DDH experiments 
(Goris, Konstantinidis et al. 2007). 
 
5.1.2.3 DNA sequencing 
 
DNA sequencing has subsequently become the best option among prokaryotic 
taxonomists for species delimitation and identification purposes. Public database 
were constructed, from which sequences can be retrieved and compared with 
sequences of unknown isolates. As a consequence, the bacterial phylogenetic 
relationships have become easier, faster and more accurate than previously (Richter 
and Rossello-Mora 2009, Moore, Mihaylova et al. 2010). 
The first gene widely used was the 16S rRNA since it is ubiquitously present in 
all prokaryotes, highly conserved, stable and generally not involved in horizontal 
gene transfer (Ramasamy, Mishra et al. 2014). A cut-off of 97% is often used to 
classify bacterial isolates as new species, when compared with species officially 
accepted. Moreover, it was proposed that the 16S rRNA gene sequence identity 
could even replace DDH (Stackebrandt and Goebel 1994, Stackebrandt, Frederiksen 
et al. 2002, Stackebrandt and Ebers 2006). 
However, as more sequences were analyzed over the years, several 
limitations of 16S rRNA as a taxonomic marker were identified, such as its high 
degree of conservation in some genera, especially in those with closely related 
organisms, and nucleotides sequence variations in a single organism when multiple 
rRNA operons are present (Rossello-Mora and Amann 2001, Ramasamy, Mishra et 
al. 2014). 
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Therefore it was recommended subsequently that the combination of 16S 
rRNA gene sequencing and DDH should be used for description of new bacterial 
species. The performance of DDH is crucial when two isolates have 16S rRNA gene 
sequence identities above 97% (Tindall, Rossello-Mora et al. 2010). 
Because the ad hoc committee recommended the evaluation and application 
of protein-coding gene sequence analysis to ‘genomically circumscribe the taxon 
species and differentiate it from neighbouring species’, the MLSA has become a 
more and more common method in taxonomic studies (Stackebrandt, Frederiksen et 
al. 2002, Gevers, Cohan et al. 2005). However, the MLSA scheme must be validated 
based on DDH data and both MLSA and DDH results should corroborated (Tindall, 
Rossello-Mora et al. 2010).  
 
5.1.2.4 Whole Genome Sequencing (WGS) 
 
With the introduction of Next-Generation Sequencing (NGS) technology, 
prokaryotic whole genomes comparison for taxonomic purposes is becoming a reality 
(Moore, Mihaylova et al. 2010). 
The first NGS platform that was widely used was the Roche 454, which was 
based on pyrosequencing. Another NGS platform, originally developed by Solexa, is 
Illumina technology, which is based on bridge-amplification. Illumina is provided as 
different instruments including HiSeq and its lower-throughput called MiSeq 
(Margulies, Egholm et al. 2005, Bentley 2006). 
Since WGS is now fairly accessible, it has been suggested that relatedness 
indices derived from computational comparison of two genome sequences should 
replace DDH for taxonomic purposes (Konstantinidis and Tiedje 2005) Among 
available computational genome relatedness indices, Average Nucleotide Identity 
(ANI), Genome Blast Distance Phylogeny (GBDP), and Tetranucleotide frequency 
correlation coefficients (TETRA) are the most used. 
ANI is a mean of identity values of all shared orthologous protein coding 
genes between the two genomes that are being compared. Konstantinidis and Tiedje 
showed that ANI is a robust measure since it has shown a good correlation with DDH 
(Konstantinidis and Tiedje 2005). Subsequently, Goris et al. refined the ANI 
calculation (Goris, Konstantinidis et al. 2007). The step of DNA fragmentation in DDH 
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experiments was computationally simulated by cutting the query genome into 
fragments of 1020 bp length. Currently, ANI is calculated as a mean identity of all 
BLASTN matches with at least 30% identity between the two compared genomes. 
This method is known as ANIb. In 2009, Richter and Rossello-Mora developed the 
MUMmer software to calculated ANI, which was named ANIm (Richter and Rossello-
Mora 2009). This software allows the comparison of large DNA sequences without 
cutting the query genome. As a consequence it renders faster results than ANIb. 
In comparative studies, ANI values between 95%–96% were equivalent to the 
70% DDH threshold (Goris, Konstantinidis et al. 2007, Richter and Rossello-Mora 
2009). Kim et al. confirmed this ANI threshold investigating the ANI values among 
over six thousand prokaryotic genomes (Kim, Oh et al. 2014). They also 
demonstrated that this ANI threshold corresponds to 98.65% 16S rRNA sequence 
identity. Both ANIb and ANIm render very similar results especially when ANI value is 
above 90% (Richter and Rossello-Mora 2009). 
Another strategy named GBDP was introduced as an in silico replacement for 
DDH experiments. It calculates pairwise intergenomic distances based on the results 
of a genome-wide homology search using BLASTN and produces a phylogenetic tree 
(Henz, Huson et al. 2005). It provides a quick and reliable alternative to the wet-lab 
DDH technique and its improved DDH prediction capability produces classifications 
which correlate better with the traditional DDH values than do any of the ANI 
implementations (Meier-Kolthoff, Auch et al. 2013). 
In addition to ANI and GBDP, an alignment-free method using Tetranucleotide 
frequency correlation coefficients (TETRA) was developed. Since there are four 
types of bases in DNA (A, T, C and G) 256 combinations of tetranucleotide 
sequences are possible. This method determines the frequency of occurrence of 
each combination in the genome. In a pairwise comparison, the tetranucleotide 
frequencies of each genome are plotted, a regression line is obtained and the 
RSquare value is calculated. It is expected that closely related genomes present high 
correlation values (RSquare close to 1) since they have similar tetranucleotide 
frequencies. It was demonstrated that the 95–96% ANI threshold corresponds to 
TETRA correlation coefficient values above 0.99 (Richter and Rossello-Mora 2009).  
TETRA analysis has been reported to be more reliable than the G+C content 
as a measure of sequence relatedness. Takahashi et al. showed that TETRA is 
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useful for bacterial classification and for phylogenetic relationships estimation among 
closely related species (Takahashi, Kryukov et al. 2009). Furthermore, since TETRA 
is an alignment-free method, it can be applied on draft genomes (Ngeow, Wong et al. 
2015). In addition, due to the speed of computation analysis, TETRA allows 
comparisons among high number of genomes (Richter and Rossello-Mora 2009). 
 
5.2 Minimal standards for assignment new species to the Mycobacterium 
genus 
 
According to Recommendation 30b of the International Code of Nomenclature 
of Bacteria, the analyses should conform at least to the minimal standards (if 
available) established for the taxon studied (Lapage, Sneath et al. 1992).  
In 1992, Levy-Frebault and Portaels proposed that the minimal standards for 
assignment of a strain to the Mycobacterium genus included acid-alcohol fastness, a 
DNA G+C content in the range from 61 to 71 mol%, and mycolic acid detection with 
characterization of C22 to C26 pyrolysis esters (Levy-Frebault and Portaels 1992). 
These authors also proposed the minimal standards for describing new SGM 
species; however, no recommendations were made regarding RGM.  
In order to increase the standardization of methodologies performed for new 
mycobacteria species description, Tortoli reviewed the phenotypic and genotypic 
tests used for the description of both new SGM and RGM species in the 1990s 
(Tortoli 2003). The most common cultural tests included acid-alcohol fastness 
demonstration, growth temperatures, growth rate, pigmentation type, colony 
morphology, plus, for RGM, NaCl tolerance, and MacConkey growth. Arylsulfatase, 
nitrate reduction, Tween 80 hydrolysis, urea hydrolysis, 68°C catalase, and 
semiquantitative catalase were the most used biochemical tests. Moreover, the 
performance of lipid analysis using HPLC or other available techniques is 
recommended since it could be used as an important species identification criterion. 
Moreover, following the detection of the high G+C content, the characterization of the 
mycobacterial genome in comparison with other microorganisms, should be 
investigated in the new species, including 16S rRNA gene sequencing. In spite of its 
limitations (discussed in section 3.3.1.1), the sequencing of 16S rRNA gene is crucial 
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for mycobacteria taxonomic studies because it shows the nearest phylogenetic 
neighbors of the studied isolate (Tortoli, Bartoloni et al. 2001). 
After the publication of Tortoli (2003) no additional studies were performed to 
examine more accurately the minimal standards for mycobacteria species description 
with focus in the era of genomics. Comparing the recent publications of new RGM 
species, it is clear that the genotypic tests have a greater impact on the assignment 
of new species nowadays. The DDH has become less and less popular in recent 
species description. However, the descriptions of all species that were recently 
validly named included DNA sequencing of three or more targets, including 16S 
rRNA, rpoB, hsp65, and ITS. Moreover, the concatenation of these genes has been 
shown to increase the robustness of the phylogenetic tree (Brown-Elliott, Wallace et 
al. 2010, Sahraoui, Ballif et al. 2011, Zhang, Zhang et al. 2012, Guerin-Faublee, 
Flandrois et al. 2013, Shojaei, Daley et al. 2013, Zhang, Chen et al. 2013, Balcazar, 
Planas et al. 2014, Fusco da Costa, Fedrizzi et al. 2015, Kim, Kim et al. 2015, 
Shahraki, Cavusoglu et al. 2015). In 2015, the description of two new mycobacteria 
species included analysis of WGS. The genomes of Mycobacterium paraense nov. 
sp. isolates were compared, showing that they belong to the same species (Fusco da 
Costa, Fedrizzi et al. 2015). ANI values were calculated to compare the genomes of 
Mycobacterium celeriflavum nov. sp. and species showing highly similar 16S rRNA 
gene sequences, to demonstrate that it was a species not yet described (Shahraki, 
Cavusoglu et al. 2015). 
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6 Samples and Isolates 
 
This study included 36 isolates of M. chelonae-M. abscessus complex 
comprising a set of isolates of INNO-LiPA® CHII cluster and a set of isolates that 
failed to match the recognized species patterns.  
The INNO-LiPA® assay was developed in the 1990´s. Type strains and several 
mycobacterial isolates from human, animal and environmental sources were used for 
its development. These isolates were identified to the species level using tests based 
on phenotypic characteristics. A set of 9 probes specific to the M. chelonae-M. 
abscessus complex were developed that enabled the subdivision of the isolates of 
this complex into four clusters (CHI, CHII, CHIII and CHIV) according to their 
hybridization profile. However, the commercial version of this test used only 3 probes, 
MCH-1, MCH-2 and MCH-3. Using these probes, the isolates of cluster CHI were 
characterized by the hybridization with the probes MCH-1 and MCH-3, the cluster 
CHIII with the probes MCH-1 and MCH-2, and the clusters CHII and CHIV only with 
the probe MCH-1. During its development, it was verified that M. abscessus isolates, 
including the type strain ATCC 19977, belonged to cluster CHIII (Portaels, Rigouts et 
al. 1998). Therefore, it was expected that isolates included in the other clusters 
showed phenotypic characteristics consistent with the species M. chelonae, such as 
the incapacity to grow in the presence of 5% Sodium Chloride (NaCl) at 37oC and the 
ability to use citrate as the sole carbon source (Kusunoki and Ezaki 1992). However, 
CHII cluster isolates showed high variability in phenotypic characteristics, suggesting 
the existence of different taxonomic groups among these isolates. Interestingly, some 
CHII strains showed phenotypic characteristics consistent with the species M. 
abscessus. In order to explore the CHII cluster internal variability, a set of CHII 
isolates was kindly provided by Prof. Françoise Portaels including six clinical isolates 
(five from human and one from animal) from the Institute of Tropical Medicine Prince 
Leopold, Antwerp, Belgium and twenty-one environmental isolates recovered by Prof. 
Roland Schulze-Röbbecke at the University of Dusseldorf, Dusseldorf, Germany. 
One representative strain of each INNO-LiPA® cluster of the M. chelonae-M. 
abscessus complex was also provided: 6410 as the representative strain of cluster 
CHI, 96-892 of CHII, 8223 of CHIII and 96-443 of CHIV.  
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Five additional isolates (EPM 10906, EPM 10695, IAL 3785, JAN1 and JAN2) 
that failed to match the recognized species patterns were also included in this study. 
They share indistinguishable PRA-hsp65 patterns – BstEII [bp] (235, 210) and HaeIII 
[bp] (145, 60, 50) – which is highly similar to M. abscessus 1 profile – BstEII [bp] 
(235, 210) and HaeIII [bp] (145, 70, 60, 50) – but lack the 70 bp HaeIII band. This 
profile is not present in the PRASITE database. The first two isolates (EPM 10906 
and EPM 10695) were obtained in 1999 from corneal specimens of two patients with 
infectious crystalline keratopathy after LASIK (Laser-Assisted in Situ Keratomileusis). 
Both isolates were provided by Prof. Denise de Freitas (Departamento de 
Oftalmologia, Escola Paulista de Medicina, Universidade Federal de São Paulo – 
EPM-UNIFESP, São Paulo, Brazil). The third isolate (IAL 3785) was recovered in 
2007 from a cervical lymph node biopsy, in Ribeirão Preto, São Paulo state, Brazil 
and sent to the mycobacterial reference laboratory at Instituto Adolfo Lutz (IAL), São 
Paulo, Brazil for identification. Preliminary analyses based on DNA sequencing of 
hsp65, rpoB, ITS and 16S rRNA revealed that the Brazilian isolates were most similar 
to isolates JAN1 and JAN2 obtained from zebrafish. These isolates were classified 
as belonging to the M. chelonae-M. abscessus complex due to their phenotypic and 
genotypic characteristics (Whipps, Butler et al. 2007), but they were not assigned to 
any species of this complex. The JAN1 and JAN2 isolates were kindly provided by 
Dr. Christopher Whipps from University of Utah, USA for this work.  
The following type strains of the M. chelonae-M. abscessus complex were also 
included in this study: M. abscessus subsp. abscessus ATCC 19977T, M. abscessus 
subsp. bolletii CCUG 50184T, M. massiliense CCUG 48898T (now classified as M. 
abscessus subsp. bolletii), M. chelonae ATCC 35752T, M. immunogenum ATCC 
700505T and M. salmoniphilum ATCC 13758T. Although not validly published, "M. 
franklinii" DSM 45524T was also included in this study. 
All type strains and isolates included in this study are listed in Table 6.1. 
 
Table 6.1. Isolates and type strains included in this study. 
Isolate Isolation Source Procedence INNO-LiPA
®
 
96-1705 Foot biopsy ITM, Belgium CHII 
96-1712 Tissue from calf ITM, Belgium CHII 
96-1717 Tissue from hand ITM, Belgium CHII 
96-1720 Leg abscess ITM, Belgium CHII 
96-1724 Leg abscess ITM, Belgium CHII 
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96-1728 Lizard liver tissue ITM, Belgium CHII 
D16R24 Water work UD, Germany CHII 
D16R27 Tap water UD, Germany CHII 
D16Q13 Tap water UD, Germany CHII 
D16Q14 Tap water UD, Germany CHII 
D16Q16 Water work UD, Germany CHII 
D16Q19 Water work UD, Germany CHII 
D16Q20 Water work UD, Germany CHII 
D16Q24 Tap water UD, Germany CHII 
D17A2 Water work UD, Germany CHII 
D16R4 Tap water UD, Germany CHII 
D16R12 Surface water UD, Germany CHII 
D16R18 Tap water UD, Germany CHII 
D16Q15 Tap water UD, Germany CHII 
D16R2 Tap water UD, Germany CHII 
D16R3 Tap water UD, Germany CHII 
D16R7 Tap water UD, Germany CHII 
D16R9 Tap water UD, Germany CHII 
D16R10 Surface water UD, Germany CHII 
D16R14 Tap water UD, Germany CHII 
D16R19 Surface water UD, Germany CHII 
D16R20 Surface water UD, Germany CHII 
6410* - ITM, Belgium CHI 
96-892* - ITM, Belgium CHII 
8223* - ITM, Belgium CHIII 
96-443* - ITM, Belgium CHIV 
EPM 10695 LASIK surgery EPM-UNIFESP, Brazil ND 
EPM 10906 LASIK surgery EPM-UNIFESP, Brazil ND 
IAL 3785 Linfonode IAL, Brazil ND 
JAN1 Zebrafish University of Utah, USA ND 
JAN2 Zebrafish University of Utah, USA ND 
M. abscessus subsp. abscessus - ATCC 19977
T
 CHIII 
M. abscessus subsp. bolletii - CCUG 50184
T
 ND 
M. massiliense
#
 - CCUG 48898
T
 ND 
M. chelonae - ATCC 35752
 T
 CHII/IV 
M. immunogenum - ATCC 700505
T
 ND 
M. salmoniphilum - ATCC 13758
T
 ND 
M. franklinii - DSM 45524
T
 ND 
(EPM-UNIFESP): Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil; 
(UD): University of Dusseldorf, Dusseldorf, Germany; (ITM): Institute of Tropical Medicine Prince Leopold, 
Antwerp, Belgium; (IAL): Instituto Adolfo Lutz, São Paulo, Brazil; (ND): not determined 
*representative strains of each cluster used during the development of INNO-LiPA
®
 assay 
#
now classified as M. abscessus subsp. bolletii 
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7 Preliminary Identification of the Isolates 
 
7.1 Introduction 
 
In the first phase of this study, all isolates were preliminarily characterized 
using the commercial test Genotype® Mycobacterium CM and AS and the PCR 
Restriction Enzyme Analysis of the hsp65 gene (PRA-hsp65) and 16S-23S ITS 
(PRA-ITS) 
 
7.2 Materials and Methods 
 
7.2.1 DNA extraction 
 
Cultures were grown on Lysogeny Broth (LB) agar incubated at 30oC. DNA 
was prepared by boiling one loop full of bacteria for 10 min in 300 μL of TET (10 mM 
Tris, 1 mM EDTA, 1% Triton X-100 [pH 8.0]) followed by centrifugation at 14,000 g 
for 2 min.  
 
7.2.2 GenoType® Mycobacterium CM and AS 
 
GenoType® CM and AS were performed according to the manufacturer’s 
instructions (Hain, Nehren, Germany). 
 
7.2.3 PRA-hsp65 and PRA-ITS 
 
For PRA-hsp65, a 441-bp fragment of the hsp65 gene was amplified as 
described by Telenti et al. with some modifications (Telenti, Marchesi et al. 1993). 
The composition of the PCR mixture (50 µL) was 140 μM (each) dNTP, 0.4 μM Tb11 
(5’ ACCAACGATGGTGTGTCCAT), 0.4 μM Tb12 (5’ 
CTTGTCGAACCGCATACCCT), 1.5 mM MgCl2, 10% reaction buffer (150 mM Tris-
HCl, pH 8.75, 500 mM KCl and 1% Triton X-100), 5% glycerol and 0.6 U Taq 
polymerase. Five microliters of DNA lysate were added to each reaction tube. The 
reaction was subjected to an initial denaturation at 96oC for 5 minutes, followed by 45 
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cycles of amplification (1 min at 95°C, 1 min at 65°C, 1 min at 72°C), and 10 min of 
final extension at 72°C. Subsequently, amplicons were digested in two separate 
tubes with BstEII and HaeIII restriction enzymes at 60oC and 37oC, respectively.  
For PRA-ITS, the ITS fragment was amplified as described by Roth et al. with 
some modifications (Roth, Reischl et al. 2000). The composition of the PCR mixture 
(30 µL) was 200 μM (each) dNTP, 0.4 μM Sp1 (5’ ACCTCCTTTCTAAGGAGCACC), 
0.4 μM Sp2 (5’ GATGCTCGCAACCACTATCCA), 1.5 mM MgCl2, 10% reaction buffer 
(150 mM Tris-HCl, pH 8.75, 500 mM KCl and 1% Triton X-100) and 0.5 U Taq 
polymerase. Ten microliters of DNA lysate were added to each reaction tube. The 
reaction was subjected to an initial denaturation at 96oC for 5 minutes, followed by 45 
cycles of amplification (1 min at 94°C, 1 min at 60°C, 1 min at 72°C), and 10 min of 
final extension at 72°C. Amplicons were digested with TaqI restriction enzyme at 
65oC.  
Both PRA-hsp65 and PRA-ITS digestion products were visualized in 3% 
agarose gels (MetaPhorTM Agarose, Lonza, USA) stained with ethidium bromide after 
electrophoresis, using 50-bp and 25-bp ladder as molecular size standards. The 
restriction fragment sizes were estimated using the BioNumerics program version 7.6 
(Applied Maths, Sint-Martens-Latem, Belgium) and compared to the patterns 
included in the PRASITE (http://app.chuv.ch/prasite/index.html) for PRA-hsp65 and 
published by Roth, Reischl et al. (2000) for PRA-ITS. 
 
7.3 Results and discussion 
 
Using Genotype® CM all isolates showed hybridization with probes 5 and 10, 
with exception of isolates 8223 and 6410 that showed hybridization with probes 5, 6 
and 10. According to the manufacturer, the first hybridization profile corresponds to 
M. chelonae and the second to M. abscessus. 
The type strains M. abscessus subsp. abscessus ATCC 19977T, M. 
abscessus subsp. bolletii CCUG 50184T and M. massiliense CCUG 48898T showed 
hybridization with probes 5, 6 and 10 (hybridization profile of M. abscessus/M. 
immunogenum), while M. chelonae ATCC 35752T, M. immunogenum ATCC 
700505T, M. salmoniphilum ATCC 13756T and "M. franklinii" DSM 45524T showed 
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hybridization with probes 5 and 10 (hybridization profile of M. chelonae/M. 
immunogenum). 
Using Genotype Mycobacterium AS, all isolates and type strains showed the 
same hybridization profile (hybridization with probe 12) that corresponds to a species 
different from the mycobacteria species identifiable by this assay. 
The performance of GenoType® assay confirmed that all isolates included in 
this study belong to the M. chelonae-M. abscessus complex. 
According the PRA results, the isolates were separated into groups wherein 
the isolates of each group showed the same restriction profile of both PRA-hsp65 
and PRA-ITS (Table 7.1 and Figure 7.1). 
 
 
 
Table 7.1. Restriction profiles of PRA-hsp65 and PRA-ITS of all isolates included in this study and 
their identification based on PRASITE and Roth et al., 2000, respectively. The horizontal lines 
separate the groups that have the same restriction profile of PRA-hps65 and PRA-ITS. The two last 
groups contain four isolates used to develop INNO-LiPA
®
 and the M. chelonae- M. abscessus 
complex type strains, respectively.  
  
Isolate 
PRA-hsp65  PRA-ITS 
BSTEII HAEIII Identification  TaqI Identification 
96-1712 320/130 200/60/55/50 M. chelonae type 1  No restriction M. chelonae type I 
D16R4 320/130 200/60/55/50 M. chelonae type 1  No restriction M. chelonae type I 
96-1717 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
96-1720 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
96-1724 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
96-1728 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16Q24 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R2 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R3 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R7 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R9 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R10 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R14  320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R19 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
D16R20 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
96-1705 320/130 200/55/50 M. chelonae type 2*  No restriction M. chelonae type I 
D16Q13 320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
D16Q14  320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
D16Q16 320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
D16Q20 320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
D16R24 320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
D17A2 320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
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*not present in the PRASITE database 
 
D16Q15 320/130 200/115/60/50 Not registered  120/105/30 M. chelonae type III 
D16R12 320/130 200/115/60/50 Not registered  120/105/30 M. chelonae type III 
D16R18 320/130 200/115/60/50 Not registered  120/105/30 M. chelonae type III 
D16Q19 320/130 200/70/60/55 M. immunogenum type 2  225/30 M. abscessus 
D16R27 320/130 200/70/60/55 M. immunogenum type 2  225/30 M. abscessus 
EPM 10906 235/210 145/60/55/50 Not registered  225/30 M. abscessus 
EPM 10695 235/210 145/60/55/50 Not registered  225/30 M. abscessus 
IAL 3785 235/210 145/60/55/50 Not registered  225/30 M. abscessus 
JAN1 235/210 145/60/55/50 Not registered  225/30 M. abscessus 
JAN2 235/210 145/60/55/50 Not registered  225/30 M. abscessus 
6410 (CHI) 310/130 200/70/60/55 M. immunogenum type 2  No restriction M. chelonae type I 
96-892 (CHII) 320/130 200/55/50 M. chelonae type 2*  225/30 M. abscessus 
8223 (CHIII) 235/210 145/70/60/55 M. abscessus type 1  225/30 M. abscessus 
96-443 (CHIV) 320/130 200/60/55/50 M. chelonae type 1  140/120 M. chelonae type II 
ATCC 19977
T
 235/210 145/70/60/50 M. abscessus type 1  225/30 M. abscessus 
CCUG 50184
T
 235/210 200/70/60/50 M. abscessus type 2  225/30 M. abscessus 
CCUG 48898
T
 235/210 200/70/60/50 M. abscessus type 2  225/30 M. abscessus 
ATCC 35752
T
 320/130 200/60/55/50 M. chelonae type 1  No restriction M. chelonae type I 
ATCC 700505
T
 320/130 145/70/60/55 M. immunogenum type 1  150/125 Not registered 
ATCC 13758
T
 320/130 200/60/55/50 M. chelonae type 1  120/105/30 M. chelonae type III 
DSM 45524
T
 320/130 200/70/60/55 M. immunogenum type 2  225/30 M. abscessus 
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Figure 7.1. Gel electrophoresis of PCR Restriction Enzyme Analysis of the hsp65 gene (PRA-
hsp65) and the 16S-23S Internal Transcribed Spacer (PRA-ITS) of all isolates and type strains 
included in this study. 
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The representative strains of the CHI, CHII, CHIII and CHIV cluster used 
during the development of INNO-LiPA® showed different restrictions profiles, 
confirming that they represent different taxa. The same was observed with the M. 
chelonae-M. abscessus type strains, except for M. abscessus subsp. bolletii and M. 
massiliense, which share the same PRA patterns. By the current accepted 
classification both are grouped in the same subspecies, that of M. abscessus subsp. 
bolletii.  
Fifteen isolates (96-1712, D16R4, 96-1717, 96-1720, 96-1724, 96-1728, 
D16Q24, D16R2, D16R3, D16R7, D16R9, D16R10, D16R14, D16R19, D16R20) and 
the representative strain of CHIV cluster (96-443) showed the M. chelonae type 1 
PRA-hsp65 profile and two different restriction profiles of PRA-ITS using the enzyme 
TaqI (M. chelonae type I and type II).  
One isolate (96-1705) showed a novel PRA-hsp65 profile similar to that of M. 
chelonae type 1 but lacking the 60-bp Hae III restriction band, named here M. 
chelonae type 2 and the PRA-ITS profile of M. chelonae type I.  
Seven isolates (96-892, D16Q13, D16Q14, D16Q16, D16Q20, D16R24 and 
D17A2) were identified as by PRA-hsp65 as M. chelonae type 2 and as M. 
abscessus by PRA-ITS. This PRA patterns were shared by the representative strain 
of CHII cluster (96-892). 
Isolates D16Q15, D16R12 and D16R18 were identified as M. chelonae type III 
by PRA-ITS and showed a new PRA-hsp65 restriction profile, not registered in the 
PRASITE database.  
D16Q19 and D16R27 were identified as M. immunogenum type 2 by PRA-
hsp65 and M. abscessus by PRA-ITS. This profile was shared by “M. franklinii” DSM 
45524.  
Five isolates (EPM 10906, EPM 10695, IAL 3785, JAN1 and JAN2) were 
identified as M. abscessus by PRA-ITS and showed a new PRA-hsp65 profile, not 
registered in the PRASITE database.  
During INNO-LiPA® development, variability in phenotypic tests of CHII cluster 
isolates was observed, suggesting the existence of different taxonomic groups 
among these isolates. Here we demonstrated that the CHII cluster isolates were 
distributed in different groups according to their PRA-hsp65 and PRA-ITS restriction 
profiles demonstrating high genotypic variability. The groups formed by PRA-hsp65 
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and PRA-ITS profiles can represent distinct taxa. However a conclusive classification 
was not achieved for all isolates. 
Since the taxonomic position of several isolates remained doubtful, a 
polyphasic analysis was subsequently carried out in order to explore the internal 
variability of CHII cluster isolates and to clarify the taxonomic position of the isolates 
with no conclusive species identification. First of all, the isolates were characterized 
using phenotypic analyses traditionally used for the identification of mycobacteria, 
based on culture characteristics and biochemical features; drug susceptibility testing; 
and DNA sequencing of the 16S rRNA, hsp65 and rpoB genes and the 16S-23S ITS. 
Then some isolates were submitted to DNA-DNA hybridization experiments leading 
to the description of M. franklinii sp. nov. (CHAPTER 8) and M. saopaulense sp. nov. 
(CHAPTER 9), respectively. Even after the performance of several phenotypic and 
molecular methodologies, the taxonomic classification of several isolates was not 
achieved. Therefore, the CHII cluster isolates were submitted to WGS and pairwise 
genome comparisons in order to clarify their classification and taxonomic position 
and to explore their internal variability (CHAPTER 10). 
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8 Mycobacterium franklinii sp. nov., a species closely related to 
members of the Mycobacterium chelonae-Mycobacterium 
abscessus group 
 
Redraft from: Nogueira CL, Simmon KE, Chimara E, Cnockaert M, Palomino JC, 
Martin A, Vandamme P, Brown-Elliott BA, Wallace R Jr, Cardoso Leão S. 
Mycobacterium franklinii sp. nov., a species closely related to members of the 
Mycobacterium chelonae-Mycobacterium abscessus group. International Journal 
of Systematics and Evolutionary Microbiology 65 (7): 2148-53, 2015. 
 
Abstract 
 
Two isolates from water, D16Q19 and D16R27, were shown to be highly similar in 
their 16S rRNA, 16S-23S internal transcribed sequence (ITS), hsp65 and rpoB 
gene sequences to Mycobacterium franklinii DSM 45524T, described but not 
validly named in 2011. They are all nonpigmented rapid growers and are 
phenotypically and genetically related to the Mycobacterium chelonae-
Mycobacterium abscessus group. Extensive characterization by phenotypic 
analysis, biochemical tests, drug susceptibility testing, PCR-Restriction Enzyme 
Analysis of the hsp65 gene and ITS, DNA sequencing of housekeeping genes and 
DNA-DNA hybridization demonstrated that M. franklinii DSM 45524T, D16Q19 and 
D16R27 belong to a single species that is separated from other members of the M. 
chelonae-M. abscessus group. On the basis of these results we propose the 
formal recognition of Mycobacterium franklinii sp. nov. Strain DSM 45524T (=ATCC 
BAA-2149T) is the type strain. 
 
The GenBank/EMBL/DDBJ accession numbers for the partial 16S rRNA, hsp65, 
rpoB and ITS sequences of isolate D16R27 are KM392061, KM392060, 
KM392057 and KM392062, respectively. Those for the partial hsp65 and rpoB 
gene sequences of M. franklinii DSM 45524T are KM392059 and KM392056, 
respectively and for the partial rpoB gene sequence of M. salmoniphilum ATCC 
13758T is KM392058. 
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The Mycobacterium chelonae-Mycobacterium abscessus group comprises 
closely related rapidly growing mycobacteria. They are widespread saprophytes 
that can cause several opportunistic infections in humans, ranging from localized 
abscesses to pulmonary and disseminated disease (Wallace Jr, Swenson et al. 
1983, Brown-Elliott and Wallace 2002). Skin and soft tissue infections caused by 
members of M. chelonae-M. abscessus group have been increasingly reported in 
recent years, representing a serious public health problem in some settings. The 
ubiquitous distribution of these organisms facilitates the contamination of medical 
equipment and solutions, which may be associated with the growing number of 
therapeutic interventions leading to nosocomial infections and outbreaks (Tortoli 
2009, Brown-Elliott and Wallace Jr. 2012a). 
Until 2007, the M. chelonae-M. abscessus group was composed of 
Mycobacterium chelonae, Mycobacterium abscessus (Kusunoki and Ezaki 1992), 
Mycobacterium immunogenum (Wilson, Steingrube et al. 2001), Mycobacterium 
massiliense (Adekambi, Reynaud-Gaubert et al. 2004a, Adékambi, Reynaud-
Gaubert et al. 2006), Mycobacterium bolletii (Adekambi, Berger et al. 2006) and 
Mycobacterium salmoniphilum (Whipps, Butler et al. 2007). Recently, this group 
has undergone taxonomic changes, including the unification of M. abscessus, M. 
massiliense and M. bolletii in a single species (M. abscessus) with two subspecies 
(M. abscessus subsp. abscessus and M. abscessus subsp. bolletii). Strains 
formerly named M. massiliense were reclassified as M. abscessus subsp. bolletii 
(Leao, Tortoli et al. 2009, Leao, Tortoli et al. 2011). Although beyond the scope of 
this paper, recently whole genomic sequencing has provided evidence that there 
are indeed three taxonomic groups within M. abscessus. It is not clear yet how this 
will affect the 2011 reclassification (Tettelin, Davidson et al. 2014). 
In 2011, Simmon et al. studied a group of clinical isolates from 
Pennsylvania, and primarily the Northeastern United States, that were initially 
misidentified as M. chelonae with an atypical antimicrobial drug susceptibility 
profile (Simmon, Brown-Elliott et al. 2011). This study included the proposal of 
Mycobacterium franklinii as a new member of M. chelonae-M. abscessus group, 
but this name has not been validly published.  
During taxonomic studies of isolates from the collection of Prof. Françoise 
Portaels (Antwerp, Belgium), two isolates (D16Q19 and D16R27) showed high 
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similarity with M. franklinii by sequencing of 16S rRNA, hsp65, rpoB and the 16S–
23S internal transcribed spacer (ITS). Strains D16Q19 and D16R27 were isolated 
in Germany by Prof. Roland Schulze-Röbbecke (Düsselforf, Germany) from water 
work and tap water, respectively.  
The aim of the present study was to examine the taxonomic position of 
these two isolates and M. franklinii DSM 45524T using phenotypic and genotypic 
tests. The results were compared with those displayed by other members of M. 
chelonae-M. abscessus group, M. abscessus subsp. abscessus ATCC 19977T, M. 
abscessus subsp. bolletii CCUG 50184T, M. chelonae ATCC 35752T, M. 
immunogenum ATCC 700505T and M. salmoniphilum ATCC 13758T.  
Cultures were grown on solid-phase media including Middlebrook 7H10 and 
Luria-Bertani agar and in liquid medium including Muller-Hinton and Luria-Bertani 
broth with 1% Tween 80. All cultures were incubated at 28–30oC. Microscopic 
examination of isolated colonies by Zhiel-Neelsen staining showed that isolates 
D16Q19, D16R27 and M. franklinii DSM 45524T were acid-fast bacilli. Pigment 
production, single-source carbon utilization (mannitol, inositol and citrate), growth 
at 26oC and 37oC and the ability to grow in the presence of 5% NaCl, 0.2% picric 
acid, para-nitrobenzoic acid (PNB) and nitrite were performed on 7H10 medium. 
Nitrate reduction and Tween 80 hydrolysis were also examined. The results of 
these tests were read after 7 and 14 days incubation at 28oC, except for Tween 80 
hydrolysis, which was read after 5 and 10 days, as described in standard protocols 
for biochemical testing of mycobacteria (Tsukamura 1984, Kent and Kubica 1985). 
The isolates D16Q19, D16R27 and M. franklinii DSM 45524T exhibited 
indistinguishable phenotypic and biochemical characteristics, which are indicated 
in Table S8.1. Colonies that appeared on Middlebrook 7H10 and Luria-Bertani 
agar after aerobic incubation were nonpigmented. On these solid media, visible 
growth required 3 to 5 days at 25oC to 37oC; optimum growth occurred at 28oC. 
The bacterial cells showed tendency to form large clumps when grown in liquid 
media and the use of 0.1% Tween 80 helped to obtain dispersed growth. They 
grew in the presence of 5% NaCl, picric acid, PNB and nitrite. They were negative 
for nitrate reduction and Tween hydrolysis and growth did not occur when mannitol 
or inositol was used as single-source of carbon. D16Q19, D16R27, M. chelonae 
ATCC 35752T and M. immunogenum ATCC 700505T grew in the presence of 
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citrate but not M. franklinii DSM 45524T or the other type strains of the M. 
chelonae-M. abscessus group. These phenotypic and biochemical tests were not 
useful for distinguishing D16Q19, D16R27 and M. franklinii DSM 45524T from 
other members of the M. chelonae-M. abscessus group. 
Antimicrobial susceptibility testing was performed in cation-supplemented 
Mueller–Hinton broth by the microdilution method, according to the 
recommendations of the Clinical and Laboratory Standards Institute for rapidly 
growing mycobacteria (CLSI 2011). The antimicrobials tested were amikacin, 
cefoxitin, ciprofloxacin, clarithromycin, doxycycline, minocycline, moxifloxacin and 
tobramycin. According to CLSI interpretative standards, isolates D16Q19, D16R27 
and M. franklinii DSM 45524T were susceptible to amikacin, ciprofloxacin, 
doxycycline, minocycline, and moxifloxacin.  D16Q19 and D16R27 were 
susceptible to clarithromycin at 3 days incubation but extended clarithromycin 
MICs (14 days incubation) was not performed. Susceptibility of D16Q19 and 
D16R27 to cefoxitin was intermediate and they were resistant or intermediate to 
tobramycin while M. franklinii DSM 45524T was susceptible to both drugs (Table 
8.1). The results obtained with cefoxitin were in agreement with results obtained 
by Simmon & Brown-Elliott et al., who reported intermediate and susceptible rates 
of 88% and 22%, respectively, for M. franklinii isolates (Simmon, Brown-Elliott et 
al. 2011). D16Q19, D16R27 and M. franklinii DSM 45524T were more susceptible 
to antimicrobial drugs than the other members of the M. chelonae-M. abscessus 
group, but studies of larger strain numbers have shown greater MIC variability 
than exhibited by these reference type strains (Table 8.1). 
GenoType® Mycobacterium common mycobacteria (CM) and additional 
species (AS) assays (Hain Lifescience, Nehren Germany), two commercial DNA 
strip assays for mycobacteria identification, were performed according to 
manufacturer’s instructions. Using GenoType® CM, the isolates D16Q19, D16R27 
and M. franklinii DSM 45524T showed the M. chelonae profile (hybridization with 
probes 5 and 10). They showed the same GenoType® AS profile, hybridization 
with probe 12, which assigns the isolates to a species of mycobacteria different 
from the eighteen species identifiable with the AS strip. 
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Table 8.1. Antimicrobial susceptibility results with isolates and type strains included here 
and 25 CV* isolates from the previous study (Simmon, Brown-Elliott et al. 2011)  
 
Isolates/strains: 1, D16Q19; 2, D16R27; 3, M. franklinii DSM 45524
T
; 4, Range of results of 25 CV* 
isolates; 5, M. abscessus subsp. abscessus ATCC 19977
T
; 6, M. abscessus subsp. bolletii CCUG 
50184
T
; 7, M. chelonae ATCC 35752
T
; 8, M. immunogenum ATCC 700505
T
; 9, M. salmoniphilum 
ATCC 13758
T
. The antimicrobial susceptibility breakpoints were those established by CLSI (2011) 
for rapidly growing mycobacteria. 
 
Drugs 
 MIC (μg ml
-1
) 
1 2 3 4 5 6 7 8 9 
Amikacin 8 16 ≤ 4 8-32 
(n=25) 
8 16 8 ≤ 4 16 
Ciprofloxacin ≤ 0.25 ≤ 0.25 0.5 ≤0.25-8 
(n=25) 
4 8 0.5 1 1 
Clarithromycin 
(3 days) 
≤ 0.5 ≤ 0.5 ≤ 0.5 ≤0.12-1 
(n=25) 
≤ 0.5 ≤ 0.5 ≤ 0.5 ≤ 0.5 ≤ 0.5 
Clarithromycin 
(14 days) 
ND ND ND <2 
(n=8) 
ND ND ND ND ND 
Doxycycline ≤ 0.25 ≤ 0.5 ≤ 0.25 ≤0.25->32 
(n=12) 
>32 >32 4 >32 >32 
Cefoxitin 64 64 16 16-64 
(n=25) 
64 32 512 256 512 
Tobramycin 4 16 2 4-16 
(n=24) 
8 16 2 4 4 
Minocycline 1 ≤ 0.25 ≤ 0.25 ≤0.5-16 
(n=22) 
8 16 2 8 2 
Moxifloxacin 0.5 1 1 0.5-8 
(n=11) 
8 8 ≤ 0.25 1 2 
 (ND) not determined, (n) number of isolates tested by Simmon & Brown-Elliott et al. (Simmon, Brown-Elliott et 
al. 2011) 
*Simmon, Brown-Elliott et al. (2011) labeled M. franklinii isolates as CV indicating M. chelonae variant 
 
For molecular identification by PCR Restriction Enzyme Analysis (PRA) of 
the hsp65 gene and ITS, the DNA was prepared by boiling one loop full of bacteria 
for 10 min in 300 μL of TET (10 mM Tris, 1 mM EDTA, 1% Triton X-100 [pH 8.0]) 
followed by centrifugation at 14,000 g for 2 min. For PRA-hsp65, a 441-bp 
fragment of the hsp65 gene was amplified using primers Tb11 and Tb12 (Table 
S2), as previously described (Telenti, Marchesi et al. 1993). The amplicons were 
digested in two separate tubes with BstEII and HaeIII restriction enzymes. For 
PRA-ITS, the ITS fragment was amplified using primers Sp1 and Sp2 (Table 
S8.2), as previously described (Roth, Reischl et al. 2000). ITS amplicons were 
digested with TaqI restriction enzyme. The digestion products of both PRA-hsp65 
and PRA-ITS were visualized after electrophoresis in 3% agarose gels stained 
with ethidium bromide, using 50-bp ladder as the molecular size standard. The 
restriction fragment sizes were estimated using BioNumerics program version 5.1 
(Applied Maths, Sint-Martens-Latem, Belgium) and compared to the patterns 
included in the PRASITE (http://app.chuv.ch/prasite/index.html) for PRA-hsp65 
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and published by Roth et al. (2000) for PRA-ITS. Isolates D16Q19, D16R27 and 
M. franklinii DSM 45524 showed indistinguishable PRA-hsp65 patterns – BstEII 
[bp] (320, 130) and HaeIII [bp] (200, 70, 60, 55). They showed the same PRA-ITS 
pattern – TaqI [bp] (225, 30), which is common to M. abscessus. Both assays, 
Genotype® and PRA were not useful for distinguishing D16Q19, D16R27 and M. 
franklinii DSM 45524T from other members of the M. chelonae-M. abscessus 
group (data not shown). 
Partial sequences of 16S rRNA (Harmsen, Dostal et al. 2003, Adekambi 
and Drancourt 2004b, Gomila, Ramirez et al. 2007), hsp65 (Telenti, Marchesi et 
al. 1993), rpoB (Adekambi, Colson et al. 2003) and ITS (Roth, Reischl et al. 2000) 
were obtained with isolates D16Q19 and D16R27. The primers used for PCR 
amplification and sequencing are listed in Table S8.2. PCR products were purified 
using QIAquick PCR purification Kit (Qiagen, Germany). Dideoxy sequencing was 
performed using BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, USA) and run in ABI PRISM 3100 DNA Analyzer (Applied 
Biosystems). Sequences from both isolates D16Q19 and D16R27 shared 100% 
identity and only the sequences from isolate D16R27 were deposited in the 
GenBank database. The corresponding sequences of the M. chelonae-M. 
abscessus group type strains were retrieved from the GenBank database 
(http://www.ncbi.nlm.nih.gov/genbank/). The hsp65 and rpoB genes of M. franklinii 
DSM 45524T and the rpoB gene of M. salmoniphilum ATCC 13758T were 
resequenced, as the sequences deposited in the GenBank database were 
incomplete. All sequences of isolates D16R27 and D16Q19 showed the highest 
sequence similarity with the corresponding sequences of M. franklinii DSM 
45524T, suggesting that they belong to the same taxon (Table S8.3). Sequence 
alignments and phylogenetic trees were constructed by using neighbor-joining 
method with Kimura 2-parameter distance correction model and 1,000 bootstrap 
replications in MEGA6 (Tamura, Stecher et al. 2013) (Figure 8.1).  
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Figure 8.1. Neighbor-joining tree of concatenated 16S rRNA gene, ITS, hsp65 gene 
and rpoB gene from M. chelonae-abscessus group type strains and D16Q19 and 
D16R27 isolates.  The 16S rRNA culture collection strain designation is shown next to 
the species name. Genbank accession of the 16S rRNA, 
ITS, hsp65 and rpoB genes and alternative culture collections repositories for the 
other DNA targets are noted in Table S8.3. Branch support is recorded at nodes as a 
percentage of 1,000 bootstrap iterations. *CCUG 48898 is the type strain of “M. 
massiliense”. 
 
Isolate D16R27 was selected to perform DNA–DNA hybridization (DDH) 
experiments. High-molecular weight DNA was prepared from 2 g cell mass using 
the protocol described by Pitcher et al. (1989) with modifications (Pitcher, 
Saunders et al. 1989). After centrifugation, cells were inactivated at 90°C for 30 
minutes and resuspended in 3 mL of lysis buffer containing 200 μg RNAse ml-1, 25 
mg fresh lysozyme ml-1 and 100U mutanolysine ml-1. The suspensions were 
incubated overnight at 37°C. Chloroform/isoamyl alcohol extraction, RNase 
treatment and ethanol precipitation were performed as described by Marmur 
(Mamur 1961). DDH was performed with photobiotin-labelled probes in microplate 
wells, as described by Ezaki et al. (1989), using HTS7000 Bio Assay Reader 
(Perkin-Elmer) for fluorescence measurements (Ezaki, Hashimoto et al. 1989). 
The hybridization temperature was 50oC, calculated on the basis of the DNA G+C 
contents of the isolates and type strains (Mesbah and Whitman 1989). DNA G+C 
content of isolates D16R27 and D16Q19 was 64.2 mol%. The G+C content of M. 
abscessus subsp. abscessus ATCC 19977T, M. chelonae ATCC 35752T, M. 
immunogenum ATCC 700505T, M. salmoniphilum ATCC 13758T and M. franklinii 
DSM 45524T was 64.0 mol%, 64.1 mol%, 64.2 mol%, 64.3 mol% and 64.1 mol%, 
respectively. These values are consistent with the G+C contents of this genus, 
between 59 mol% and 66 mol% (Devulder, Perouse de Montclos et al. 2005). 
DNA-DNA hybridization values are presented as averages of 
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reciprocal experiments, performed in quadruplicate hybridization reactions (Table 
8.2). The average DNA-DNA hybridization value between D16R27 and M. franklinii 
DSM 45524T was higher than the cutoff value of 70% and confirmed that both 
belong to the same species. The average hybridization values of D16R27 with M. 
abscessus subsp. abscessus ATCC19977T, M. chelonae ATCC 35752T, M. 
immunogenum ATCC 700505T, M. salmoniphilum ATCC 13758T were all below 
70%, further confirming that the isolate D16R27 represents a distinct species of 
the M. chelonae-M. abscessus group (Table 8.2). 
 
Table 8.2. DNA-DNA hybridization values of D16R27 against the type strains of M. 
chelonae-M. abscessus group. Reciprocal experiments were performed in 
quadruplicate hybridization reactions.  
Species Strain 
DNA-DNA 
relatedness (%)* 
Reciprocal 
values 
M. franklinii  DSM 45524
T 
78.5 (2.5) 76;81 
M. abscessus subsp. abscessus
 
 ATCC 19977
T 
50.5 (4.5) 46;55 
M. chelonae  ATCC 35752
T 
55 (8) 47;63 
M. immunogenum  ATCC 700505
T 
45.5 (4.5) 41;50 
M. salmoniphilum  ATCC 13758
T 
51 (10) 41;61 
*Values are mean with standard deviation 
 
In conclusion, phenotypic and genotypic characteristics of isolates D16R27, 
D16Q19 and M. franklinii DSM 45524T indicate that these isolates belong to the M. 
chelonae-M. abscessus group. In addition, several results clearly indicate that 
D16R27, D16Q19 and M. franklinii DSM 45524T form a homogeneous group 
separated from other members of M. chelonae-M. abscessus. Therefore, we 
propose to formally name this new member of the M. chelonae-M. abscessus 
group M. franklinii sp. nov., which was originally described but not validly named 
by Simmon & Brown-Elliott et al. (Simmon, Brown-Elliott et al. 2011). 
 
Description of M. franklinii sp. nov. 
 
M. franklinii (frank.li′ni.i I, N.L. masc. gen. n. franklinii of Franklin, pertaining 
to Benjamin Franklin, famous United States of America statesman and scientist 
from Pennsylvania where the first isolates originated).  
The cells are acid-fast bacilli and visible growth on solid media requires 3-5 
days of incubation at 28oC. Colonies are nonpigmented and growth occurs in the 
presence of 5% NaCl, picric acid, PNB and nitrite. Growth is not observed when 
mannitol or inositol is used as single-source of carbon. The type strain M. franklinii 
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DSM 45524T does not grow when citrate is used as single-source of carbon. 
Negative reactions are observed for nitrate reduction and Tween 80 hydrolysis. 
Conventional biochemical tests cannot distinguish M. franklinii from other 
members of M. chelonae-M. abscessus group and should not be used as 
confirmatory tests for identification of this species. M. franklinii isolates were 
susceptible to clarithromycin at 3 days. Eight of the original 25 isolates had 
clarithromycin MICs at ≤2 at 14 days. However, these data were not previously 
published. Isolates were susceptible to amikacin, ciprofloxacin, moxifloxacin, 
doxycycline, and minocycline. Tobramycin and cefoxitin had variable susceptibility 
(see Table 1). Partial sequencing of rpoB gene can distinguish M. franklinii from 
other members of M. chelonae-M. abscessus group – M. franklinii has 726 bp 
fragment length while the corresponding sequences of the type strains of M. 
chelonae-M. abscessus group have a 711 bp fragment length. The PRA-hsp65 
pattern that characterizes M. franklinii is BstEII [bp] (320, 130) and HaeIII [bp] 
(200, 70, 60, 55), these fragment sizes are closely related to the pattern of M. 
immunogenum type 2. 
The type strain is DSM 45524T (= ATCC BAA-2149T). 
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Supplementary material 
 
Table S8.1. Comparison of phenotypic and biochemical characteristics of the isolates and the 
type strains included in this study.  
 
Isolates/strains: 1, D16Q19; 2, D16R27; 3, M. franklinii DSM 45524
T
; 4, M. abscessus subsp. 
abscessus ATCC 19977
T
; 5, M. abscessus subsp. bolletii CCUG 50184
T
; 6, M. chelonae ATCC 
35752
T
; 7, M. immunogenum ATCC 700505
T
; 8, M. salmoniphilum ATCC 13758
T 
 
Phenotypic and 
biochemical tests 
Isolates and strains 
1 2 3 4 5 6 7 8 
Colony morphology RG SM SM SM SM SM RG SM 
Pigmentation absent absent absent absent absent absent absent absent 
Growth in the presence of:         
          Picric acid + + + + + + + + 
          PNB* + + + + + + + + 
          Nitrite + + + + + + + + 
          5% NaCl + + + + + + + + 
Nitrate reduction - - - - - - - - 
Tween hydrolysis - - - - - - - - 
single-source carbon 
utilization of: 
        
          mannitol - - - - - - + - 
          inositol - - - - - - - - 
          citrate + + - - - + + - 
*PNB, p-aminobenzoic acid; SM, smooth; RG, rough 
 
 
Table S8.2. Primers used in genotypic characterization of strains and isolates included in 
this study 
Gene  Primers  Sequence 5´-3´ References 
16S rRNA 16S-27F* AGAGTTTGATCCTGGCTCAG (Harmsen, Dostal et al. 2003) 
16S rRNA 800F ATTAGATACCCTGGTAG (Adekambi and Drancourt 2004b) 
16S rRNA 16S-907R* CCGTCAATTCCTTTGAGTTT (Harmsen, Dostal et al. 2003) 
16S rRNA 16R-1492* TACGGCTACCTTGTTACGACTT (Gomila, Ramirez et al. 2007) 
rpoB MycoF GGCAAGGTCACCCCGAAGGG (Adekambi, Colson et al. 2003) 
rpoB MycoR AGCGGCTGCTGGGTGATCATC (Adekambi, Colson et al. 2003) 
hsp65 Tb11 ACCAACGATGGTGTGTCCAT (Telenti, Marchesi et al. 1993) 
hsp65 Tb12 CTTGTCGAACCGCATACCCT (Telenti, Marchesi et al. 1993) 
ITS Sp1 ACCTCCTTTCTAAGGAGCACC (Roth, Reischl et al. 2000) 
ITS Sp2 GATGCTCGCAACCACTATCCA (Roth, Reischl et al. 2000) 
*Primers were modified based on the M. abscessus subsp. abscessus
 
ATCC 19977
T
 genome 
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Table S8.3. Percent identity of the partial sequences of isolates D16Q19 and D16R27 and the 
sequences of the M. chelonae-M. abscessus group type strains.  
 
Only the regions between the primers used for amplification and present in all sequences were 
considered for comparison, excluding indels. 
 
Gene Type strain* 
Accession 
number 
D16Q19 = 
D16R27 
16S rRNA (1384 bp)# 
M. abscessus subsp. abscessus
 
CIP 104536
T
 AY457071 99.71% 
M. abscessus subsp. bolletii CIP 108541
T
 AY859681 99.71% 
M. abscessus subsp. bolletii CCUG 48898
 
 NR043002 99.71% 
M. chelonae CIP 104535
T
 AY457072 100.00% 
M. immunogenum DSM 45595
T
 HE654001 99.35% 
M. salmoniphilum ATCC 13758
T
 NR_043989 99.64% 
M. franklinii DSM 45524
T
 HQ153090 100.00% 
hsp65 (401 pb) 
M. abscessus subsp. abscessus
 
CIP 104536
 T
 AY458075 92.77% 
M. abscessus subsp. bolletii CIP 108541
T
 AY859675 92.77% 
M. abscessus subsp. bolletii CCUG 48898
 
 AY596465 93.02% 
M. chelonae CIP 104535
T
 AY458074 96.01% 
M. immunogenum CIP 106684
T
 AY458081 98.25% 
M. salmoniphilum ATCC 13758
T
 DQ866777 97.26% 
M. franklinii DSM 45524
T
 KM392059 99.75% 
rpoB (711 bp)§ 
M. abscessus subsp. abscessus
 
CIP 104536
 T
 AY147164 93.95% 
M. abscessus subsp. bolletii CIP 108541
T
 AY859692 95.22% 
M. abscessus subsp. bolletii CIP 108297 EU254721 95.92% 
M. chelonae CIP 104535
T
 AY147163 96.77% 
M. immunogenum CIP 106684
T
 AY262739 96.48% 
M. salmoniphilum ATCC 13758
T
 KM392058 96.20% 
M. franklinii DSM 45524
T
 KM392056 98.59% 
ITS (214 bp)¶ 
M. abscessus subsp. abscessus
 
CIP 104536
T
 AY593976 93.46% 
M. abscessus subsp. bolletii CCUG 50184
T
 GU143888.2 93.46% 
M. abscessus subsp. bolletii CCUG 48898
 
 AY593978 92.99% 
M. chelonae ATCC 35752
T
 AY498739 96.26% 
M. immunogenum CIP 106684
T
 AY593977 89.72% 
M. salmoniphilum ATCC 13758
T
 DQ866768 97.66% 
M. franklinii DSM 45524
T
 HQ153093 99.07% 
* strain designations according to the deposits in culture collections and GenBank sequence database. CCUG 
48898 and CIP 108297 are the type strain of “M. massiliense” 
# The 16S rRNA gene partial sequence of M. immunogenum DSM 45595
T
 has 1385 bp due to a 1 bp insertion 
after nucleotide 1354.  
§ The rpoB partial sequences of D16R27, D16Q19 and M. franklinii DSM 45524
T
 have 726 bp and the 
corresponding sequences of the other type strains of the M. chelonae-M. abscessus group have 711 bp. This 
difference is due to two insertions in the M. franklinii isolates, one with 6 bp, between nucleotides 409 and 410 
and the other with 9 bp, between nucleotides 424 and 425 of the 711 bp sequence.  
¶ The ITS sequences of D16R27, D16Q19, M. franklinii DSM 45524
T
 and M. salmoniphilum ATCC 13758
T
 have 
214 bp, those of M. abscessus subsp. abscessus ATCC 19977
T
, M. abscessus subsp. bolletii CCUG 50184
T
 and 
M. chelonae ATCC 35752
T
 have 215 bp (1 bp insertion after nucleotide 20), that of “M. massiliense” CCUG 48898 
has 216 bp and that of M. immunogenum ATCC 700505
T
 has 225 bp (10 bp insertion between nucleotides 90 and 
91) 
. 
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9 Description of Mycobacterium saopaulense sp. nov., a rapidly growing 
mycobacterium closely related with members of the Mycobacterium 
chelonae-M. abscessus group 
 
Redraft from: Nogueira CL, Whipps CM, Matsumoto CK, Chimara E, Droz S, Tortoli 
E, de Freitas D, Cnockaert M, Palomino JC, Martin A, Vandamme P, Leão SC. 
Description of Mycobacterium saopaulense sp. nov., a rapidly growing 
mycobacterium closely related with members of the Mycobacterium chelonae-M. 
abscessus group. International Journal of Systematics and Evolutionary Microbiology 
65: 4403-4409, 2015. 
 
Abstract 
 
Five isolates of non-pigmented rapidly growing mycobacteria were isolated from 
three patients and, in an earlier study, from zebrafish. Phenotypic and molecular 
tests confirmed that these isolates belong to the Mycobacterium chelonae-
Mycobacterium abscessus group, but they could not be confidently assigned to any 
known species of this group. Phenotypic analysis and biochemical tests were not 
helpful for distinguishing these isolates from other members of the M. chelonae-M. 
abscessus group. They presented higher drug resistance in comparison with other 
members of the group, showing susceptibility to clarithromycin only. The five isolates 
showed a unique PCR restriction analysis pattern of the hsp65 gene, 100% identity in 
16S rRNA and hsp65 sequences and 1-2 nucleotide differences in rpoB and in the 
internal transcribed spacer (ITS). Phylogenetic analysis of a concatenated data set 
including 16S rRNA, hsp65, and rpoB gene sequences from type strains of more 
closely related species placed these isolates together, as a distinct lineage from 
previously described species suggesting a sister relationship to a group consisting of 
M. chelonae, M. salmoniphilum, and M. immunogenum. DNA-DNA hybridization 
values >70% confirmed that the five isolates belong to the same species, while the 
values <70% between one of them and the type strains of M. chelonae and M. 
abscessus confirmed their belonging to a distinct species. The polyphasic 
characterization of these isolates, supported by DNA-DNA hybridization results, 
demonstrated that they share characteristics with M. chelonae-M. abscessus 
members, but constitute a different species, for which the name Mycobacterium 
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saopaulense sp. nov. is proposed. The type strain is EPM 10906T (CCUG 66554T = 
LMG 28586T = INCQS 0733T). 
 
 
The GenBank/EMBL/DDBJ accession numbers for the 16S rRNA sequences are 
KM973037 (EPM 10906T), KM973036 (EPM 10695), KM973038 (IAL 3785), 
DQ866774 (JAN1) and DQ866775 (JAN2); for the hsp65 are KM973026 (EPM 
10906T), KM973025 (EPM 10695), KM973027 (IAL 3785), DQ866786 (JAN1) and 
DQ866787 (JAN2); for the rpoB are KM973029 (EPM 10906T), KM973028 (EPM 
10695), KM973030 (IAL 3785), KM973031 (JAN1) and KM973032 (JAN2); and for 
the ITS are KM973034 (EPM 10906T), KM973033 (EPM 10695), KM973035 (IAL 
3785) and DQ866774 (JAN1) and DQ866775 (JAN2). 
 
 
Nontuberculous mycobacteria are ubiquitous environmental organisms and 
several species can cause opportunistic infections in humans, in particular the 
members of the Mycobacterium chelonae-Mycobacterium abscessus group. It 
comprises closely related rapidly growing mycobacteria that can cause a broad 
spectrum of infections mainly affecting lung, skin and soft tissue (Wallace Jr, 
Swenson et al. 1983, Wallace, Swenson et al. 1983, Simmon, Brown-Elliott et al. 
2011). The ubiquitous distribution of these organisms facilitates the contamination of 
medical equipment and solutions that, associated with the growing number of 
therapeutic interventions, generate nosocomial infections and outbreaks representing 
a serious public health problem in some settings (Tortoli 2009, Leao, Viana-Niero et 
al. 2010). 
Until recently, the M. chelonae-M. abscessus group was composed of M. 
chelonae, M. abscessus (Kusunoki and Ezaki 1992), Mycobacterium immunogenum 
(Wilson, Steingrube et al. 2001), Mycobacterium massiliense (Adekambi, Reynaud-
Gaubert et al. 2004a, Adekambi, Berger et al. 2006), Mycobacterium bolletii 
(Adekambi, Berger et al. 2006), and Mycobacterium salmoniphilum (Whipps, Butler et 
al. 2007). Taxonomic changes have been proposed and M. abscessus, M. 
massiliense and M. bolletii have been assigned to a single species (M. abscessus) 
with two subspecies, M. abscessus subsp. abscessus and M. abscessus subsp. 
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bolletii, the latter including those isolates previously identified as M. massiliense and 
M. bolletii (Leao, Tortoli et al. 2009, Leao, Tortoli et al. 2011). Two novel members of 
this group have been recently described, Mycobacterium franklinii (Simmon, Brown-
Elliott et al. 2011, Lourenco Nogueira, Simmon et al. 2015) and “Mycobacterium 
fukienense” (Zhang, Li et al. 2013). 
The aim of the present study was to define the taxonomic position of five 
mycobacterial isolates (EPM 10906T, EPM 10695, IAL 3785, JAN1 and JAN2) 
without conclusive species assignments, which share a PCR Restriction Analyses 
(PRA) profile of the hsp65 gene not present in the PRASITE database 
(http://app.chuv.ch/prasite/index.html). Our data indicate that these five isolates 
belong to a single taxon and represent a novel species of the M. chelonae-
M.abscessus group. We therefore propose the name Mycobacterium saopaulense 
sp. nov., with the type strain EPM 10906T. 
The first two isolates (EPM 10906T and EPM 10695) were obtained in 1999 
from corneal specimens of two patients with infectious crystalline keratopathy after 
LASIK surgery (laser-assisted in situ keratomileusis) performed in the same 
ophthalmological clinic, in São Paulo city (Brazil). These isolates were first 
misidentified as M. chelonae (Alvarenga, Freitas et al. 2002) and subsequently as M. 
abscessus (Sampaio, Junior et al. 2006), on the basis of PRA of the hsp65 gene. 
Typing of these isolates by pulsed field gel electrophoresis (PFGE) using a protocol 
previously described (Matsumoto, Chimara et al. 2011), revealed that they share 
indistinguishable patterns and thus might belong to a single strain (Fig. 9.1). The third 
isolate (IAL 3785) was obtained in 2007 from a cervical abscess in the city of 
Ribeirão Preto, São Paulo (Brazil). The other two isolates (JAN1 and JAN2) were 
isolated from zebrafish (Danio rerio) (Kent, Whipps et al. 2004) and initially 
categorized as M. chelonae. Using greater taxon sampling in a later phylogenetic 
analysis, these strains were recognized as phylogenetically distinct (Whipps, Butler 
et al. 2007), but they were not described as a new species at the time. JAN1 and 
JAN2 share highly similar PFGE patterns differing in a single band and were isolated 
from zebrafish at the same research facility about two months apart in 2003 (Kent, 
Whipps et al. 2004). Considering this they could represent a single strain. 
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Figure 9.1. Pulsed-field gel electrophoresis (PFGE) patterns of DraI 
digested DNA of the five isolates studied in this work. PFGE images 
were analyzed with the BioNumerics program v. 7.1 (Applied Maths, 
Sint-Martens-Latem, Belgium). The band-based Dice unweighted-
pair group method using average linkages was used to prepare a 
dendrogram of PFGE profiles, based on 1.5% optimization and 
position tolerance.  
 
We investigated the classification of these five isolates, comprising three 
different strains, using a polyphasic approach that included microscopic and 
macroscopic morphological examination, cultural and biochemical tests, drug 
susceptibility testing, HPLC analysis of cell wall mycolic acids, PRA, sequencing of 
three housekeeping genes and DNA-DNA hybridization. The results were compared 
with those displayed by the type strains of M. abscessus subsp. abscessus ATCC 
19977T, M. abscessus subsp. bolletii CCUG 50184T, M. chelonae ATCC 35752T, M. 
immunogenum ATCC 700505T, M. salmoniphilum ATCC 13758T and M. franklinii 
DSM 45524T. 
Cultures were grown on solid media, Löwenstein-Jensen (LJ), Middlebrook 
7H10 supplemented with OACD (oleic acid, albumin, dextrose and catalase) and 
Luria-Bertani agar, and in liquid Muller-Hinton medium or Luria-Bertani broth with 1% 
Tween 80 at 28oC–30oC for 5 days. Microscopic examination of colony smears by 
Ziehl-Neelsen staining confirmed that they are acid-fast bacilli. Analysis of pigment 
production, single-source carbon utilization (mannitol, inositol and citrate), growth at 
26oC and 37oC and tolerance to 5% NaCl, 0.2% picric acid, para-nitrobenzoic acid 
(PNB) and nitrite were performed on 7H10-OADC and LJ. Nitrate reduction, Tween 
80 hydrolysis and arylsulfatase production were also examined. All tests were 
performed as described in standard protocols for biochemical identification of 
mycobacteria (Tsukamura 1984, Kent and Kubica 1985, Leão, Martin et al. 2004). 
The five isolates exhibited indistinguishable phenotypic and biochemical 
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characteristics, which are listed in Table S9.1. These cultural and biochemical tests 
were not helpful for distinguishing these isolates from other members of the M. 
chelonae-M. abscessus group. 
Antimicrobial drug-susceptibility testing was performed using a microdilution 
method in cation-supplemented Mueller–Hinton broth, according to the 
recommendations of the Clinical and Laboratory Standards Institute for rapidly 
growing mycobacteria (CLSI 2011). Amikacin, cefoxitin, ciprofloxacin, clarithromycin, 
doxycycline, minocycline, moxifloxacin and tobramycin were tested. The five isolates 
were more drug resistant than the other members of M. chelonae-M. abscessus 
group, showing susceptibility only to clarithromycin at 3 and 14 days incubation. They 
were resistant to doxycycline, cefoxitin and tobramycin and resistant or intermediate 
to amikacin, ciprofloxacin, minocycline and moxifloxacin (Table 9.1). These results 
are consistent with susceptibility testing previously conducted for strain JAN1 (Chang 
and Whipps 2015). The drug resistance profile of M. saopaulense sp. nov. highlights 
the importance of its correct identification for patient management. 
 
Table 9.1. Antimicrobial susceptibility results for isolates and type strains included in this 
study 
 
Isolates/strains: 1, EPM 10695; 2, EPM 10906
T
; 3, IAL 3785; 4, JAN1; 5, JAN2; 6, M. abscessus 
subsp. abscessus ATCC 19977
T
; 7, M. abscessus subsp. bolletii CCUG 50184
T
; 8, M. chelonae ATCC 
35752
T
; 9, M. immunogenum ATCC 700505
T
; 10, M. salmoniphilum ATCC 13758
T
; 11, M. franklinii 
DSM 45524
T
. 
 
Drugs 
MIC (μg ml
-1
) 
1 2 3 4 5 6 7 8 9 10 11 
Amikacin 
32 
I 
128 
R 
32 
I 
32 
I 
32 
I 
8 
S 
16 
S 
8 
S 
≤ 4 
S 
16 
S 
≤ 4 
S 
Ciprofloxacin 
2 
I 
2 
I 
4 
R 
4 
R 
4 
R 
4 
R 
8 
R 
0.5 
S 
1 
S 
1 
S 
0.5 
S 
Clarithromycin 
(3 days) 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
Clarithromycin 
(14 days) 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
≤ 0.5 
S 
>64 
R 
>64 
R 
≤ 0.5 
S 
≤ 0.5 
S 
ND 
 
≤ 0.5 
S 
Doxycycline 
>32 
R 
>32 
R 
>32 
R 
>32 
R 
>32 
R 
>32 
R 
>32 
R 
4 
I 
>32 
R 
>32 
R 
≤ 0.25 
S 
Cefoxitin 
512 
R 
>512 
R 
512 
R 
>512 
R 
512 
R 
64 
I 
32 
I 
512 
R 
256 
R 
512 
R 
16 
S 
Tobramycin 
16 
R 
32 
R 
16 
R 
8 
R 
16 
R 
8 
R 
16 
R 
2 
S 
4 
I 
4 
I 
2 
S 
Minocycline 
32 
R 
16 
R 
4 
I 
16 
R 
8 
R 
8 
R 
16 
R 
2 
I 
8 
R 
2 
I 
≤ 0.25 
S 
Moxifloxacin 
2 
I 
8 
R 
4 
R 
4 
R 
2 
I 
8 
R 
8 
R 
≤ 0.25 
S 
1 
S 
2 
I 
1 
S 
(R) resistant, (I) intermediate, S (susceptible) – criteria for rapidly growing mycobacteria established by CLSI 
(2011) 
(ND) not done  
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For HPLC analysis of cell wall mycolic acids two strains of the panel 
characterized here were selected (the proposed type strain EPM 10906T and JAN1) 
and three reference strains belonging to the closely related M. chelonae-M. 
abscessus group (ATCC 19977T, CCUG 48898T and CCUG 50184T). The cells of the 
strains above, grown in culture on Middlebrook 7H10 agar, were saponified, 
extracted and derivatized as recommended by the Sherlock Mycobacteria 
Identification System (SMIS; MIDI) and separated using a gradient of methanol and 
isopropanol. All the strains analyzed produced nearly identical HPLC patterns 
characterized by two late emerging clusters of peaks (Figure 9.2). The Sherlock 
software (version Myco 1.0) identified all of them as M. chelonae-M. abscessus with 
very high similarity indexes (range 0.802-0.899). The low discriminatory power of 
HPLC analysis in differentiating most rapidly growing mycobacterial species (Tortoli 
2003) is therefore confirmed for the proposed new species, with this approach being 
unsuitable to go further in the assignation to the M. chelonae-M. abscessus group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.2. Representative mycolic acid pattern of 
Mycobacterium saopaulense sp. nov. EPM10906
T 
paired 
with the reference profile of Mycobacterium chelonae-
Mycobacterium abscessus (Sherlock database). LMMIS, 
low molecular mass internal standard; HMMIS, high 
molecular mass internal standard. 
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GenoType® Mycobacterium (Hain Lifescience, Nehren Germany), a 
commercial DNA strip assay for mycobacteria identification, was performed 
according to manufacturer’s instructions. Using the GenoType® CM strip, the isolates 
showed the M. chelonae profile (hybridization with probes 5 and 10). GenoType® AS 
only identified the isolates at level of Mycobacterium species.  
For molecular identification, the PRA of the hsp65 gene and of ITS and the 
partial sequencing of the small subunit (16S) rRNA gene, rpoB, hsp65 and ITS were 
performed. The DNA was prepared by boiling one loop full of bacteria for 10 min in 
300 μL of TET (10 mM Tris, 1 mM EDTA, 1% Triton X-100 [pH 8.0]) followed by 
centrifugation at 14,000 g for 2 min. For PRA-hsp65, a 441-bp fragment of the hsp65 
gene was amplified using primers Tb11 and Tb12 (Table S9.2), and the amplicon 
was digested in two separate tubes with BstEII and HaeIII restriction enzymes 
(Telenti, Marchesi et al. 1993). For PRA-ITS, amplicons generated with primers Sp1 
and Sp2 (Table S9.2) were digested with TaqI restriction enzyme (Roth, Reischl et al. 
2000). PRA-hsp65 and PRA-ITS digestion products were visualized in 3% agarose 
gels stained with ethidium bromide after electrophoresis, using 50-bp ladder as the 
molecular size standard. The restriction fragment sizes were estimated using the 
BioNumerics program version 7.1 (Applied Maths, Sint-Martens-Latem, Belgium) and 
compared to the patterns included in the PRASITE for PRA-hsp65 and published by 
Roth et al. (2000) for PRA-ITS (Roth, Reischl et al. 2000). The five isolates showed 
identical PRA-hsp65 patterns – BstEII [bp] (235, 210) and HaeIII [bp] (145, 60, 50), 
which differs from patterns of other M. chelonae-M. abscessus members. This profile 
was not registered in the PRASITE database. They showed the same PRA-ITS 
pattern – TaqI [bp] (225, 30), which is common to M. abscessus and M. franklinii. 
Therefore, only PRA-hsp65 was useful for differentiation of M. saopaulense sp. nov.  
The primers used for PCR amplification and partial sequencing of 16S rRNA, 
hsp65, rpoB and ITS are listed in Table S9.2. PCR products were purified using 
QIAquick PCR purification Kit (Qiagen, Germany). Dideoxy sequencing was 
performed using BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, USA) and run in ABI PRISM 3100 DNA Analyzer (Applied Biosystems). 
Using ClustalW multiple alignment (BioEdit version 7.2.5), the obtained sequences of 
isolates EPM 10906T, EPM 10695, IAL 3785, JAN1 and JAN2 were aligned and the 
percentages of sequence identity were calculated after alignment. The five isolates 
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shared 100% identity in the partial hsp65 and 16S rRNA sequences and had 1-2 
nucleotide differences in the partial sequences of rpoB and ITS. The high similarity of 
the 16S rRNA to M. chelonae had been previously recognized by Kent et al. (Kent, 
Whipps et al. 2004) who assigned the two isolates investigated to such species. 
Greater differences in other genes (rpoB, hsp65, ITS) and in the PRA-hsp65 pattern 
subsequently revealed that these isolates are distinct (Sampaio, Junior et al. 2006, 
Whipps, Butler et al. 2007), and this is supported by the data presented here.  
Previous phylogenetic analyses (Sampaio, Junior et al. 2006, Whipps, Butler 
et al. 2007) of individual genes had shown sister relationships of JAN1 and JAN2 
isolates to different species. In the tree from hsp65 tree, these isolates were sister to 
M. abscessus. In the tree from rpoB they showed a sister relationship to the entire M. 
chelonae-M. abscessus group. In the tree from ITS a sister relationship between M. 
saopaulense sp. nov. and M. abscessus emerged. Analysis of 16S rRNA alone 
revealed that sequences from the five isolates, M. abscessus, and M. chelonae are 
intermixed (Figure S9.1). Thus, 16S rRNA alone was not sufficient to resolve these 
relationships and other genes yielded conflicting results. For this study, we chose to 
analyze a concatenated data set using 16S rRNA, hsp65, and rpoB from type 
species (Table S9.3). Sequences were aligned with Clustal X version 1.8 
(Thompson, Gibson et al. 1997) with default parameters (penalty for gap opening = 
10, gap extension = 0.2). A maximum likelihood analysis was performed using 
PhyML (Guindon and Gascuel 2003) and bootstrap confidence values were 
calculated with 100 replicates. The resulting tree was edited and annotated in Adobe 
Illustrator (Adobe Systems Inc. San Jose, California). The ITS region was excluded 
from the final analysis because homologous sites were difficult to confidently identify 
from outgroup taxa; however, when ITS data are included (unalignable data treated 
as missing) tree topology was unaltered (data not shown). In either analysis, the five 
isolates showed a sister relationship to a clade made up of 4 species (M. chelonae, 
M. salmoniphilum, M. immunogenum, and M. franklinii) (Figure 9.3).  
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Figure 9.3. Estimate of phylogeny of Mycobacterium saopaulense sp. 
nov. and other closely related rapid growers based on maximum 
likelihood analysis of concatenated data set of 16S rRNA, hsp65, and 
rpoB. Bootstrap support values greater than 50% are shown at nodes. 
Genbank accession of the 16S rRNA, hsp65 and rpoB genes are shown 
in Table S3. 
 
These plus the five isolates are sister to M. abscessus. This concatenated 
data present the phylogenetic hypothesis that the five isolates are sister to M. 
chelonae versus M. abscessus as suggested by individual gene trees from hsp65 
and ITS (Whipps, Butler et al. 2007). Regardless of the precise sister relationship, all 
analyses support inclusion in the M. chelonae-M. abscessus group, and a 
phylogenetic position for the five isolates that is distinct from all other nominal 
species.  
For DDH, high-molecular weight DNA was prepared from 2 g of cell mass 
using the protocol described by Pitcher et al. (1989) with modifications (Pitcher, 
Saunders et al. 1989). Bacterial cells were centrifuged, inactivated at 90°C for 30 
minutes and resuspended in 3 mL of lysis buffer containing 200 μg RNase ml-1, 25 
mg fresh lysozyme ml-1 and 100U mutanolysine ml-1. The suspensions were 
incubated overnight at 37°C and the DNA was extracted with chloroform/isoamyl 
alcohol, treated with RNase and precipitated with ethanol as described by Mamur 
(1961). DDH was performed as described by Ezaki et al. (1989), using photobiotin-
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labelled probes in microplate wells (Ezaki, Hashimoto et al. 1989). Fluorescence was 
measured in HTS7000 Bio Assay Reader (Perkin-Elmer). DNA-DNA hybridization 
values are presented as averages of reciprocal experiments, performed in 
quadruplicate hybridization reactions. The DNA G+C content, estimated as described 
by Mesbah and Whitman (1989), was 64.6 mol% (EPM 10906T), 64.8 mol% (EPM 
10695), 64.7 mol% (IAL 3785), 64.5 mol% (JAN1) and 64.7 mol% (JAN2). These 
values were used for calculation of the 50oC hybridization temperature. They are 
consistent with the G+C contents of this genus, between 59 mol% and 66 mol% 
(Devulder, Perouse de Montclos et al. 2005). DDH experiments performed with the 
five isolates yielded hybridization values above 70% (data not shown), confirming 
that they belong to the same species. EPM 10906T was selected to perform DDH 
reciprocal experiments with the type strains of the M. chelonae-M. abscessus group. 
All values were below 70%, confirming that EPM 10906T and the other four isolates 
belong to a distinct species of the M. chelonae-M. abscessus group (Table 9.2). 
 
Table 9.2. DNA-DNA hybridization values of EPM 10906
T
 against the type strains of 
M. chelonae-M. abscessus group. Reciprocal experiments were performed in 
quadruplicate hybridization reactions. 
Species Strain 
DNA-DNA 
relatedness (%)* 
Reciprocal 
values 
M. abscessus subsp. abscessus
 
 ATCC 19977
T 
41.5 (2.5) 39;44 
M. abscessus subsp. bolletii CCUG 50184
T 
40 (1) 39;41 
M. chelonae  ATCC 35752
T 
47 (5) 42;52 
M. immunogenum  ATCC 700505
T 
40 (7) 33;47 
M. salmoniphilum  ATCC 13758
T 
44.5 (1.5) 43;46 
M. franklinii  DSM 45524
T 
51 (4) 47;55 
*Values are mean with standard deviation 
 
In conclusion, phenotypic and genotypic tests indicated that EPM 10906T, 
EPM 10695, IAL 3785, JAN1 and JAN2 belong to the M. chelonae-M. abscessus 
group. In addition, several results clearly indicated that they form a uniform group 
separated from the other members of this group. Therefore, we propose to classify 
these isolates as a new member in the M. chelonae-M. abscessus group, with the 
name M. saopaulense sp. nov. 
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Description of Mycobacterium saopaulense sp. nov. 
 
Mycobacterium saopaulense (sa.o.paul.en'se. (N.L. neut. adj. saopaulense, of 
or pertaining to the Brazilian state of São Paulo, where the first strains were isolated). 
The cells are acid-fast bacilli and visible growth on solid media requires 3-5 
days at 28oC. Colonies are nonpigmented and smooth. After some days the medium 
often acquires a brown color. Growth occurs in the presence of 5% NaCl, picric acid, 
PNB, nitrite. Growth is observed in the presence of citrate as single-source of carbon 
but not of mannitol or inositol. Negative reactions are observed for nitrate reduction 
and Tween 80 hydrolysis. Conventional biochemical testing cannot distinguish M. 
saopaulense sp. nov. from other members of M. chelonae-M. abscessus group. The 
antimicrobial pattern is characterized by susceptibility to clarithromycin and 
resistance to doxycycline, tobramycin and cefoxitin. Variable results, intermediate or 
resistant, were obtained with amikacin, ciprofloxacin, minocycline and moxifloxacin. 
The mycolic acid profile is similar to that of M. chelonae-M. abscessus by HPLC 
analysis. Genotype® CM shares the same profile of M. chelonae. The partial 
sequencing of rpoB and hsp65 genes can distinguish M. saopaulense sp. nov. from 
other members of M. chelonae-M. abscessus group. The PRA-hsp65 pattern that 
characterizes M. saopaulense sp. nov. is BstEII [bp] (235, 210) and HaeIII [bp] (145, 
60, 50). The type strain of M. saopaulense sp. nov. is EPM 10906T (CCUG 66554T = 
LMG 28586T = INCQS 0733T). 
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Supplementary material 
 
 
Table S9.1. Comparison of phenotypic and biochemical characteristics of the isolates and 
the type strains included in this study. 
 
Isolates/strains: 1, EPM10906; 2, EPM10695; 3, IAL 3785; 4, JAN1; 5, JAN2, 6, M. abscessus 
subsp. abscessus ATCC 19977
T
; 7, M. abscessus subsp. bolletii CCUG 50184
T
; 8, M. chelonae 
ATCC 35752
T
; 9, M. immunogenum ATCC 700505
T
; 10, M. salmoniphilum ATCC 13758
T
; 11, M. 
franklinii DSM 45524
T 
 
Characteristics 1 2 3 4 5 6 7 8 9 10 11 
Colony morphology SM SM SM SM SM SM SM SM RG SM SM 
Pigmentation nc nc nc nc nc nc nc nc nc nc nc 
Growth in the presence of:            
          Picric acid + + + + + + + + + + + 
          PNB* + + + + + + + + + + + 
          Nitrite + + + + + + + + + + + 
          5% NaCl + + + + + + + + + + + 
Nitrate reduction - - - - - - - - - - - 
Tween 80 hydrolysis - - - - - - - - - - - 
single-source carbon utilization of:            
          mannitol - - - - - - - - + - - 
          inositol - - - - - - - - - - - 
          citrate + + + + + - - + + - - 
*PNB, p-aminobenzoic acid; SM, smooth; RG, rough; nc, nonchromogenic 
 
 
 
 
Table S9.2. Primers used in genotypic characterization of strains and isolates included in 
this study 
Gene  Primers  Sequence 5´-3´ References 
16S rRNA 16S-27F*# AGAGTTTGATCCTGGCTCAG (Harmsen, Dostal et al. 2003) 
16S rRNA 800F
*
 ATTAGATACCCTGGTAG (Adekambi and Drancourt 2004b) 
16S rRNA 16S-907R*# CCGTCAATTCCTTTGAGTTT (Harmsen, Dostal et al. 2003) 
16S rRNA 16R-1492*# TACGGCTACCTTGTTACGACTT (Gomila, Ramirez et al. 2007) 
23S rRNA 23S1R
*
 CCCAAAGCCTATATATTCAGC (Matsumoto, Chimara et al. 2012) 
rpoB MYCOF1* TCCGATGAGGTGCTGGCAGA (Macheras, Roux et al. 2011) 
rpoB MYCOR2* ACTTGATGGTCAACAGCTCC (Macheras, Roux et al. 2011) 
hsp65 Tb11 ACCAACGATGGTGTGTCCAT (Telenti, Marchesi et al. 1993) 
hsp65 Tb12 CTTGTCGAACCGCATACCCT (Telenti, Marchesi et al. 1993) 
hsp65 hsp667F* GGCCAAGACAATTGCGTACG (Selvaraju, Khan et al. 2005) 
hsp65 hsp667R* GGAGCTGACCAGCAGGATG (Selvaraju, Khan et al. 2005) 
ITS Sp1* ACCTCCTTTCTAAGGAGCACC (Roth, Reischl et al. 2000) 
ITS Sp2 GATGCTCGCAACCACTATCCA (Roth, Reischl et al. 2000) 
ITS 23S1R* CCCAAAGCCTATATATTCAGC (Matsumoto, Chimara et al. 2012) 
*Primers used for PCR amplification and sequencing of 16S rRNA, hsp65, rpoB and ITS 
# Primers were modified based on M. abscessus subsp. abscessus
 
ATCC 19977 genome 
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Table S9.3. Species, strains and GenBank accession numbers of sequences used for 
phylogenetic analyses. Number of characters in each DNA sequence alignment shown in 
final row.  
Mycobacterium species Strain 16S rRNA hsp65 rpoB 
M. abscessus subsp. abscessus CIP 104536
T 
AY457071 AY458075 AY147164 
M. abscessus subsp. boletti CIP 108541
T 
AY859681 AY859675 AY859692 
M. aubagnense CIP 108543
T 
AY859683 AY859677 AY859694 
M. chelonae CIP104535
T 
AY457072 AY458074 AY147163 
M. fortuitum CIP 104534
T 
AY457066 AY458072 AY147165 
M. franklinii DSM 45524
T 
HQ153090  KM392059 HQ153091 
M. immunogenum CIP 106684
T 
AY457080 AY458081 AY262739 
M. mucogenicum ATCC 49650
T 
AY457074 AY458079 AY147170 
M. phocaicum CIP 108542
T 
AY859682 AY859676 AY859693 
M. salmoniphilum ATCC 13758
T 
DQ866768 DQ866777 DQ866790 
M. saopaulense JAN1 DQ866774 DQ866786 DQ866800 
M. saopaulense JAN2 DQ866775 DQ866787 DQ866801 
M. saopaulense EPM 10695 KM973036  KM973025  KM973028  
M. saopaulense EPM 10906
T 
KM973037  KM973026  KM973029  
M. saopaulense IAL 3785 KM973038  KM973027  KM973030  
Characters in alignment 
 
1387 401 676 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S9.1. Estimate of phylogeny of Mycobacterium species based on small subunit 
(16S) ribosomal DNA sequences. Names and strains are shown, with Genbank accession 
numbers in parentheses. A superscript ‘T’ represents sequences from type species. 
Bootstrap values greater than 50% are shown at nodes. The M. chelonae-M. abscessus 
group has 100% bootstrap support and is shown in a grey box. Within the group, most 
relationships are unresolved using 16S, and species are intermixed with the exception of 
M. immunogenum and M. salmoniphilum.  
0.1
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M. farcinogenes NCTC 10955T (AY457084)
67
M. aubagnense CIP 108543T (AY859683)
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“M. fuerth” HXN1000 (AJ441307)
“M. fuerth” 01.22.181 (AF152558)
M. chelonae ATCC 19237 (AY457082)
M. saopaulense sp. nov. JAN2 (DQ866775 )
M. chelonae ATCC 35752 (AF480594)
M. franklinii D16R27 (KM392061)
M. chelonae MB834 (AJ416941)
M. chelonae strain CIP104535T (AY457072)
75
M. salmoniphilum SOL 803 (AY489137)
M. salmoniphilum TRA (DQ866770)
M. salmoniphilum AUS (DQ866764)
M. salmoniphilum ATCC13758T (DQ866768)
M. salmoniphilum NCIMB13533 (EF535601)
79
M. salmoniphilum MON (DQ866767)
97
58
93
100
58
65
100
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10 Characterization of Mycobacterium chelonae-like Strains by 
Comparative Genomics 
 
Christiane Lourenço Nogueira, Luiz Gonzaga Paula de Almeida, Maria Carmen 
Menendez, Maria Jesus Garcia, Luciano Antonio Digiampietri, Erica Chimara, 
Margo Cnockaert, Juan Carlos Palomino, Anandi Martin, Peter Vandamme, 
Sylvia Cardoso Leão. Genomic variability of Mycobacterium chelonae 
(Submitted to Frontiers in Microbiology). 
 
Abstract 
 
Isolates of the Mycobacterium chelonae-M. abscessus complex are subdivided 
into four clusters (CHI to CHIV) in the INNO-LiPA® Mycobacterium spp DNA 
strip assay. A considerable phenotypic variability was observed among isolates 
of the CHII cluster. In this study, we examined the diversity of 26 CHII cluster 
isolates by phenotypic analysis, drug susceptibility testing, whole genome 
sequencing and single-gene analysis. Pairwise genome comparisons were 
performed using several approaches, including average nucleotide identity 
(ANI) and genome-to-genome distance (GGD) among others. Based on ANI 
and GGD the isolates were identified as M. chelonae (14 isolates), M. franklinii 
(2 isolates) and M. salmoniphium (1 isolate). The remaining 9 isolates were 
subdivided into three novel putative genomospecies. Phenotypic analyses 
including drug susceptibility testing, as well as whole genome comparison by 
TETRA and delta differences, were not helpful in separating the groups 
revealed by ANI and GGD. The analysis of standard four conserved genomic 
regions showed that rpoB alone and the concatenated sequences clearly 
distinguished the taxonomic groups delimited by whole genome analyses. In 
conclusion, the CHII INNO-LiPA® is not a homogeneous cluster; on the 
contrary, it is composed of closely related different species belonging to the M. 
chelonae-M. abscessus complex and also several unidentified isolates. The 
detection of these isolates, putatively novel species, indicates a wider inner 
variability than the presently known in this complex. 
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10.1 Introduction 
 
 The Mycobacterium chelonae-M. abscessus complex consists of closely 
related rapidly growing mycobacteria. Although ubiquitous environmental 
organisms, they can cause several opportunistic infections in humans, 
especially pulmonary and skin infections (Wallace, Swenson et al. 1983, Brown-
Elliott and Wallace 2002, Whipps, Butler et al. 2007). This complex is the most 
commonly identified mycobacterial group causing diseases in humans after the 
Mycobacterium tuberculosis and Mycobacterium avium complexes (Sassi and 
Drancourt 2014). Nowadays, M. abscessus is one of the main infectious agents 
causing respiratory exacerbation in patients with cystic fibrosis (Bryant, 
Grogono et al. 2013). 
 Several changes in the classification of the members of the M. chelonae-
M. abscessus complex have occurred over the years. Currently the species that 
are formally accepted include M. chelonae, M. abscessus (Kusunoki and Ezaki 
1992) – with three subspecies, M. abscessus subsp. abscessus, M. abscessus 
subsp. massiliense and M. abscessus subsp. bolletii (Leao, Tortoli et al. 2009, 
Leao, Tortoli et al. 2011, Tortoli, Kohl et al. 2016), M. immunogenum (Wilson, 
Steingrube et al. 2001), M. salmoniphilum (Whipps, Butler et al. 2007), M. 
franklinii (Simmon, Brown-Elliott et al. 2011, Lourenco Nogueira, Simmon et al. 
2015) and M. saopaulense (Nogueira, Whipps et al. 2015). 
 Despite technological advances, accurate species level identification of 
M. chelonae- M. abscessus complex bacteria represents a challenge for clinical 
laboratories. In general, these species have indistinguishable phenotypic and 
biochemical characteristics (Simmon, Brown-Elliott et al. 2011, Lourenco 
Nogueira, Simmon et al. 2015, Nogueira, Whipps et al. 2015). Moreover, partial 
16S rDNA sequences are too similar, underestimating their diversity and not 
distinguishing all taxa (Adekambi, Colson et al. 2003, Simmon, Brown-Elliott et 
al. 2011). M. chelonae- M. abscessus complex members can be differentiated 
by the analysis of DNA polymorphisms in the rpoB and hsp65 genes and in the 
16S-23S rRNA internal transcribed spacer (ITS-1). However, Adekambi et al. 
(2003) demonstrated that M. abscessus isolates have >4.3% rpoB sequence 
divergence, which is a considerable intra species variability that adds another 
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challenge to the identification of M. chelonae- M. abscessus complex bacteria 
(Adekambi, Colson et al. 2003).  
 A considerable variability was also observed among M. chelonae isolates 
during the development of a DNA strip assay named INNO-LiPA® 
Mycobacterium spp (Innogenetics, Belgium). This reverse hybridization line 
probe assay was developed based on the high ITS-1 sequence heterogeneity of 
mycobacteria. DNA probes specific for the clinically important mycobacterial 
species were selected, including a set of 9 probes specific for the M. chelonae- 
M. abscessus complex that allowed the subdivision of isolates from this group 
into four clusters (CHI, CHII, CHIII and CHIV) according to their hybridization 
profiles (Portaels, Rigouts et al. 1998). The commercial version of this test used 
only 3 probes, MCH-1, MCH-2 and MCH-3. Isolates that showed hybridization 
with probes MCH-1 and MCH-3 were identified as cluster CHI. Cluster CHIII 
showed hybridization with probes MCH-1 and MCH-2, and clusters CHII and 
CHIV only with probe MCH-1. M. abscessus isolates and the type strain ATCC 
19977T were encompassed in the CHIII cluster (Portaels, Rigouts et al. 1998). 
Interestingly, a high variability in phenotypic characteristics of isolates belonging 
to CHII cluster was observed, suggesting the existence of different taxonomic 
entities within the group. For example, M. chelonae isolates cannot grow in the 
presence of 5% NaCl and can use citrate as the sole carbon source (Yakrus, 
Hernandez et al. 2001). However some CHII isolates showed conflicting results 
by these tests (Portaels, Rigouts et al. 1998). 
 To explore the variability observed during the development of INNO-
LiPA® assay, a set of CHII cluster isolates was studied. Whole genome 
sequencing and pairwise genome comparisons were performed to better 
understand the diversity of the CHII cluster. The ability of DNA targets 
commonly used for identification of mycobacteria in discriminating the groups 
separated by genomic comparisons was also verified. 
 
PART III: EXPERIMENTAL WORK 
91 
10.1 Materials and Methods 
 
Isolates, reference strains and growth media 
 This study was carried out with 26 isolates belonging to INNO-LiPA® 
cluster CHII recovered from clinical and environmental specimens by Prof. 
Françoise Portaels (Institute of Tropical Medicine Prince Leopold, Antwerp, 
Belgium) and Prof. Roland Schulze-Röbbecke (University of Dusseldorf, 
Dusseldorf, Germany). M. smegmatis mc2155, M. tuberculosis H37Rv and the 
type strains of M. chelonae- M. abscessus complex (M. abscessus subsp. 
abscessus ATCC 19977T, M. abscessus subsp. bolletii CCUG 50184T, M. 
abscessus subsp. massiliense CCUG 48898T, M. chelonae ATCC 35752T, M. 
immunogenum ATCC 700505T, M. salmoniphilum ATCC 13758T, M. franklinii 
DSM 45524T and M. saopaulense CCUG 66554T) were included for comparison 
(Table 10.1).  
 Cultures were grown aerobically at 28-30oC on solid media including 
Löwenstein-Jensen (LJ) and Middlebrook 7H10 (Becton-Dickinson (BD), USA) 
supplemented with oleic acid, albumin, dextrose and catalase (OADC – BD) 
and in liquid media including Middlebrook 7H9 (BD), Mueller-Hinton and 
Lisogeny Broth with 1% Tween 80. 
 
Table 10.1. Isolates and type strains of M. chelonae-M. abscessus complex included in 
this study.  
Isolate Isolation Source Procedence INNO-LiPA
®
 
96-1705 Human foot biopsy ITM, Belgium CHII 
96-1717 Human hand tissue ITM, Belgium CHII 
96-1720 Human leg abscess ITM, Belgium CHII 
96-1724 Human leg abscess ITM, Belgium CHII 
96-1728 Lizard liver tissue ITM, Belgium CHII 
D16R24 Water work UD, Germany CHII 
D16Q13 Tap water UD, Germany CHII 
D16Q14 Tap water UD, Germany CHII 
D16Q15 Tap water UD, Germany CHII 
D16Q16 Water work UD, Germany CHII 
D16Q20 Water work UD, Germany CHII 
D16Q24 Tap water UD, Germany CHII 
D16R2 Tap water UD, Germany CHII 
D16R3 Tap water UD, Germany CHII 
D16R7 Tap water UD, Germany CHII 
D16R9 Tap water UD, Germany CHII 
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D16R10 Surface water UD, Germany CHII 
D16R12 Surface water UD, Germany CHII 
D16R14 Tap water UD, Germany CHII 
D16R18 Tap water UD, Germany CHII 
D16R19 Surface water UD, Germany CHII 
D16R20 Surface water UD, Germany CHII 
D17A2 Water work UD, Germany CHII 
D16Q19 Water work UD, Germany CHII 
D16R27 Tap water UD, Germany CHII 
96-892 - ITM, Belgium CHII 
M. abscessus subsp. abscessus - ATCC 19977
T
 CHIII 
M. abscessus subsp. bolletii - CCUG 50184
T
 ND 
M. massiliense - *CCUG 48898
T
 ND 
M. chelonae - ATCC 35752
T
 CHII/IV 
M. immunogenum - ATCC 700505
T
 ND 
M. salmoniphilum - ATCC 13758
T
 ND 
M. franklinii - DSM 45524
T
 ND 
M. saopaulense - CCUG 66554
T
 ND 
(UD): University of Dusseldorf, Dusseldorf, Germany; (ITM): Institute of Tropical Medicine Prince Leopold, 
Antwerp, Belgium; (Unk): Unknown; (ND): not determined 
* now classified as M. abscessus subsp. bolletii 
 
Phenotypic analyses 
Phenotypic analyses were performed as described in standard protocols 
for biochemical identification of mycobacteria (Tsukamura 1984, Kent and 
Kubica 1985, Leão, Martin et al. 2004). Analysis of pigment production, single-
source carbon utilization (mannitol, inositol and citrate), growth at 26oC and 
37oC and tolerance to 5% NaCl, 0.2% picric acid, para-nitrobenzoic acid (PNB) 
and nitrite were performed on 7H10-OADC and LJ. Nitrate reduction, Tween 80 
hydrolysis and arylsulfatase production were also examined.  
 
Susceptibility testing 
Antimicrobial drug-susceptibility testing was performed using the 
microdilution method in cation-supplemented Mueller–Hinton broth, according to 
the recommendations of the Clinical and Laboratory Standards Institute (CLSI 
2011) for rapidly growing mycobacteria. The antimicrobials tested were 
amikacin, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, minocycline, 
moxifloxacin and tobramycin. 
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DNA extraction 
Chromosomal DNA was extracted using QIAamp DNA mini kit (Qiagen, 
Germany) as previously described (Bryant, Grogono et al. 2013). DNA 
concentration was determined using a Qubit high-sensitivity (HS) assay kit (Life 
Technologies, USA). 
 
Whole Genome Sequencing and assembly 
 High quality DNA of the 26 isolates and of M. abscessus subsp. bolletii 
CCUG 50184T, M. immunogenum ATCC 700505T, M. salmoniphilum ATCC 
13758T and M. franklinii DSM 45524T were subjected to multiplexed paired end 
sequencing using the Illumina Miseq platform. The genome of M. saopaulense 
CCUG 66554T was sequenced in a previous project from the laboratory of the 
Universidade Federal de São Paulo (accession number CP010271). The 
genomes of M. abscessus subsp. abscessus ATCC19977T (accession number 
CU458896), M. abscessus subsp. massiliense CCUG48898T (accession 
number NZ_AKVF01000001 to NZ_AKVF01000005) and M. chelonae ATCC 
35752T (accession number CP010946) were retrieved from the GenBank 
database (http://www.ncbi.nlm.nih.gov/genbank/). Sequencing errors in reads 
were corrected with the program Quake v0.3 (Kelley, Schatz et al. 2010) and 
reads trimmed with the program Trimmomatic v0.33 (Bolger, Lohse et al. 2014). 
The assembly was performed with Newbler program v3.0 (20140318_1550) - 
version with support for reads with Illumina's Casava accession number v1.8 
format) using default parameters. Raw sequencing data was deposited on the 
NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra) under 
accession number SRP075879 and the assembled genomes were deposited as 
BioProject PRJNA323571. 
 
Procedures of whole genome sequence comparison 
 
Average Nucleotide Identity (ANI) and Tetranucleotide frequency 
correlation coefficients (TETRA) analysis  
 Average Nucleotide Identity by BLAST (ANIb) and by MUMmer (ANIm) 
and TETRA-nucleotide usage patterns were calculated using JSpecies v1.2.1. 
Cutoff values for species separation were ≥ 95% ANIb and ANIm and ≥ 0.99 
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TETRA (Kurtz, Phillippy et al. 2004, Teeling, Meyerdierks et al. 2004, Goris, 
Konstantinidis et al. 2007). A tree based on the obtained ANIb values was 
constructed using MEGA7 software (Saitou and Nei 1987, Kumar, Stecher et al. 
2016) using the genomes of M. smegmatis mc2155 (accession number 
NC_018289) and M. tuberculosis H37Rv (accession number NC_018143) as 
outgroups. 
 
Genome-to-Genome Distance (GGD) calculations 
 GGD was calculated using the Genome-to-Genome Distance Calculator 
(GGDC at http://ggdc.dsmz.de). The distance values between the genomes 
were determined and the digital DNA-DNA hybridization (dDDH) was calculated 
from these distances. Cutoff values for species differentiation were ≤ 0.0258 
distance value and ≥ 70% dDDH (Meier-Kolthoff, Auch et al. 2013). A tree 
based on GGD values was constructed using MEGA7 software (Saitou and Nei 
1987, Kumar, Stecher et al. 2016) using the genomes of M. smegmatis mc2155 
(accession number NC_018289) and M. tuberculosis H37Rv (accession number 
NC_018143) as outgroups. 
 
Genomic Signature (delta values) 
 The relative abundance of di-, tri- and tetra-nucleotides distributed along 
the genomes was calculated using the program available at 
http://www.cmbl.uga.edu/software.htm. The delta value obtained by comparing 
a genome with itself is considered the threshold for species separation for that 
particular genome (Karlin, Mrazek et al. 1997).  
 
Comparison of isolates by single-gene sequencing  
Taxonomically informative partial sequences of 16S rDNA, rpoB, hsp65 
and 16S-23S ITS-1 fragments were PCR amplified and sequenced using 
primers listed in Table S10.1. PCR products were purified using QIAquick PCR 
purification Kit (Qiagen, Germany). Dideoxy sequencing was performed using 
BigDye® 19 Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, USA) 
and run in ABI PRISM 3100 DNA Analyzer (Applied Biosystems).  
Individual and concatenated phylogenetic trees based on the partial 
sequences of the previous genomic regions were constructed using PhyML 
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(http://www.atgc-montpellier.fr/phyml/) (Guindon and Gascuel 2003), using as 
input the multiple alignment of these sequences produced by MUSCLE 
(http://www.ebi.ac.uk/Tools/msa/muscle/help/) with default parameters (penalty 
for gap opening = 400, gap extension = 0). Confidence bootstrap values were 
calculated with 100 replicates. The corresponding sequences of the M. 
chelonae- M. abscessus complex type strains and outgroups (M. tuberculosis 
H37Rv and M. smegmatis mc2155) were retrieved from the GenBank database 
(http://www.ncbi.nlm.nih.gov/genbank/) (Table S10.2). 
 
GenBank/EMBL/DDBJ accession numbers 
 The 16S rDNA, rpoB, hsp65 and 16S-23S ITS-1 partial sequences of the 
isolates under study were deposited in the GenBank/EMBL/DDBJ under 
accession numbers: KT779787 to KT779815 (16S rDNA), KT779816 to 
KT779844 (hsp65), KT779874 to KT779902 (rpoB) and KT779845 to KT779873 
(16S-23S ITS-1). 
 The genomes were deposited in the GenBank/EMBL/DDBJ under 
accession numbers: MAEQ00000000 (M. chelonae 96-1705), MAER00000000 
(M. chelonae 96-1717), MAES00000000 (M. chelonae 96-1720), 
MAET00000000 (M. chelonae 96-1724), MAEU00000000 (M. chelonae 96-
1728), MAEV00000000 (M. sp. D16R24), MAEP00000000 (M. franklinii 
D16R27), MAEW00000000 (M. sp. D16Q13), MAEX00000000(M. sp. D16Q14), 
MAEY00000000 (M. sp. D16Q16), MAFS00000000 (M. franklinii D16Q19), 
MAEZ00000000 (M. sp. D16Q20), MAFA00000000 (M. chelonae D16Q24), 
MAFB00000000 (M. sp. D17A2), MAFC00000000 (M. sp. D16R12), 
MAFD00000000 (M. sp. D16R18), MAFE00000000 (M. salmoniphilum 
D16Q15), MAFF00000000 (M. chelonae D16R2), MAFG00000000 (M. 
chelonae D16R3), MAFH00000000 (M. chelonae D16R7), MAFI00000000 (M. 
chelonae D16R9), MAFJ00000000 (M. chelonae D16R10), MAFK00000000 (M. 
chelonae D16R14), MAFL00000000 (M. chelonae D16R19), MAFM00000000 
(M. chelonae D16R20), MAFN00000000 (M. sp. 96-892), MAFO00000000 (M. 
abscessus subsp. bolletii BD), MAFP00000000 (M. immunogenum MC 779), 
MAFQ00000000 (M. franklinii CV002), MAFR00000000 (M. salmoniphilum SC). 
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10. 2 Results 
 
Phenotypic analyses and Susceptibility testing 
 All CHII isolates grew in the presence of PNB. They did not reduce 
nitrate or hydrolyze Tween 80, but they exhibited arylsulfatase activity within 3 
days. All CHII isolates grew in the presence of 5% NaCl at 30oC, but 9/26 
isolates did not tolerate it at 37oC. It is expected that all rapidly growing 
mycobacteria tolerate 0.2% nitrite and 0.2% picric acid (Tsukamura 1984). 
Among the isolates studied in the present work, 8/26 did not grow in the 
presence of nitrite. However, all isolates grew in the presence of picric acid and 
generated visible colonies on solid culture media within 7 days. Additionally, 
5/26 isolates were not capable of growing in the presence of citrate as single 
carbon source (Table S10.3).  
 All isolates tested were susceptible to clarithromycin and resistant to 
cefoxitin, except for M. franklinii DSM 45524T, which was susceptible to cefoxitin 
(MIC=16 μg/mL). Variable results were obtained with the other tested 
antimicrobials (Table S10.4).  
 
Whole Genome Sequencing and assembly 
 The number of assembled bases ranged from 4,768,278 to 5,548,818, 
with an average G+C content of 63.94%. The number of generated scaffolds 
ranged from 15 to 82 with an N50 size from 110,426 bp to 682,599 bp (Table 
S10.5). 
 
Average Nucleotide Identity (ANI)  
 Pairwise ANIb and ANIm values of the M. chelonae- M. abscessus 
complex type strains were all below 95%, except between M. abscessus subsp. 
abscessus ATCC 19977T, M. abscessus subsp. bolletii CCUG 50184T and M. 
abscessus subsp. massiliense CCUG 48898T. These results confirmed that the 
type strains represent distinct species within the M. chelonae- M. abscessus 
complex and that the strains ATCC 19977T, CCUG 50184T and CCUG 48898T 
are appropriately classified into a single species, M. abscessus (Table 10.2 and 
Table S10.6). 
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Table 10.2 Taxonomic groups based on results of ANI, GGD, dDDH, TETRA and delta 
differences. (A) results between isolates inside each group and (B) results between each group 
of isolates and the M. chelonae-M. abscessus type strains. 
Isolates 
ANI GGD dDDH TETRA 
delta 
differences 
A B A B A B A B A B 
96-1705 
96-1717 
96-1720 
96-1724 
96-1728 
D16Q24 
D16R2 
D16R3 
D16R7 
D16R9 
D16R10 
D16R14 
D16R19 
D16R20 
>95% 
>95% 
ATCC 
35752
T 
<0.0258 >0.0258 >70% <70% >0.99 >0.99 21-27 21-27 
D16Q15 - 
>95% 
ATCC 
13758
T 
- >0.0258 - 
>70% 
ATCC 
13758
T 
>0.99 >0.99 21-27 21-27 
D16Q19 
D16R27 
>95% 
>95% 
DSM 
45524
T 
<0.0258 >0.0258 >70% 
>70% 
DSM 
45524
T 
>0.99 >0.99 21-27 21-27 
D16Q14 
D16Q20 
D16R24 
D17A2 
>95% <95% <0.0258 >0.0258 >70% <70% >0.99 >0.99 21-27 21-27 
96-892 
D16Q16 
D16Q13 
>95% <95% <0.0258 >0.0258 >70% <70% >0.99 >0.99 21-27 21-27 
D16R12 
D16R18 
>95% <95% >0.0258 >0.0258 <70% <70% >0.99 >0.99 21-27 21-27 
 
 Based on ANIb and ANIm values, the CHII isolates could be separated 
into different taxonomic groups. The pairwise genome alignment of 14 isolates 
(96-1705, 96-1717, 96-1720, 96-1724, 96-1728, D16Q24, D16R2, D16R3, 
D16R7, D16R9, D16R10, D16R14, D16R19, D16R20) yielded >95% ANIb and 
ANIm values, showing that they belong to the same species. The ANI values 
between these isolates and the type strains yielded values slightly higher than 
95% with ATCC 35752T, showing that they could be classified into the species 
M. chelonae according to their ANI. Isolate D16Q15 yielded ANIb and ANIm 
values above 95% with ATCC 13758T, showing that it belongs to the species M. 
salmoniphilum by this approach; and isolates D16Q19 and D16R27 yielded 
ANIb and ANIm values above 95% with DSM 45524T, indicating that they 
belong to the species M. franklinii, thus confirming previously reported data 
(Lourenco Nogueira et al., 2015). The remaining nine isolates yielded ANI 
values below 95% with all type strains indicating a clear separation from the M. 
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chelonae- M. abscessus complex at the species level. These isolates could be 
grouped in three genomospecies using their ANI values: D16Q14, D16Q20, 
D16R24 and D17A2 (Genomospecies A), 96-892, D16Q13 and D16Q16 
(Genomospecies B); and D16R12 and D16R18 (Genomospecies C). Pairwise 
ANI values of isolates within each genomospecies were above 95% (Table 10.2 
and Table S10.6). The complete ANIb data distribution was represented in a 
tree (Figure 10.1). The tree obtained using ANIm data showed the same 
distribution (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.1 The evolutionary history was inferred using the Neighbor-Joining 
method (Saitou and Nei 1987). The tree based on ANIb analysis is drawn to 
scale, with branch lengths in the same units as those of the evolutionary 
distances used to infer the phylogenetic tree. Evolutionary analyses were 
carried out in MEGA7 (Kumar, Stecher et al. 2016).  
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Tetranucleotide frequency correlation coefficients (TETRA) analysis 
 The pairwise TETRA coefficients were all above the 0.99 threshold, even 
between the different type strains (Table 10.2). Isolates with pairwise ANI 
values above 95% showed TETRA values above 0.999 and pairwise ANI values 
below 95% corresponded to TETRA values between 0.99 and 0.999. ANI 
values below 95% and TETRA values above 0.999 were obtained in pairwise 
comparisons of D16Q16 and D16Q20, D16R18 and D16Q15, D16R18 and M. 
salmoniphilum ATCC 13758T (Table S10.7). These results showed a low 
discriminative power of TETRA analysis applied to the CHII group. 
 
Genome-to-Genome Distance (GGD) calculations 
 The genome distance displayed by the genomes under study confirmed 
the grouping obtained with ANI, however some partially discordant data were 
observed (Table 10.2 and Figure 10.2, Table S10.8). The 14 isolates found to 
belong to M. chelonae by ANI, showed data suggesting that they could belong 
to a different but very closely related species (GGD around 0.045 and dDDH 
around 64%) (Table S10.8). A similar result was found when comparing 
genomospecies C genomes each other (isolates D16R12 and D16R18) (Table 
S10.8), while GGD and dDDH data confirmed data for genomospecies A and B 
(Table 10.2). 
 On the other hand, isolate D16Q15 vs. M. salmoniphilum and D16Q19-
D16R27 vs. M. franklinii showed GGD values slightly higher than the accepted 
threshold (0.033-0.034, see Table S10.6); yet, dDDH percentage values higher 
than 70% were obtained for both pairs of strains (Table 10.2). 
 As expected, the genomes from reference type-strains showed GGD and 
dDDH values corresponding to those of different species (GGD between 
0.1272-0.1627; dDDH <33%; Table S10.6). Again, genome distance analysis 
showed values slightly higher than the threshold (0.0266-0.0288) corresponding 
to dDDH >70%, when comparing genomes of M. abscessus subspecies to each 
other (Table S10.8).  
 Data obtained of the genome distance, represented in a tree (Figure 
10.2), showed similar genome distribution to that derived from ANI data (Figure 
10.1). 
 
PART III: EXPERIMENTAL WORK 
100 
Figure 10.2 The evolutionary history was inferred using the Neighbor-Joining method (Saitou and Nei 
1987). The tree based on GGD analysis is drawn to scale, with branch lengths in the same units as 
those of the evolutionary distances used to infer the phylogenetic tree. Evolutionary analyses were 
carried out in MEGA7 (Kumar, Stecher et al. 2016). 
 
Genomic signature (delta values) 
 The obtained delta values fell within the range of the calculated cutoff 
values, between 21 and 27, indicating that all isolates and type strains are 
closely related. The type strains M. abscessus subsp. abscessus ATCC 19977T, 
M. abscessus subsp. bolletii CCUG 50184T and M. abscessus subsp. 
massiliense CCUG 48898T showed the lowest delta values (22 to 24) and, as 
expected, were grouped as a single species. In accordance with the distribution 
found with ANI and GGD, the three M. abscessus subspecies and M. 
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immunogenum ATCC 700505T appeared more separated from the other strains 
and isolates within the group (delta values of 24 to 28) (Table 10.2 and Table 
S10.9). 
 
Single-gene analyses  
 Individual trees obtained with 16S rDNA, rpoB, hsp65 and ITS-1 
sequences grouped the CHII isolates among members of M. chelonae-
abscessus complex (Figure 10.3 and Figure S10.1). 
The individual trees obtained with 16S rDNA, hsp65, and ITS sequences 
showed some discordant groupings when compared to ANI and GGD trees 
(Figure S10.1). In the 16S rDNA tree all M. chelonae isolates clustered with M. 
saopaulense CCUG 66554T. Moreover, it was not possible to discriminate M. 
chelonae ATCC 35752T from M. franklinii isolates as well isolates of 
genomospecies A and genomospecies B. In the hsp65 tree, isolates of 
genomospecies A clustered with M. salmoniphilum ATCC 13758T and isolates 
D16Q19 and D16R27 did not cluster with M. franklinii DSM 45524T. Moreover 
isolate D16Q15 did not cluster with M. salmoniphilum ATCC 13758T. In the 16S-
23S ITS tree, isolate D16Q15 clustered with isolates of genomospecies A and 
not with M. salmoniphilum ATCC 13758T. Furthermore, isolates of 
genomospecies C were not grouped. In the rpoB and the concatenated trees 
all M. chelonae isolates clustered with M. chelonae ATCC 35752T, D16R27 and 
D16Q19 with M. franklinii DSM 45524T, and D16Q15 
with  M. salmoniphilum ATCC 13758T. Moreover, genomospecies A, B and C 
formed clusters separated from all type strains (Figure 10.3). Therefore, rpoB 
and concatenated trees were in agreement with the isolates distribution 
obtained using ANI and GGD procedures. 
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Figure 10.3 Trees based on the figure generated by SeaView (http://doua.prabi.fr/software/seaview). 
Bootstrap values >50% are shown at nodes. (A) rpoB (711 bp); (B) concatenated sequences of 16S rDNA 
(1384 bp), hsp65 (401 bp), 16S-23S ITS fragment (214 bp) and rpoB (711 bp). 
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10.3 Discussion 
 The variability observed during the development of the INNO-LiPA® 
assay suggested the existence of different taxonomic groups among the CHII 
isolates. In the present study, we performed various whole genome sequence 
based analyses along with single gene sequencing and a biochemical 
characterization to characterize 26 INNO-LiPA® cluster CHII isolates and 
included type strains of the established species belonging to the M. chelonae- 
M. abscessus complex.  
 Similarly to previously published data (Lourenco Nogueira, Simmon et al. 
2015, Nogueira, Whipps et al. 2015), phenotypic analyses and drug 
susceptibility tests were not helpful for distinguishing the taxonomic groups 
delimited by genomic analyses in this study.  
 Genomic analyses confirmed that the three subspecies within M. 
abscessus indeed represent a single species. M. abscessus subsp. abscessus 
ATCC 19977T, M. abscessus subsp. bolletii CCUG 50184T and M. abscessus 
subsp. massiliense CCUG 48898T showed a GGD value higher than the 
proposed cutoff (0.0266 to 0.0288 distance values); this result is in agreement 
with the recent data found by Tortoli and co-workers (Tortoli, Kohl et al. 2016) 
when describing the subspecies within M. abscessus. However, the calculated 
dDDH percentages were higher than 70%, therefore within the value expected 
for a single species (Table S10.6).  
 Analysis of the remaining type strains through the determination of ANIb, 
ANIm, TETRA, delta, GGD-dDDH values revealed that species delineation 
threshold values that are commonly used cannot consistently be applied to 
these closely related Mycobacterium species. This observation was further 
endorsed through the analysis of some of the cluster CHII isolates where e.g. 
ANI analyses demonstrated that some strains represented a single species 
while GGD and dDDH suggested they represented closely related yet distinct 
species (see below). In addition, the threshold level of 0.99 to discriminate 
species by means of their genomic TETRA values proved inadequate as the 
TETRA value of every pair of strains examined in the present study was 
consistently above 0.99, even in the case that other approaches, such as ANI, 
indicated that were different species. Similarly, delta values proved to be not 
discriminatory either. 
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 Fourteen isolates showed >95% ANI values with M. chelonae ATCC 
35752T yet GGD values (0.0449 to 0.0458) and dDDH (<70%, i.e. 63.50 to 
64.00) suggested they represented a distinct species, closely related to M. 
chelonae.  
 In a similar manner, ANI and dDDH values assigned the isolate D16Q15 
to M. salmoniphilum and the isolates D16Q19, D16R27 to M. franklinii while 
GGD values suggested they represented distinct species, closely related to M. 
salmoniphilum ATCC 13758T (0.0340 distance value) and M. franklinii DSM 
45524T (0.0336 distance values), respectively. 
 Finally, the genomic data also showed that the remaining nine isolates 
represent at least three novel species closely related to M. salmoniphilum. The 
genomic parameters for genomospecies A and B are consistent. For 
genomospecies C however, ANI values demonstrate that the isolates D16R12 
and D16R18 represent a single species while GGD and dDDH data suggest 
they represent two species (0.0480 and 62.2%, respectively). When Whipps et 
al. proposed to revive the name M. salmoniphilum in 2007, a high variability 
among M. salmoniphilum isolates was observed (Whipps, Butler et al. 2007). 
Moreover, 16S rDNA and hsp65 sequences of isolates of genomospecies A, B 
and C showed a high similarity with the respective sequences of isolates 
recovered from fish, especially salmonids, in different geographic regions - 
Japan, Russia, Norway, Scotland, USA and Chile - and from tap water in the 
Netherlands (Whipps, Butler et al. 2007, van Ingen, Blaak et al. 2010, Righetti, 
Favaro et al. 2014). Together, these findings indicate that the M. salmoniphilum 
lineage comprises a broad group of closely related species that could represent 
a species complex in its own right.  
 Whole genome sequencing is still not routinely available for diagnostic 
purposes, making the analysis of few genes or informative genomic regions the 
standard procedure to identify difficult mycobacteria. Individual and 
concatenated phylogenetic trees of taxonomically informative sequences were 
constructed to evaluate if they could accurately discriminate the species/groups 
established by ANI and GGD and be useful for the identification of these taxa in 
routine laboratories. Only the rpoB and the concatenated phylogenetic tree 
clearly showed the same taxonomic groups discriminated by ANI and GGD 
analyses (Figure 10.3), therefore, comparison of these sequence could 
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accurately be used in the identification of members of the M. chelonae- M. 
abscessus complex until WGS could enter into the laboratory diagnostic routine.  
 Our results showed that the current threshold values applied in the 
procedures used for WGS species delineation could probably not be of general 
application to all the bacterial taxa, as was the case of the M. chelonae- M. 
abscessus complex, probably due to the different evolutionary routes followed 
by different bacteria, revealed after a whole genome comparison. 
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Supplementary material 
 
Figure S10.1 Trees based on the figure generated by SeaView. Bootstrap values >50% are 
shown at nodes. (A) 16S rDNA (1384 bp), (B) hsp65 (401 bp), (C) 16S-23S ITS fragment (214 
bp). 
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Table S10.1 Primers used for PCR amplification and partial sequencing of 16S rRNA, hsp65, 
rpoB and ITS fragments.  
Gene  Primers  Sequence 5´-3´ References 
16S rRNA 16S-27F* AGAGTTTGATCCTGGCTCAG (Harmsen, Dostal et al. 2003) 
16S rRNA 800F ATTAGATACCCTGGTAG (Adekambi and Drancourt 2004b) 
16S rRNA 16S-907R* CCGTCAATTCCTTTGAGTTT (Harmsen, Dostal et al. 2003) 
16S rRNA 16R-1492* TACGGCTACCTTGTTACGACTT (Gomila, Ramirez et al. 2007) 
rpoB MycoF GGCAAGGTCACCCCGAAGGG (Adekambi, Colson et al. 2003) 
rpoB MycoR AGCGGCTGCTGGGTGATCATC (Adekambi, Colson et al. 2003) 
hsp65 hsp667F GGCCAAGACAATTGCGTACG (Selvaraju, Khan et al. 2005) 
hsp65 hsp667R GGAGCTGACCAGCAGGATG (Selvaraju, Khan et al. 2005) 
ITS Sp1 ACCTCCTTTCTAAGGAGCACC (Roth, Reischl et al. 2000) 
ITS 23S1R CCCAAAGCCTATATATTCAGC (Matsumoto, Chimara et al. 2012) 
*Primers were modified based on the M. abscessus subsp. abscessus
 
ATCC 19977
T
 genome 
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Table S10.2 Mycobacterium species, strains and GenBank accession numbers used for 
construction of the phylogenetic trees 
Gene Mycobacterium species Strain Accession number 
16S rRNA 
M. abscessus subsp. abscessus CIP 104536
T
 AY457071 
M. abscessus subsp. bolletii CIP 108541
T
 AY859681 
M. massiliense
*
 CCUG 48898
T
 NR_043002 
M. chelonae CIP 104535
T
 AY457072 
M. immunogenum DSM 45595
T
 HE654001 
M. salmoniphilum ATCC 13758
T
 NR_043989 
M. franklinii DSM 45524
T
 HQ153090 
M. saopaulense CCUG 66554
T
 KM973037 
M. tuberculosis H37Rv NC_000962_3 
M. smegmatis MC2 155
T
 NC_008596 
hsp65 
M. abscessus subsp. abscessus CIP 104536
T
 AY458075 
M. abscessus subsp. bolletii CIP 108541
T
 AY859675 
M  massiliense
* 
CCUG 48898
T
 AY596465 
M. chelonae CIP 104535
T
 AY458074 
M. immunogenum CIP 106684
T
 AY458081 
M. salmoniphilum ATCC 13758
T
 DQ866777 
M. franklinii DSM 45524
T
 KM392059 
M. saopaulense CCUG 66554
T
 KM973026 
M. tuberculosis H37Rv NC_000962_3 
M. smegmatis MC2 155
T
 NC_008596 
rpoB 
M. abscessus subsp. abscessus CIP 104536
T
 AY147164 
M. abscessus subsp. bolletii CIP 108541
T
 AY859692 
M. massiliense CCUG 48898
T
 AY593981.2 
M. chelonae CIP 104535
T
 AY147163 
M. immunogenum CIP 106684
T
 AY262739 
M. salmoniphilum ATCC 13758
T
 KM392058 
M. franklinii DSM 45524
T
 KM392056 
M. saopaulense CCUG 66554
T
 KM973029 
M. tuberculosis H37Rv NC_000962_3 
M. smegmatis MC2 155
T
 NC_008596 
ITS 
M. abscessus subsp. abscessus CIP 104536
T
 AY593976 
M. abscessus subsp. bolletii CCUG 50184
T
 GU143888.2 
M. massiliense
*
 CCUG 48898
T
 AY593978.1 
M. chelonae ATCC 35752
T
 AY498739 
M. immunogenum CIP 106684
T
 AY593977 
M. salmoniphilum ATCC 13758
T
 DQ866768 
M. franklinii DSM 45524
T
 HQ153093 
M. saopaulense CCUG 66554
T
 KM973034 
M. tuberculosis ATCC 27294
T
 L15623 
M. smegmatis MC2 155
T
 NC_008596 
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Table S10.3. Comparison of phenotypic and biochemical characteristics of the isolates and type strains included in this study. 
*PNB, p-aminobenzoic acid; **nc, nonchromogenic 
 
 Pigment 
production 
Growth in the presence of  Single-source carbon utilization Nitrate 
reduction 
Tween 80 
hydrolysis 
Arylsulfatase 
production Isolate Picric 
acid 
PNB* Nitrite 5%NaCl 
30
o
C 
5%NaCl 
37
o
C 
 mannitol inositol citrate 
96-1705 nc + + + + +  - - - - - + 
96-1717 nc + + + + +  + + + - - + 
96-1720 nc + + + + +  - - + - - + 
96-1724 nc + + + + +  + + + - - + 
96-1728 nc + + + + +  - - + - - + 
D16Q24 nc + + + + +  - - + - - + 
D16R2 nc + + + + +  + + + - - + 
D16R3 nc + + + + -  - - - - - + 
D16R7 nc + + + + +  - + + - - + 
D16R9 nc + + - + +  - - + - - + 
D16R10 nc + + - + +  - - + - - + 
D16R14 nc + + + + +  - - + - - + 
D16R19  nc + + + + -  - - + - - + 
D16R20 nc + + + + +  - - + - - + 
D16Q15 nc + + - + -  - - - - - + 
D16R12 nc + + - + -  - - + - - + 
D16R18 nc + + - + -  - - + - - + 
96-892 nc + + + + +  - - + - - + 
D16Q13 nc + + + + -  - - + - - + 
D16Q16 nc + + - + -  - - + - - + 
D16Q14 nc + + + + -  - - + - - + 
D16Q20 nc + + - + -  - - + - - + 
D16R24 nc + + - + +  - - - - - + 
D17A2 nc + + + + +  - - - - - + 
D16Q19 nc + + + + +  - - + - - + 
D16R27 nc + + + + +  - - + - - + 
ATCC 19977
T
 nc + + + + +  - - - - - + 
CCUG 50184
T
 nc + + + + +  - - - - - + 
CCUG 48898
T
 nc + + + + +  - - - - - + 
ATCC 35752
T
 nc + + + + +  - - + - - + 
ATCC 700505
T
 nc + + + + +  + - + - - + 
ATCC 13758
T
 nc + + + + -  - - - - - + 
DSM 45524
T
 nc + + + + +  - - - - - + 
CCUG 66554T nc + + + + +  - - + - - + 
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Table S10.4. Antibiotic susceptibility profile of the isolates and the type strains included in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bold indicates resistance, * indicates intermediate resistance 
 
 
Isolate Amikacin Cefoxitin Ciprofloxacin Clarithromycin Doxycycline Minocycline Moxifloxacin Tobramycin 
96-1705 32* >512 2* ≤0.5 >32 16 2* 2 
96-1717 8 >512 1 ≤0.5 >32 16 2* 2 
96-1720 32* >512 2* ≤0.5 >32 32 2* 4* 
96-1724 8 >512 1 ≤0.5 >32 16 0.5 1 
96-1728 32* >512 2* ≤0.5 >32 2* 2* 4* 
D16Q24 32* >512 2* ≤0.5 >32 8 2* 4* 
D16R2 64 >512 4 ≤0.5 >32 32 4 8 
D16R3 32* >512 0.5 ≤0.5 >32 8 <0.25 4* 
D16R7 32* >512 4 ≤0.5 >32 16 4 4* 
D16R9 32* >512 2* ≤0.5 >32 16 2* 4* 
D16R10 16 >512 4 ≤0.5 >32 16 1 2 
D16R14 32* >512 8 ≤0.5 >32 32 4 4* 
D16R19  64 >512 4 ≤0.5 >32 16 8 4* 
D16R20 8 >512 2* ≤0.5 >32 4* 1 1 
D16Q15 64 >512 4 ≤0.5 >32 32 4 8 
D16R12 ≤4 >512 ≤0.25 ≤0.5 ≤0.25 1 0.5 8 
D16R18 ≤4 >512 0.5 ≤0.5 ≤0.25 0,5 1 8 
96-892 32* >512 0.5 ≤0.5 8 0.5 0.5 16 
D16Q13 32* >512 1 ≤0.5 >32 2* 2* 32 
D16Q16 16 512 ≤0.25 ≤0.5 >32 8 ≤0.25 4* 
D16Q14 16 >512 2* ≤0.5 >32 16 2* 4* 
D16Q20  8  >512  2*  ≤0.5  >32  32  0.5 2 
D16R24  16  >512  2*  ≤0.5  >32  16  2*  4* 
D17A2  - -  -   - - -  -  -  
D16Q19  8 64* ≤0.25 ≤0.5 ≤0.25 1 0.5 4* 
D16R27  16 64* ≤0.25 ≤0.5 ≤0.25 ≤0.25 1 16 
ATCC 19977
T
 8 64* 4 ≤0.5 >32 8 8  8 
CCUG 50184
T
 16 32* 8 ≤0.5 >32 16 8 16 
CCUG 48898
T
 8 >512 4 ≤0.5 ≤0.25 0.5 4 8 
ATCC 35752
T
 8 512 0.5 ≤0.5 4* 2* <0.25 2 
ATCC 700505
T
 ≤4 256 1 ≤0.5 >32 8 1 4* 
ATCC 13758
T
 16 512 1 ≤0.5 >32 2* 2* 4* 
DSM 45524
T
 ≤4 16 0.5 ≤0.5 ≤0.25 ≤0.25 1 2 
CCUG 66554
T
 128                 >512 2* ≤0.5 >32 16 8 32 
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Table S10.5. Illumina Miseq assembly details for the isolates and type strains of M. chelonae-M. 
abscessus complex 
Isolates and type strains Bases 
assembled 
Number of 
scaffolds 
N50 scaffolds 
size (bp) 
Estimated %GC 
content 
96-1705 4,998,263 29 270,676 63.98 
96-1717 5,088,556 23 533,807 63.79 
96-1720 4,989,632 27 281,017 63.89 
96-1724 5,167,153 34 433,022 63.90 
96-1728 4,940,199 22 569,132 64.07 
D16R24 5,218,400 53 219,363 63.81 
D16Q13 4,903,783 23 579,383 64.18 
D16Q14 5,171,220 65 198,484 63.77 
D16Q15 4,939,516 15 682,599 63.63 
D16Q16 5,017,561 23 370,841 64.19 
D16Q20 4,858,082 73 134,797 63.93 
D16Q24 5,457,716 50 336,599 63.82 
D16R2 5,153,513 23 350,269 63.85 
D16R3 5,201,663 21 350,642 63.96 
D16R7 5,212,684 20 500,734 63.89 
D16R9 5,126,063 23 362,638 63.88 
D16R10 5,133,965 48 187,245 63.90 
D16R12 4,808,095 27 294,619 64.08 
D16R14 5,123,766 21 575,060 63.91 
D16R18 4,991,856 82 110,426 63.89 
D16R19 4,989,084 24 306,045 63.95 
D16R20 5,182,981 41 250,323 63.92 
D17A2 5,201,188 56 219,356 63.76 
D16Q19 5,112,070 38 477,240 63.93 
D16R27 5,120,456 19 588,891 64.00 
96-892 4,931,770 37 458,987 64.13 
M. abscessus subsp. boletii  
CCUG 50184
T
 
5,044,397 21 443,298 63.90 
M. immunogenum 
 ATCC 700505
T
 
5,548,818 19 406,873 64.04 
M. salmoniphilum  
ATCC 13758
T
 
4,768,278 25 250,904 64.15 
M. franklinii  
DSM 45524
T
 
5,437,336 29 325,961 64.14 
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Table S10.6 ANIb and ANIm values obtained with the 26 isolates and the M. chelonae-M. 
abscessus type strains 
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Table S10.7 TETRA values obtained with the 26 isolates and the M. chelonae-M. 
abscessus type strains 
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Table S10.8 Genome to genome distance (GGD) and digital DNA-DNA hybridization 
(dDDH) values obtained with the 26 isolates and the M. chelonae-M. abscessus type 
strains 
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Table S10.9 Delta values obtained with the 26 isolates and the M.chelonae-M. abscessus complex type strains 
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11 General summary 
 
The members of the M. abscessus-M. chelonae complex are medically among 
the most important NTM species. In the present study we examined the taxonomic 
position of a set of clinical and environmental isolates of the M. chelonae-M. 
abscessus complex previously included in the CHII cluster by the commercial DNA 
strip assay INNO-LiPA® and isolates that failed to match the recognized species 
patterns. Four isolates used for the development of INNO-LiPA® and the type strains 
of the species formally recognized as members of the M. chelonae-M. abscessus 
complex at the beginning of this study – M. chelonae (Bergey, Harrison et al. 1923), 
M. abscessus subsp. abscessus, M. abscessus subsp. bolletii (Leao, Tortoli et al. 
2009, Leao, Tortoli et al. 2011), M. immunogenum (Wilson, Steingrube et al. 2001), 
and M. salmoniphilum (Whipps, Butler et al. 2007), plus M. massiliense (Adekambi, 
Reynaud-Gaubert et al. 2004a, Adekambi, Berger et al. 2006) and "M. franklinii" 
(Simmon, Brown-Elliott et al. 2011) were included for comparison. 
In the first phase of this study (CHAPTER 7), the isolates were preliminarily 
characterized using GenoType® Mycobacterium CM and AS, PRA-hps65 and PRA-
ITS.  
The GenoType® assay confirmed that all isolates included in this study 
belonged to the M. chelonae-M. abscessus complex.  
Using PRA-hsp65 and PRA-ITS, the representative strains of INNO-LiPA® 
CHI, CHII, CHIII and CHIV clusters showed different PRA-hsp65 and PRA-ITS 
restriction profiles confirming that they belong to separate genotypes. These clusters 
were established during INNO-LiPA® development, since a set of M. chelonae-M. 
abscessus complex isolates showed different hybridization profiles with specific 
INNO-LiPA® DNA probes. When INNO-LiPA® was developed in the 1990s, the only 
formally recognized species of M. chelonae-M. abscessus complex were M. 
abscessus and M. chelonae. It was observed that INNO-LiPA® CHIII cluster 
encompassed M. abscessus and, accordingly, CHI, CHII and CHIV isolates were 
classified as M. chelonae (Portaels, Rigouts et al. 1998). In this work, isolate 8223, 
the representative strain of CHIII INNO-LiPA® cluster, was identified as M. abscessus 
by PRA-hsp65 and PRA-ITS. The representative strain of CHIV (96-443) was 
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assigned to M. chelonae. However the identification of the representative strains of 
CHI (6410) and CHII (96-892) was not achieved, since discrepant results of PRA-
hsp65 and PRA-ITS were observed.  
During INNO-LiPA® development high variability in phenotypic characteristics 
of CHII cluster isolates was observed, which is the reason why this group was 
evaluated in this thesis. In the first phase of this study high genotypic variability was 
observed among these CHII isolates and they were subdivided into six groups based 
on their PRA-hsp65 and PRA-ITS restriction profiles. This high genotypic variability 
indicated that CHII isolates could indeed belong to distinct taxonomic groups, as 
suggested during the development of INNO-LiPA®. With the results of PRA-hsp65 
and PRA-ITS 16/28 CHII isolates were identified as M. chelonae and the taxonomic 
position of 12/28 isolates remained inconclusive, because they showed discordant 
results of PRA-hsp65 and PRA-ITS (see Table 7.1). Isolates EPM 10906, EPM 
10695, IAL 3785. JAN1 and JAN2 also remained without conclusive taxonomic 
classification after PRA-hsp65 and PRA-ITS.  
A polyphasic analysis was carried out in the second phase of this study in 
order to clarify the taxonomic position of the isolates with no conclusive species 
identification and to further explore the internal variability of CHII cluster isolates. 
Isolates were characterized using phenotypic analyses, drug susceptibility testing, 
DNA sequencing of the 16S rRNA, hsp65 and rpoB genes and the 16S-23S ITS. 
Seven isolates showed results that confirmed that they belong to the M. chelonae-M. 
abscessus complex, but did not belong to any of the accepted species and therefore 
they likely represented clinically important new species. These isolates were then 
submitted to DDH experiments against the type strains of the M. chelonae-M. 
abscessus complex to confirm that they represented novel species of this complex. 
Most taxonomists agree that DDH is still the cornerstone in the delineation of 
bacterial species (Stackebrandt, Frederiksen et al. 2002, Goris, Konstantinidis et al. 
2007, Ramasamy, Mishra et al. 2014). 
Isolates D16Q19 and D16R27 (that belong to CHII INNO-LiPA® cluster) 
showed high 16S rRNA, rpoB, hsp65 and 16S-23S ITS sequence identities with the 
respective sequences of “M. franklinii” DSM 45524T. This species was proposed in 
2011 by Simmon et al. when clinical isolates from patients with sinopulmonary 
disease were studied (Simmon, Brown-Elliott et al. 2011). However, this proposal 
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was effectively published in Emerging Infectious Diseases, and not in the IJSEM and 
the authors did not valide the effectively published name “M. franklinii”. In order to 
confirm that this taxon is really a new species of M. chelonae-M. abscessus complex, 
isolate D16R27 was submitted to the DDH experiment against the type strains of the 
M. chelonae-M. abscessus complex. The average DDH value between D16R27 and 
“M. franklinii” DSM 45524T was higher than the cutoff value of 70% confirming that 
both belong to the same species. Moreover, the average hybridization values of 
D16R27 with M. abscessus subsp. abscessus ATCC19977T, M. chelonae ATCC 
35752T, M. immunogenum ATCC 700505T and M. salmoniphilum ATCC 13758T were 
all below 70%, confirming that isolate D16R27 represents a distinct species of the M. 
chelonae-M. abscessus complex. After phenotypic and genotypic characterization of 
these isolates, the name M. franklinii sp. nov. was formally published in IJSEM which 
validated its name (CHAPTER 8). 
Isolates EPM 10906, EPM 10695, IAL 3785, JAN1, JAN2 also appeared to 
represent a clinically important new species. The two EPM isolates (EPM 10906 and 
EPM 10695) and IAL 3785 were obtained from clinical samples in different years and 
cities of Brazil, while isolates JAN1 and JAN2 were obtained from zebrafish in USA. 
They showed overlapping phenotypic and genotypic characteristics with members of 
M. chelonae-M. abscessus complex. Moreover, discordant results were observed in 
DNA sequencing results. The hsp65, rpoB and ITS sequences shared highest 
identity with the corresponding sequences of M. abscessus subsp. abscessus CIP 
104536T, M. chelonae CIP 104535T and M. franklinii DSM 45524T, respectively 
(ANNEX 1). DDH experiments confirmed that the five isolates belong to the same 
species since hybridization values above 70% were obtained. Then the isolate EPM 
10906T was selected to perform DDH with the type strains of the M. chelonae-M. 
abscessus complex. All values were below 70%, confirming that EPM 10906T and 
the other four isolates belong to a distinct species of the M. chelonae-M. abscessus 
complex. The name M. saopaulense sp. nov. was proposed and validly published in 
IJSEM (CHAPTER 9). 
The DDH technique needs considerable amounts of high quality DNA. Since 
mycobacteria have a complex cell wall structure that is impermeable and difficult to 
lyse, an effective DNA extraction is not easy. Most of the commonly used DNA 
isolation procedures result in poor quality and low yield of DNA. Consequently, to 
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achieve high amounts of high quality DNA more than 1 liter of liquid bacterial culture 
is required. Furthermore, to achieve the required DNA concentration it is necessary 
to repeat the DNA extraction protocol several times and pool the harvested DNA 
preparations. All these facts turn the whole process expensive, time-consuming and 
labor-intensive. With the introduction of NGS technology, the use of entire genome 
sequence analysis in taxonomic studies of prokaryotes has become an important tool 
to replace of DDH (Moore, Mihaylova et al. 2010).  
Therefore in the third phase of this study (CHAPTER 10) the isolates of CHII 
INNO-LiPA® cluster were submitted to WGS in order to clarify their taxonomic 
position at species level. Although some isolates of the CHII cluster were already 
identified as M. chelonae in the first phase of this study, the taxonomic position of 10 
isolates of the CHII INNO-LiPA® cluster (96-892, D16Q13, D16Q14, D16Q16, 
D16Q20, D16R24, D17A2, D16Q15, D16R12 and D16R18) still remained doubtful. 
All CHII isolates were submitted to WGS and pairwise genome comparisons in order 
to better understand the population structure and diversity of this cluster. Several 
pairwise genome comparisons, including ANI, TETRA analysis, genomic signature 
(delta values), GGD calculations and digital DNA-DNA hybridization, were performed 
to explore the relationships among the isolates and the species of the M. chelonae-
M. abscessus complex. Unfortunately the DNA of isolates 96-1712 and D16R4 were 
contaminated and it was not possible to perform the genome assembly. These 
isolates were not included in the genome comparisons analyses. 
Briefly, considering the results of the whole genome sequence comparisons, 
the 26 isolates from INNO-LiPA® cluster CHII could be identified as follows: 14 
isolates as M. chelonae, two as M. franklinii, one as M. salmoniphilum and nine 
belonging to three novel genomospecies. These results confirmed that the CHII 
cluster encompasses different species of M. chelonae-M. abscessus complex. 
However, discordant results were verified between ANI values and the other 
genome comparison analyses, suggesting that the cut-off values currently used for 
other bacteria could not be applied to closely relatated species of mycobacteria, such 
as the members of M. chelonae- M.abscessus complex. 
Pairwise genome comparisons between the type strains of the M. chelonae-M. 
abscessus complex including the two new species described, M. franklinii DSM 
45524T and M. saopaulense CCUG 66554T, were also performed in order to revisit 
PART IV: GENERAL DISCUSSION 
122 
the current taxonomic classification of M. chelonae-M. abscessus complex. The ANI 
values between the type strains were all below 95%, except between M. abscessus 
subsp. abscessus ATCC 19977T, M. abscessus subsp. bolletii CCUG 50184T and M. 
massiliense CCUG 48898T, which were above 95%. These results confirmed that the 
type strains represent distinct species of M. chelonae-M. abscessus complex and 
that strains ATCC 19977T, CCUG 50184T and CCUG 48898T belong to the same 
species (M. abscessus). 
Finally, at the end of the third phase of this study, the taxonomic position of the 
isolates was clarified. However, different approaches were needed to determine their 
taxonomic status. Phenotypical and some molecular tests used for mycobacteria 
identification were unable to correctly determine the assignment at species level of 
some isolates. Furthermore, some discrepancies among different methodologies 
were observed which could lead to erroneous identification at species level and 
consequently to implications in patient management. Discrepancies and some 
difficulties in species identification faced during this study will be discussed in the 
next sections of this chapter.  
 
12 Discussions 
 
12.1 Phenotypic identification 
 
Biochemical and culture tests were poorly discriminative in this study. All 
isolates exhibited overlapping characteristics with the type strains and none of the 
phenotypic tests was able to discriminate the M. chelonae-M. abscessus complex 
species, especially those new species described in this study. Moreover, several 
tests needed to be repeated because interpretation of the results was doubtful. 
Previous studies commonly reported that phenotypic tests are time-consuming and 
lack discriminatory power (Butler and Guthertz 2001, Tortoli, Bartoloni et al. 2001, 
Cook, Turenne et al. 2003, Chimara, Ferrazoli et al. 2008, Simmon, Brown-Elliott et 
al. 2011). Interspecies homogeneity and intraspecies variability in phenotypic tests 
for identification of mycobacteria were previously observed by different authors 
(Butler and Guthertz 2001, Tortoli, Bartoloni et al. 2001, Cook, Turenne et al. 2003, 
Chimara, Ferrazoli et al. 2008, Simmon, Brown-Elliott et al. 2011).This explains in 
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part why they were replaced by molecular methods for mycobacteria species 
identification in clinical laboratories. However, it has been proposed that phenotypic 
characterization should be performed in taxonomic studies and for the descriptions of 
new species (Brown-Elliott and Wallace Jr. 2012b). 
As observed during INNO-LiPA® development, isolates of the CHII cluster, 
which should be assigned to M. chelonae, showed a high variability in phenotypic 
test results and some phenotypic characteristics were compatible with an 
identification of M. abscessus (Françoise Portaels, personal communication). As 
reported by Kusunoki and Ezaki (1992), M. abscessus is distinguished from M. 
chelonae by tolerance to 5% NaCl and incapacity to use citrate as single-source-
carbon. In the present study, all isolates that belong to M. chelonae tolerated 5% 
NaCl at 30oC and only two isolates didn’t tolerate it at 37oC. Only two M. chelonae 
isolates did not grow in the presence of citrate. 
According to standard protocols for phenotypic and biochemical identification 
of mycobacteria, culture tests should be performed on Löwenstein-Jensen medium 
and incubated at 37oC (Tsukamura 1984, Kent and Kubica 1985, Leão, Martin et al. 
2004). However, some isolates of the M. chelonae-M. abscessus complex do not 
grow well on Löwenstein-Jensen. Moreover, their optimum growth occurs at 30oC 
(except for M. abscessus that grows better at 37oC). This is the reason why the tests 
performed in the present study were incubated at 30oC. It is possible that in this 
condition M. chelonae isolates tolerate 5% NaCl and can use citrate as single-
source-carbon. 
Inappropriate culture medium and incubation temperature could be 
responsible for misdiagnosis of mycobacterial infections. Routine laboratories should 
be alert to the possibility of an infection caused by M. chelonae-M. abscessus 
complex members, for example when the clinical specimen is from infections after 
traumatic injuries or surgeries. In these situations, cultures should be incubated also 
at 30oC. 
  
12.2 Drug Susceptibility testing 
 
The DST was performed by the microdilution method as recommended by 
CLSI; however, some problems were faced during its performance. Some tests had 
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to be repeated several times because the color of the positive control did not change 
to pink after one day of incubation with rezasurin; more often the color changed after 
two days of incubation. With some drugs, MIC determination was doubtful and it was 
necessary to perform the test several times until the interpretation was clear. The 
majority of isolates studied here formed large clumps when grown in liquid medium. 
Even when using a vortex to disperse the bacteria it was really hard to dissolve the 
clumps and therefore it was very difficult to adjust the inoculum suspension turbidity 
to 0.5 McFarland standard, explaining at least in part the problems faced during DST. 
MIC was not determined for isolate D17A2 that didn’t grow in the test plates in five 
experiments. 
DST has also been used in conjunction with molecular results to confirm the 
species identification since members of M. chelonae-M. abscessus complex have 
different antimicrobial susceptibility patterns (Brown-Elliott and Wallace 2002, Brown-
Elliott and Wallace Jr. 2012b). M. chelonae generally has MIC ≥256 μg/mL for 
cefoxitin, whereas with M. abscessus MIC ranges from 32 to 64 μg/mL. Moreover, M. 
abscessus is generally resistant to tobramycin (MIC ≥ 8 µg/mL) while M. chelonae is 
susceptible (MIC ≤ 2 µg/mL) (Brown-Elliott and Wallace 2002). M. immunogenum is 
generally resistant to both cefoxitin and tobramycin (Wilson, Steingrube et al. 2001). 
These data are consistent with the results of the present study, except for isolate 
D16R2 (M. chelonae) that showed resistance to tobramycin and M. immunogenum 
ATCC 700505T that showed intermediate resistance to tobramycin. M. massiliense 
was reported to be susceptible to doxycycline (MIC ≤ 1 µg/mL) (Adekambi, Reynaud-
Gaubert et al. 2004a) and M. abscessus subsp. bolletii (CCUG 50184T) to be 
resistant to most antimicrobial agents including clarithromycin (MIC ≥ 8 µg/mL) 
(Adekambi, Berger et al. 2006). In our study M. massiliense CCUG 48898T was 
susceptible to doxycycline; however M. abscessus subsp. bolletii (CCUG 50184T) 
was susceptible to clarithromycin. There are no consistent data about antimicrobial 
susceptibility patterns of M. salmoniphilum in the literature. In the present study the 
type strain ATCC 13758T was resistant to cefoxitin and doxycycline, while D16Q15 
was susceptible only to charithromycin.  
The two new species described in this study showed particular susceptibility 
patterns. M. franklinii was more susceptible and M. saopaulense was more resistant 
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to antimicrobial drugs than the other isolates and members of the M. chelonae-M. 
abscessus complex.  
From the clinical point of view, antibiotic therapy is often based on species 
identification alone, since some species present characteristic antimicrobial patterns. 
As described above variable results were found in comparison with data from the 
literature. Furthermore, variable results also occurred with isolates that belong to the 
same species. These findings highlight the necessity to perform DST in clinical 
isolates of the M. chelonae-M. abscessus complex to initiate adequate therapy. 
 
12.3 GenoType® Mycobacterium CM and AS 
 
As reported in several studies, GenoType® Mycobacterium is a rapid, easy-to-
perform, and easy-to-interpret assay (Richter, Rusch-Gerdes et al. 2006, Russo, 
Tortoli et al. 2006, Neonakis, Gitti et al. 2008). Indeed, in our study the experiments 
did not need to be repeated and no technical difficulties or doubts in results 
interpretation occurred. 
Using GenotyTpe® AS, all isolates and type strains studied showed the same 
hybridization profile (hybridization with probe 12) that corresponds to a species 
different from the mycobacteria species identifiable by this assay. In fact, the 
manufacturer does not recommend this assay to identify species of M. chelonae-M. 
abscessus complex. However these results show that there are no overlapping 
hybridization profiles between the species identifiable by GenotyTpe® AS and 
members of M. chelonae-M. abscessus complex, especially the species recently 
described, M. salmoniphilum, M. franklinii and M. saopaulense.  
However GenoType® CM showed limitations regarding species identification of 
M. chelonae-M. abscessus complex isolates and failed to identify the new species. 
GenoType® CM correctly identified isolate 8223 and the type strains ATCC 19977T, 
CCUG 50184T and CCUG 48898T as M. abscessus (hybridization with probes 5, 6 
and 10). The other type strains and isolates were identified as M. chelonae 
(hybridization with probes 5 and 10). According to the manufacturer M. 
immunogenum can either show the hybridization profile of M. chelonae or that of M. 
abscessus and there is no information about overlapping profiles among the other 
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members of the M. chelonae-M. abscessus complex, which were validated after the 
introduction of this test. 
Some previous studies reported overlapping profiles of GenoType® CM in 
other species of NTM. However this assay was considered suitable to identify 
clinically important mycobacteria (Richter, Rusch-Gerdes et al. 2006, Russo, Tortoli 
et al. 2006, Neonakis, Gitti et al. 2008). In the present study overlapping hybridization 
profiles were verified among M. chelonae, M. immunogenum, M. salmoniphilum, M. 
franklinii and M. saopaulense. Infections caused by M. chelonae-M. abscessus 
complex members have been increasingly reported (Griffith, Aksamit et al. 2007, 
Alcaide and Esteban 2010, Koh, Jeon et al. 2011, Nunes Lde, Baethgen et al. 2014) 
and, except for M. salmoniphilum, all these species have been recovered from 
humans (Meyers, Brown-Elliott et al. 2002, Sampaio, Junior et al. 2006, Del-Castillo, 
Palmero et al. 2009, Shedd, Edhegard et al. 2010, Mitchell, Isenstein et al. 2011, 
Simmon, Brown-Elliott et al. 2011, Biggs, Chudgar et al. 2012, Bhandari, Sriganesh 
et al. 2015, Chatzikokkinou, Luzzati et al. 2015, Edens, Liebich et al. 2015, 
Greninger, Langelier et al. 2015, Nogueira, Whipps et al. 2015, Shah, Relhan et al. 
2016). This finding is an important issue for routine laboratories, especially in 
European countries, that use GenoType® for NTM species identification (van der 
Werf, Kodmon et al. 2014). We therefore conclude that our study demonstrated that 
GenoType® CM is suitable for identifying strains as belonging to M. chelonae-M. 
abscessus complex, but is not capable of distinguishing all individual species of this 
complex.  
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12.4 PRA-hsp65 and PRA-ITS 
 
The PRA methodology has been adopted for the identification of mycobacteria 
in several countries because it is low-cost and easy to perform. Moreover, PRA-
hsp65 profiles of most validated species are available in the PRASITE 
(http://app.chuv.ch/prasite/index.html). However, overlapping patterns have been 
reported and multiple patterns within a single species may also occur. Both situations 
represent the major limitation of PRA (da Silva Rocha, da Costa Leite et al. 1999, 
Roth, Reischl et al. 2000, Leao, Bernardelli et al. 2005, Martin, Uwizeye et al. 2007, 
Chimara, Ferrazoli et al. 2008). Indeed, several overlapping patterns and multiple 
patterns within a species were observed in the present study.  
Among the type strains, PRA-hsp65 was useful to discriminate M. abscessus 
subsp. abscessus ATCC 19977T, M. immunogenum ATCC 700505T and M. 
saopaulense CCUG 66554T. M. abscessus subsp. bolletii CCUG 50184T and M. 
massiliense CCUG 48898T showed the same restriction profile (M. abscessus type 2) 
as well as M. chelonae ATCC 35752T and M. salmoniphilum (M. chelonae type 1). 
Moreover, M. franklinii DSM 45524T showed a restriction profile registered as M. 
immunogenum type 2.  
New restriction profiles of PRA-hsp65 were identified in the present study. All 
M. chelonae isolates showed M. chelonae type 1 profile, except for isolates 96-1705 
and 96-892 (the representative strain of CHII cluster), which showed a novel 
restriction profile not registered in PRASITE database – BstEII [bp] (320,130) and 
HaeIII [bp] (200,55,50). Since their identification was confirmed by ANI analyses as 
M. chelonae (CHAPTER 10), this restriction profile was named M. chelonae type 2. 
However, isolates of genomospecies A and B, also showed this profile, indicating 
that it can overlap with other species of the M. chelonae-M. abscessus complex. 
Isolate D16Q15, identified by ANI analyses as M salmoniphilum, also showed a 
restriction profile not registered in PRASITE database – BstEII [bp] (320,130) and 
HaeIII [bp] (200,115, 60, 50), which is different of that of the M. salmoniphilum type 
strain profile. This profile was also observed in isolates of genomospecies C. Among 
the new profiles identified in this study, only that of M. saopaulense– BstEII [bp] 
(235,210) and HaeIII [bp] (145,60,55,50) – did not overlap with other species of the 
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M. chelonae-M. abscessus complex. This profile will be named M. saopaulense type 
1. 
Several overlapping patterns were also observed in PRA-ITS. M. abscessus 
subsp. abscessus ATCC 19977T, M. abscessus subsp. bolletii CCUG 50184T, M. 
massiliense CCUG 48898T and M. franklinii DSM 45524T showed the same restriction 
profile, registered as M. abscessus profile, which was also identified in isolates of M. 
saopaulense, M. franklinii and genomospecies A and B. M. salmoniphilum ATCC 
13758T showed a restriction profile registered as M. chelonae type III, which was the 
same for isolate D16Q15 and isolates of genomospecies C. Moreover, M. chelonae 
isolates showed M. chelonae type I or type II restriction profiles. Only M 
immunogenum ATCC 700505T showed a new PRA-ITS profile – TaqI [bp] (150/125). 
Therefore, in general, the discriminative power of PRA-hsp65 was higher than 
those of PRA-ITS and the commercial assay GenoType® CM. However, several 
overlapping patterns were observed, hindering the discrimination of all species of the 
M. chelonae-M. abscessus complex. Since PRA-hsp65 is less expensive than 
commercial assays and DNA sequencing, it is still widely used for NTM identification 
by reference laboratories in low-income countries, such as Brazil. Therefore, the 
laboratories should be aware of overlapping restriction patterns and multiple patterns 
among members of M. chelonae-M. abscessus complex. Both situations can lead to 
ambiguous or erroneous species identification. Furthermore, the laboratories should 
also be aware of the description of new species and their restriction profiles.  
Species identification by PRA is based on the patterns included in the 
PRASITE for PRA-hsp65 and in the publication of Roth et al. (2000) for PRA-ITS 
(Roth, Reischl et al. 2000). However, the PRASITE is not updated since 2008 and 
the patterns of the species recently described M. salmoniphilum, M. franklinii and M. 
saopaulense have not been included. The study of Roth et al. was published in 2000 
when M. abscessus and M. chelonae were the only officially accepted species of the 
M. chelonae-M. abscessus complex.  
Other problems were faced during the performance of PRA-hsp65 and PRA-
ITS. As they are not automated techniques, they are performed as in house 
methodologies requiring additional work to standardize all steps, including PCR and 
electrophoresis conditions. For some isolates, it was necessary to change the 
concentration of PCR reagents to amplify hsp65 or ITS. Moreover, the quality of 
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agarose also influenced the results. To better separate the bands with small bp 
differences, a high-resolution agarose was used, increasing the costs. Even using it, 
sometimes the interpretation of digestion profiles was doubtful and the assay needed 
to be repeated. Therefore, in general the whole process of PRA-hsp65 and PRA-ITS 
was time-consuming and labor-intensive. 
 
12.5 DNA sequencing 
 
In the present study, the partial 16S rRNA sequences (1384 bp) of all isolates 
shared more than 99% identity with the respective sequences of all type strains of 
the M. chelonae-M. abscessus complex (ANNEX 1). The 16S rRNA inability to 
differentiate closely related species has been described in several studies (Rogall, 
Wolters et al. 1990, Adekambi, Colson et al. 2003, Adekambi and Drancourt 2004b, 
Simmon, Brown-Elliott et al. 2011, Joao, Cristovao et al. 2014). However, the use of 
16S rRNA sequencing in mycobacteria taxonomic studies is important since it shows 
the nearest phylogenetic neighbors (Tortoli, Bartoloni et al. 2001). 
In particular, regarding the two new species described in this study, partial 
sequencing of rpoB and hsp65 genes appears to be a good tool for distinguishing M. 
franklinii and M. saopaulense from other members of M. chelonae-M. abscessus 
complex. 
Over the last decades studies have shown the inaccuracy of a single gene for 
differentiation of mycobacterial species since particular limitations of each gene have 
been identified (Macheras, Roux et al. 2009, Dai, Chen et al. 2011). Besides the 
limited variation in 16S rRNA sequences (Rogall, Wolters et al. 1990, Adekambi, 
Colson et al. 2003, Adekambi and Drancourt 2004b, Joao, Cristovao et al. 2014), 
high intra-species variability of rpoB sequences has been reported (Adekambi, 
Colson et al. 2003). Moreover, several studies suggested the occurrence of genetic 
exchange among the M. chelonae-M. abscessus complex members involving 
housekeeping genes such as hsp65, sodA, rpoB, cya and glpK genes (Kim, Kook et 
al. 2008, Viana-Niero, Lima et al. 2008, Zelazny, Root et al. 2009, Macheras, Roux et 
al. 2011). Macheras et al. (2011) demonstrated the occurrence of horizontal transfer 
of rpoB sequences among between M. abscessus and M. massiliense (Macheras, 
Roux et al. 2011). Genetic exchange can lead to recombination events between 
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homologous genes and therefore isolates can show a composition of genes of 
different members of the M. chelonae-M. abscessus complex (Macheras, Roux et al. 
2009, Macheras, Roux et al. 2011). As a consequence, the use of a single gene can 
lead to misidentification at species level. 
In the present study, we demonstrated that the use of a single gene could be a 
pitfall when working with species that have never been described. The analysis of a 
single gene would lead to a misclassification since high identities are found with other 
members of M. chelonae-M. abscessus complex (ANNEX 1). In fact, this occurs 
because the members of this complex are closely related. However, when using two 
or more genes, discordant results were observed, indicating the possibility of being a 
new species.  
Other issue that deserves special attention is that identification based on DNA 
sequencing is dependent on databases such as GenBank. In general, sequences 
submitted to databases are not evaluated in terms of quality and sequences with 
errors, incomplete sequences and sequences with misassigned names can be 
deposited. As a consequence, erroneous identification can occur when sequences 
are compared to those deposited in databases. A practical example was the deposit 
of rpoB sequence of M. massiliense CCUG 48898. The first deposited sequence 
contained 5 erroneous nucleotides. The sequence was then corrected and now a 
second version is available (AY593981.2). 
 
12.6 DNA-DNA Hybridization (DDH) 
 
As previously reported, several difficulties were faced during DDH experiments 
performance, especially regarding the purity and DNA concentration. As discussed 
above, it is really hard to achieve high purity and high concentration DNA when 
working with mycobacteria, since they have a complex cell wall structure. Therefore, 
several protocols were tested and that described by Pitcher et al. (Pitcher, Saunders 
et al. 1989), which has been widely used for gram positive bacteria, showed the best 
results. It uses a lysis buffer containing lysozyme and mutanolysine. Lysozyme 
hydrolyzes the peptidoglycan present in the cell wall and it has been used for DNA 
extraction of mycobacteria (van Soolingen, de Haas et al. 1994). Mutanolysine 
cleaves the linkage of peptidoglycan-polysaccharide of the bacterial cell wall. Its use 
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is not common in DNA extraction protocols for mycobacteria; however, in this study it 
produced significantly higher DNA concentrations. 
Another problem faced in DDH experiments was related to the values of the 
reciprocal experiments. In some cases they were discordant and the experiments 
had to be repeated several times. 
As DDH was long considered the reference method in taxonomic studies for 
species delineation (Vandamme 2012), it was performed for the description of the 
new species, M. franklinii and M. saopaulense. 
DDH experiments were also performed with the type strains of M. chelonae-M. 
abscessus complex. Reciprocal experiments between all type strains were below 
70%, except between M. abscessus subsp. abscessus ATCC 19977T, M. abscessus 
subsp. bolletii CCUG 50184T and M. massiliense CCUG 48898T, that were above 
70%. These results confirmed that the type strains represent distinct species of M. 
chelonae-M. abscessus complex and that strains ATCC 19977T, CCUG 50184T and 
CCUG 48898T belong to the same species (M. abscessus). These results were 
subsequently used to validate the genome comparisons. 
 
12.7 Whole Genome Sequence Comparison 
 
Pairwise genome comparisons were performed using average nucleotide 
identity (ANI), tetranucleotide frequency correlation coefficients (TETRA) analysis, 
genomic signature (delta values), genome-to-genome distance (GGD) calculations, 
and digital DNA-DNA hybridization (dDDH). All genome comparisons results were 
presented in CHAPTER 10.  
ANI between the type strains of M. chelonae-M. abscessus complex were 
concordant with DDH experiments. These results validated the application of ANI in 
comparisons using other isolates included in this study.  
The isolates identified as M. chelonae in the first phase of this study (96-1705, 
96-1717, 96-1720, 96-1724, 96-1728, D16Q24, D16R2, D16R3, D16R7, D16R9, 
D16R10, D16R14, D16R19 and D16R20) yielded ANI values above 95% with ATCC 
35752T and below 95% with the other type strains, confirming that they indeed 
belong to the species M. chelonae. Isolate D16Q15 yielded ANI values above 95% 
with ATCC 13758T, showing that it belongs to the species M. salmoniphilum. Isolates 
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D16R27 and D16Q19 yielded ANI values above 95% with DSM 45524T, indicanting 
that they belong to the species M. franklinii. However the other isolates yielded ANI 
values below 95% with all type strains indicating a clear separation from the known 
species of the M. chelonae-M. abscessus complex. Among these isolates, three 
genomospecies were identified: D16Q14, D16Q20, D16R24 and D17A2 
(Genomospecies A), 96-892, D16Q13 and D16Q16 (Genomospecies B); and 
D16R12 and D16R18 (Genomospecies C). The pairwise comparison of isolates in 
each genomospecies yielded ANI values above 95%, indicating that they belong to 
the same species. 
Discrepant results between ANI and TETRA were observed. All TETRA 
coefficients, even between pairwise type strains, were above the 0.99 threshold. 
Moreover, isolates with pairwise ANI values above 95% showed TETRA values 
above 0.999. TETRA coefficients between pairwise type strains of M. abscessus 
showed values above 0.999 while comparisons between the other type strains were 
above 0.99 but below 0.999. This finding shows that for closely related species of the 
M. chelonae-M. abscessus complex the TETRA threshold could be higher than 0.99. 
ANI has been recognized as one of the most reliable tools to measure 
genomic relatedness between bacterial strains (Kim, Oh et al. 2014). Richter and 
Rossello-Mora (2009) showed that TETRA correlates with ANI and assists to decide 
if a pair of isolates belongs to the same species. However Ngeow et al. (2015) also 
found discrepancies between ANI and TETRA when studying closely related 
mycobacteria from M. terrae complex. TETRA indicated that some strains belonged 
to the same species while ANI values were all below 95%. This discrepancy was 
attributed to the influence of environmental factors, such as the acquisition of foreign 
sequences, which probably lead to a genome diversification without changing the 
TETRA signature. Indeed, a previous study reported that closely related bacteria 
present in the same environment have small differences in G+C distributions 
(Foerstner, von Mering et al. 2005). Considering that the majority of the isolates 
included in the present study were recovered from water sources, the hypothesis of 
Ngeow et al. (2015) could explain the discrepant results of TETRA. As the members 
of M. chelonae-M. abscessus complex are closely related and live in similar habitats, 
genome size expansion can occur while TETRA signature is conserved. Further 
PART IV: GENERAL DISCUSSION 
133 
investigations should be performed to confirm this hypothesis, including the study of 
mycobacteria isolates that don’t belong to M. chelonae-M. abscessus complex.  
A similar approach, namely genomic signature, was performed. It allowed the 
calculation of delta differences between genomes. The obtained results were not 
useful to differentiate the isolates from this study, suggesting that the correlation of 
frequencies of di- or tetra nucleotides is not applicable for species delimitation of 
closely related mycobacteria, such as those of the M. chelonae-M. abscessus 
complex.  
 The results obtained with GGD were in general congruent with the results 
obtained with ANI. However, some GGD values were above the cutoff value in some 
cases in which GGD values below the cutoff were expected. Remarkably, M. 
abscessus subsp. abscessus ATCC 19977T, M. abscessus subsp. bolletii CCUG 
50184T and M. abscessus subsp. massiliense CCUG 48898T showed a distance 
higher than the accepted cutoff (0.0266 to 0.0288 distance values) although the 
calculated dDDH values were those expected for a single species (75.5% to 77.3%). 
The same was observed with two groups clustered by ANI: D16Q15 and M. 
salmoniphilum ATCC 13758T showed 0.0340 distance value; D16Q19, D16R27 and 
M. franklinii DSM 45524T showed 0.0336 distance values. Both groups had >70%, 
dDDH values, which were in accordance with ANI values of 96.5%.  
The 14 isolates that showed >95% ANI values with M. chelonae ATCC 35752T 
showed distance values above the cutoff for species differentiation (0.0449 to 
0.0458) and <70% dDDH (63.50 to 64.00) with the M. chelonae type strain. Similar 
results were found after comparison of genomes of strains D16R12 and D16R18 
(GGD=0.0480; dDDH=62.2%) – the proposed genomospecies C. D16R12 and 
D16R18 showed ANI values lower than 95.5%, near the threshold value, thus 
suggesting the occurrence of some sequence divergence between these genomes. 
These data suggest that a revision of the threshold values for GGD is needed, 
particularly for species with inner variability, such as M. abscessus and other 
mycobacteria included in this study. 
 Considering that isolates of this study were recovered from water sources and 
that infection by members of M. chelonae-M. abscessus complex are mainly acquired 
from environmental exposure including interactions with water (Brown-Elliott and 
Wallace Jr. 2012b, Donohue, Mistry et al. 2015), the use of genomic tools for 
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identification should be implemented in the clinical laboratory for better discrimination 
of these isolates. However, WGS comparison has been scarcely used in the species 
differentiation of mycobacteria and, therefore, more studies are required to explain 
the discrepancies found in this study by using different WGS comparative 
approaches. Probably the current threshold values applied in the procedures used for 
WGS species delineation should be reevaluated for closely related species of 
mycobacteria, such as the members of the M. chelonae-M. abscessus complex. 
 As shown in CHAPTER 10, before WGS becomes affordable in the routine 
laboratory, this study indicates that analysis of rpoB gene or concatenated 
sequences of 16S rRNA, hsp65, rpoB and ITS can be useful for the identification of 
members of M. chelonae-M. abscessus complex. 
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12.8 Impact of the present study 
 
Members of the M. chelonae-M. abscessus complex have been isolated from 
several water sources (Falkinham 2009, van Ingen, Blaak et al. 2010, Gomez-
Alvarez, Revetta et al. 2012, Velayati, Farnia et al. 2014, Donohue, Mistry et al. 
2015, Petti, Polimeni et al. 2015). As they are disinfectant-resistant, they can resist 
water treatment entering houses, buildings and hospitals plumbing (Brown-Elliott and 
Wallace 2002, Primm, Lucero et al. 2004, Donohue, Mistry et al. 2015, Falkinham 
2016). Gomes-Alvarez et al. (2012) showed that several members of the M. 
chelonae-M. abscessus complex could be isolated from drinking water distribution 
systems (Gomez-Alvarez, Revetta et al. 2012). Although the majority of the 
environmental investigations failed to identify the source of infection, it is generally 
presumed that infections occur after environmental exposure, such as after contact 
with water (Brown-Elliott and Wallace Jr. 2012b, Donohue, Mistry et al. 2015). 
In 2012, an outbreak of infectious keratitis following LASIK occurred in the 
state of São Paulo, Brazil. Clinical and environmental samples from the 
ophthalmological facility were collected and sent to our laboratory. The samples were 
analyzed in parallel with the isolates included in this study. The presence of a unique 
strain of M. chelonae recovered from clinical samples and distilled water was 
demonstrated. Distilled water was prepared on a daily base in the surgical facility 
from tap water and kept in plastic reservoirs. This study concluded that the original 
source of the M. chelonae strain was the tap water demonstrating the environmental 
source of contamination (ANNEX 2). Considering that the majority of the isolates in 
the present study were recovered from water sources and infections may occur due 
to environmental exposure, all challenges faced in our study to achieve the 
identification at species level could be also faced in a clinical laboratory. 
Furthermore, the methodologies used in our study are applicable in future 
investigations of infections and outbreaks caused by members of M. chelonae-M. 
abscessus complex. 
As demonstrated in this study, WGS is a reliable tool for species identification. 
However, it is not available in clinical microbiology laboratories yet. Therefore, other 
methodologies, such as partial DNA sequencing and MALDI-TOF are being used to 
replace the phenotypic and culture tests that are time consuming and sometimes not 
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discriminatory enough. The commercial kit GeneXpert® (Cepheid), based on real-time 
PCR, has been incorporated in clinical laboratories for M. tuberculosis identification 
and rifampicin susceptibility testing, for example. Moreover, reference laboratories 
are performing partial DNA sequencing to confirm NTM species identification. 
However, as shown in this study, before WGS becomes affordable in routine 
laboratories, species identification should not be based on a single methodology. The 
use of two or more methods makes species identification more accurate and can 
reveal the presence of species not yet described. As demonstrated, analysis of rpoB 
gene or concatenated sequences of 16S rRNA, hsp65, rpoB and ITS are good tools 
for the correct identification of members of M. chelonae-M. abscessus complex, 
which is really important for patient management. 
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12 Conclusions 
 
1. A high phenotypic and genotypic variability in the CHII INNO-LiPA® cluster isolates 
was confirmed.  
2. Biochemical and culture tests were poorly discriminative and none of the 
phenotypic tests was able to fully discriminate the members of M. chelonae-M. 
abscessus complex. 
3. Variability of antimicrobial patterns within members of M. chelonae-M. abscessus 
complex was observed emphasizing the necessity to perform DST in clinical isolates 
before treatment initiation. 
4. GenoType® CM did not allow to distinguish all individual species of the M. 
chelonae-M. abscessus complex. 
5. Overlapping and multiple patterns of PRA-hsp65 and PRA-ITS were observed 
hindering discrimination of the M. chelonae-M. abscessus complex members using 
these techniques. 
6. A novel PRA-hsp65 pattern, called M. chelonae type 2 [BstEII (320 bp,130 bp, 
HaeIII (200 bp, 55 bp, 50 bp)] was described. 
7. The inability of single gene sequence analysis for species identification of 
members of the M. chelonae-M. abscessus complex was reaffirmed.  
8. WGS and genome comparisons were useful to determine the taxonomic status of 
isolates which were not resolved into definite species with conventional tests. 
9. Current threshold values applied in comparative genomics using TETRA and delta 
differences could not be used for separation of closely related members of the M. 
chelonae- M. abscessus complex. 
10. Two new species were described and validly named; M. franklinii and M. 
saopaulense, and three novel genomospecies were identified.  
11. The correct identification of M. franklinii and M. saopaulense is epidemiologically 
and clinically important. Both species can cause human diseases. M. franklinii 
caused pulmonary infections; M. saopaulense caused eye infections and cervical 
lymphadenitis. Infections caused by M. saopaulense were really difficult to treat; the 
patients with eye infection had to be submitted to corneal transplants and the patient 
with lymphadenitis died with disseminated mycobacterial infection. Moereover an 
important difference in drug susceptibility was demonstrated, as M. franklinii is 
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susceptible to most tested antimicrobials, while M. saopaulense is the most drug 
resistant species withtin the M. chelonae-M. abscessus complex.  
12. Finally, this study emphasizes that mycobacteria identification should not be 
based on a single methodology. The use of two or more methodologies makes the 
species identification more accurate and can also reveal the presence of species not 
yet described. 
PART V: CONCLUSIONS AND PERSPECTIVES 
140 
13 Perspectives 
 
With the greater accessibility of WGS, bacterial taxonomy has been launched 
into a new era of genomic taxonomy. The present study showed that WGS was 
useful to determine the taxonomic status of unknown isolates from the M. chelonae-
M. abscessus complex and could be used in future investigations of infections and 
outbreaks caused by members of M. chelonae-M. abscessus complex, allowing more 
precise species classification.  
One of the problems faced by genomic taxonomy is the scarcity of genomes 
deposited in public database for comparative analysis. The raw sequencing data of 
all type strains and isolates sequenced in the present study, including the three new 
genomospecies and the two new species, were deposited in NCBI, enlarging the 
database for future investigations. A comparative analysis of the genomes of all 
members of M. chelonae-M. abscessus complex, could allow the identification of new 
molecular targets for identification of its members. Moreover, a new line probe assay 
for accurate species identification within the M. chelonae-M. abscessus complex 
could be developed. 
With the increasing performance of analyses based on WGS, additional 
taxonomic changes such as reclassifications and the description of new species will 
probably occur in the M. chelonae-M. abscessus complex. It is important to highlight 
that taxonomic changes should be accompanied by a constant evaluation of the 
methods used for mycobacteria identification at species level in order to ensure 
proper identification of clinical and environmental isolates. 
Finally, the present study evidenced that the identification of mycobacterial 
species should not be based on a single methodology. The use of two or more 
methods makes species identification more accurate and can reveal the presence of 
species not yet described. 
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ENGLISH ABSTRACT  
 
The methodologies used to delineate bacterial species are changing with the 
development of new technologies. The Mycobacterium chelonae-Mycobacterium 
abscessus complex is composed of closely related rapidly growing mycobacteria that 
are ubiquitous in the environment and sometimes responsible for a wide spectrum of 
opportunistic infections in humans, especially pulmonary infections and localized skin 
and soft tissue infections. This complex has expanded over the years to include, 
besides the classical species M. chelonae and M. abscessus, also M. 
immunogenum, M. salmoniphilum, and two subspecies M. abscessus subsp. 
abscessus and M. abscessus subsp. bolletii. Despite all technological advances, the 
taxonomic relations of members of M. chelonae-M. abscessus complex still generate 
several doubts, due to important similarities in their phenotypic and genotypic 
characteristics. Considering the importance of correct species identification for 
understanding the taxonomy of this group and for outbreak detection and therapeutic 
patient management, the present project aimed at investigating the taxonomic 
position of a set of M. chelonae-M. abcessus complex isolates without conclusive 
species identification and a set of isolates of the CHII INNO-LiPA® cluster. A 
polyphasic approach, including phenotypic analyses traditionally used for 
identification of mycobacteria, drug susceptibility testing, the commercial test 
Genotype® Mycobacterium CM and AS, PCR Restriction Enzyme Analysis of the 
hsp65 gene and 16S-23S internal transcribed spacer (ITS), DNA sequencing of the 
16S rRNA, hsp65 and rpoB genes and the 16S-23S ITS, DNA-DNA hybridization 
(DDH), Whole Genome Sequencing (WGS) and genome comparisons were carried 
out. The previously reported high variability of the CHII INNO-LiPA® cluster was 
confirmed. Two species were validly named as new members of M. chelonae-M. 
abscessus complex, M. franklinii and M. saopaulense, and three additional 
genomospecies were identified. Moreover, genomic analyses confirmed that the type 
strains of the M. chelonae-M. abscessus complex, including the two recently 
described species (M. franklinii and M. saopaulense), belong to different species, 
confirming the current taxonomic classification of this complex in the era of genomic 
taxonomy. This study illustrates the use of WGS to determine the taxonomic status of 
isolates which conventional tests fail to identify. Furthermore it emphasizes that 
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mycobacteria identification should not be performed based only in a single 
methodology. This study will be useful for future investigations of infections and 
outbreaks caused by members of M. chelonae-M. abscessus complex. 
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NEDERLANDSE SAMENVATTING  
 
De onderzoeksmethoden die gebruikt worden om bacteriële soorten af te bakenen 
veranderen met technologische ontwikkelingen. De Mycobacterium chelonae-
Mycobacterium abscessus groep bevat een aantal nauwverwante snelgroeiende 
mycobacteriën die zeer algemeen in de omgeving voorkomen en die 
verantwoordelijk zijn voor een waaier van opportunistische infecties in mensen, 
waaronder voornamelijk longinfecties, huidinfecties en infecties in zachte weefsels. 
Deze groep van bacteriën is gedurende de recente jaren uitgebreid en bevat naast 
de traditionele species M. chelonae en M. abscessus eveneens M. immunogenum, 
M. salmoniphilum, en de twee subspecies M. abscessus subsp. abscessus en M. 
abscessus subsp. bolletii. Ondanks alle technologische vooruitgang is er nog veel 
onduidelijkheid rond de taxonomische verwantschappen van leden van de M. 
chelonae-M. abscessus groep, en dit omwille van grote gelijkenissen in hun 
fenotypische en genotypische eigenschappen. Gezien het belang van correcte 
species identificatie om de taxonomie van deze bacteriën te begrijpen en omwille van 
de detectie van uitbraken en van therapeutische beslissingen in verband met 
patiëntbehandeling en -management, stelde het voorliggend project zich tot doel de 
taxonomische verwantschappen te bepalen van M. chelonae-M. abcessus groep 
isolaten zonder eenduidige species identificatie en van een set van isolaten die 
behoren tot het CHII INNO-LiPA® cluster. Een polyfasische benadering werd hiervoor 
toegepast. Deze bevatte fenotypische testen die traditioneel gebruik worden voor de 
identificatie van mycobacteriën, antibioticumgevoeligheidsbepalingen, de 
commerciële testsystemen Genotype® Mycobacterium CM en AS, PCR restrictie-
enzymanalyse van het hsp65 gen en van de 16S-23S interne spacer (ITS), partiële 
sequenering van de 16S rRNA, hsp65 en rpoB genen en van de 16S-23S ITS, DNA-
DNA hybridisatie en onderzoek van volledige genoomsequenties. De eerder 
gerapporteerde grote variabiliteit binnen het CHII INNO-LiPA® cluster werd 
bevestigd. Twee species warden op een geldige manier beschreven als nieuw leden 
van de M. chelonae-M. abscessus groep, namelijk M. franklinii en M. saopaulense, 
en drie nieuwe genomospecies werden voor het eerst gerapporteerd. Onze studies 
van volledige genoomsequenties bevestigden dat de type stammen van de M. 
chelonae-M. abscessus groep, met inbegrip van de nieuwe species M. franklinii en 
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M. saopaulense, effectief verschillende species vertegenwoordigen, wat hun huidige 
taxonomische status onderschrijft. Ons onderzoek toonde ook aan dat het gebruik 
van genoomsequenties om de taxonomische status van problematische isolaten te 
bepalen een haalbare kaart is. Daarenboven benadrukte ons werk dat de identificatie 
van mycobacteriën beter niet gesteund is op één enkele methodologie. Onze studie 
zal ten slotte een basis vormen voor verder onderzoek naar infecties en uitbraken 
veroorzaakt door vertegenwoordigers van de M. chelonae-M. abscessus groep. 
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ANNEX 1. Percentage of sequence identity between the isolates and each type strain of M. chelonae-M. abscessus complex. 
Group Isolate 
16S rRNA (1384 bp)*  hsp65 (401 bp)  rpoB (711 bp)
#
  ITS (214 bp)
§
 
1 2 3 4 5 6 7  1 2 3 4 5 6 7  1 2 3 4 5 6 7  1 2 3 4 5 6 7 
1 8223 100 100 100 99.7 99.5 99.3 99.7  100 98.5 98.8 92.8 91.8 90.8 92.5  100 95.7 96.5 93.5 94.9 92.4 93.9  100 100 99.5 91.1 89.7 93.0 93.5 
2 96-1705 99.8 99.8 99.8 99.6 99.3 99.6 99.6  93.3 92.8 93.0 98.8 96.0 96.0 97.0  93.8 95.6 95.9 99.2 97.5 96.1 97.0  91.6 91.6 91.6 99.1 91.1 94.4 94.9 
96-1712 99.9 99.9 99.9 99.8 99.4 99.4 99.8  92.8 92.3 92.5 99.5 94.8 95.8 95.8  93.5 95.5 95.8 99.7 96.9 96.3 97.0  91.6 91.6 91.6 99.5 91.6 94.4 94.9 
96-1717 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  91.1 91.1 91.1 99.1 91.1 94.9 94.4 
96-1720 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  91.1 91.1 91.1 99.1 91.1 94.9 94.4 
96-1724 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.4 95.4 95.6 99.6 97.3 96.5 96.9  90.7 90.7 90.7 99.5 91.6 95.3 94.9 
96-1728 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.3 95.2 95.5 99.4 97.2 96.3 96.8  91.1 91.1 91.1 99.1 91.1 94.9 94.4 
96-443 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16Q24 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16R2 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16R3 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16R4 99.7 99.7 99.7 100 99.3 99.6 100  92.8 92.3 92.5 99.5 94.8 95.8 95.8  93.5 95.5 95.8 99.9 97.2 96.3 97.0  91.1 91.1 91.1 100 92.1 94.9 95.3 
D16R7 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.0  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16R9 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.4 95.4 95.6 99.6 97.3 96.5 96.9  90.7 90.7 90.7 99.5 91.6 95.3 94.9 
D16R10 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.4 95.4 95.6 99.6 97.3 96.5 96.9  90.7 90.7 90.7 99.5 91.6 95.3 94.9 
D16R14 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.1  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16R19 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.1  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
D16R20 99.9 99.9 99.9 99.8 99.4 99.4 99.8  93.0 92.5 92.8 99.8 95.0 96.0 96.0  93.5 95.5 95.8 99.7 97.2 96.3 97.1  90.7 90.7 90.7 98.6 90.7 94.4 93.9 
3 6410 99.5 99.5 99.5 99.3 100 98.9 99.3  92.3 92.3 92.5 95.3 99.0 97.3 99.0  95.6 97.2 98.2 97.0 99.3 95.5 96.9  88.8 88.8 88.3 91.1 91.1 89.3 90.2 
4A 96-892 99.6 99.6 99.6 99.9 99.2 99.8 99.9  91.5 92.0 92.3 95.8 96.8 97.0 97.5  93.4 95.1 95.6 97.9 96.5 96.2 96.8  93.9 93.9 93.5 95.8 90.2 98.1 98.6 
 D16Q13 99.6 99.6 99.6 99.9 99.2 99.8 99.9  91.5 92.0 92.3 95.8 96.8 97.0 97.5  93.4 95.1 95.6 97.9 96.5 96.2 96.8  93.9 93.9 93.5 95.8 90.2 98.1 98.6 
 D16Q16 99.5 99.5 99.5 99.8 99.1 99.7 99.8  91.5 92.0 92.3 95.8 96.8 97.0 97.5  93.4 95.1 95.6 97.9 96.5 96.2 96.8  93.9 93.9 93.5 95.8 90.2 98.1 98.6 
4B D16Q14 99.6 99.6 99.6 99.9 99.2 99.8 99.9  91.3 91.8 92.0 96.0 96.8 98.0 97.3  93.0 94.4 94.9 96.5 95.5 95.4 97.3  93.0 93.0 92.5 94.4 89.7 97.2 96.7 
 D16Q20 99.6 99.6 99.6 99.9 99.2 99.8 99.9  91.3 91.8 92.0 96.0 96.8 98.0 97.3  93.0 94.4 94.9 96.5 95.5 95.4 97.3  93.0 93.0 92.5 94.4 89.7 97.2 96.7 
 D16R24 99.6 99.6 99.6 99.9 99.2 99.8 99.9  91.3 91.8 92.0 96.0 96.8 98.0 97.3  93.0 94.4 94.9 96.5 95.5 95.4 97.3  93.0 93.0 92.5 94.4 89.7 97.2 96.7 
 D17A2 99.6 99.6 99.6 99.9 99.2 99.8 99.9  91.3 91.8 92.0 96.0 96.8 98.0 97.3  93.0 94.4 94.9 96.5 95.5 95.4 97.3  93.0 93.0 92.5 94.4 89.7 97.2 96.7 
5 D16Q15 99.3 99.3 99.3 99.6 99.0 100 99.6  92.0 92.0 92.3 96.9 96.8 97.8 97.8  91.8 93.2 93.8 95.9 95.2 99.0 95.1  92.5 92.5 92.1 93.9 88.3 97.7 97.2 
D16R12 99.4 99.4 99.4 99.7 99.1 99.8 99.7  92.0 92.0 92.3 96.9 96.8 97.8 97.8  93.2 94.2 94.9 96.3 95.8 97.7 95.6  93.9 93.9 93.5 95.8 90.2 99.1 98.6 
D16R18 99.4 99.4 99.4 99.7 99.1 99.8 99.7  92.3 92.3 92.5 95.8 96.5 97.5 97.8  93.0 94.1 94.7 96.3 95.5 98.2 95.4  93.5 93.5 93.0 95.3 89.7 98.6 98.1 
6 D16Q19 99.7 99.7 99.7 100 99.3 99.6 100  92.8 92.3 93.0 96.0 98.2 97.2 99.7  94.0 95.2 95.9 96.8 96.5 96.2 98.6  93.5 93.5 96.3 93.0 89.7 97.7 99.1 
D16R27 99.7 99.7 99.7 100 99.3 99.6 100  92.8 92.3 93.0 96.0 98.2 97.2 99.7  94.0 95.2 95.9 96.8 96.5 96.2 98.6  93.5 93.5 96.3 93.0 89.7 97.7 99.1 
7 EPM 10906 99.9 99.9 99.9 99.8 99.4 99.4 99.8  97.8 96.3 96.5 93.3 92.5 92.0 93.3  94.5 95.6 96.6 97.5 97.3 95.6 97.2  96.3 96.3 95.8 94.9 89.7 96.7 97.2 
EPM 10695 99.9 99.9 99.9 99.8 99.4 99.4 99.8  97.8 96.3 96.5 93.3 92.5 92.0 93.3  94.5 95.6 96.6 97.5 97.3 95.6 97.2  96.3 96.3 95.8 94.9 89.7 96.7 97.2 
IAL 3785 99.9 99.9 99.9 99.8 99.4 99.4 99.8  97.8 96.3 96.5 93.3 92.5 92.0 93.3  94.4 95.5 96.5 97.3 97.2 95.5 97.0  95.3 95.3 94.9 93.9 88.8 95.8 96.3 
JAN1 99.9 99.9 99.9 99.8 99.4 99.4 99.8  97.8 96.3 96.5 93.3 92.5 92.0 93.3  94.5 95.8 96.5 97.6 97.2 95.8 97.3  95.8 95.8 95.3 94.4 89.3 96.3 96.7 
JAN2 99.9 99.9 99.9 99.8 99.4 99.4 99.8  97.8 96.3 96.5 93.3 92.5 92.0 93.3  94.5 95.8 96.5 97.6 97.2 95.8 97.3  95.8 95.8 95.3 94.4 89.3 96.3 96.7 
(1) M. abscessus subsp. abscessus, (2) M. abscessus subsp. bolletii, (3) M. massiliense, (4) M. chelonae, (5) M. immunogenum, (6) M. salmoniphilum, (7) “M. franklinii” 
*The 16S rRNA partial sequence of 6410 and M. immunogenum DSM 45595
T
 has 1385 bp due to a 1 bp insertion after nucleotide 1354.  
#
The rpoB partial sequences of the isolates of groups 4B and 6, and M. franklinii DSM 45524
T
 have 726 bp. The sequences of the other type strains of the M. chelonae-M. abscessus complex have 
711 bp. This difference is due to two insertions, one with 6 bp, between nucleotides 409 and 410 and the other with 9 bp, between nucleotides 424 and 425 of the 711 bp sequence.  
§
The ITS sequences of the groups 4, 5 and 6, M. franklinii DSM 45524
T
 and M. salmoniphilum ATCC 13758
T
 have 214 bp, those of the isolates of groups 1, 2 and 7, M. abscessus subsp. abscessus 
CIP 104536
T
, M. abscessus subsp. bolletii CCUG 50184
T
, M. massiliense CCUG 48898
T 
and M. chelonae ATCC 35752
T
 have 215 bp (1 bp insertion after nucleotide 20), that of 6410 has 217 bp (1 
bp insertion after nucleotide 20 and 2 bp insertion between nucleotides 171 and 172) and that of M. immunogenum CIP 106684
T
 has 225 bp (1 bp insertion after nucleotide 20 and 10 bp insertion 
between nucleotides 90 and 91). 
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ABSTRACT 
 
Microbial keratitis is a rare complication of refractive surgery, especially seen in laser-
assisted in situ keratomileusis (LASIK). Nontuberculous Mycobacteria (NTM), in 
particular Mycobacterium chelonae, are frequent agents of sporadic cases and 
outbreaks of post-LASIK NTM keratitis. Environmental investigation to identify the 
source of post-LASIK keratitis has been rarely reported. In this work we described 
the environment and microbiological investigation of an ophthalmological surgical 
facility after the occurrence of an outbreak of infections by NTM following LASIK. 
Using a combination of microbiological and molecular methods, including culture 
before and after decontamination procedures, identification of the isolated 
microorganisms and drug susceptibility testing and pulsed field gel electrophoresis 
typing of isolated NTM, we demonstrated the presence of a unique strain of M. 
chelonae causing the outbreak that was associated with a common environmental 
source of contamination, the distilled water used in the ophthalmological facility 
where the surgeries were performed. We concluded that the use of tap water distilled 
locally represents a great risk of infection in ophthalmologic surgical facilities. Special 
care should be taken in rinsing surgical instruments even through the steamer 
equipment and in ensuring that the water supply, air filters, and sterilizing facilities in 
the laser center are free of contamination to reduce the probability of outbreaks. 
Finally, technical aspects of the surgical procedure need to be optimized because 
they can have an impact in the occurrence of infection. 
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INTRODUCTION  
 
Nontuberculous mycobacteria (NTM) are widely distributed in the environment, 
especially in fresh water sources (rivers, lakes, tap water) and can also contaminate 
medical reagents, materials and equipment (Falkinham 2009). These organisms 
have emerged in the last years as an important cause of hard-to-treat postoperative 
infections, especially following plastic and ophthalmologic surgeries, as well as other 
invasive medical procedures such as mesotherapy (Wallace, Brown et al. 1998; 
Freitas, Alvarenga et al. 2003; Viana-Niero, Lima et al. 2008). 
Microbial keratitis is a serious ocular infection that develops in eyes with 
predisposing risk factors such as trauma and corneal surgeries. It is a rare 
complication of refractive surgery, especially seen in laser-assisted in situ 
keratomileusis (LASIK), a surgical technique widely used for correction of refractive 
errors. The LASIK procedure involves the creation of a thin-hinged flat on the front of 
the cornea using a microkeratome. The flap is lifted during surgery for laser 
reshaping of the eye and is then replaced to restore the corneal structure. The flap-
stroma interface may confine organisms that were eventually carried over to the 
surgical site during the procedure. The compromised penetration of prophylactic 
antibiotics in the corneal stroma, associated with the anti-inflammatory effects of 
steroids, frequently used postoperatively, can contribute to the development of 
infectious keratitis following this surgery (Paschal, Holland et al. 1992; Moorthy, 
Valluri et al. 2012). 
According to the American Society of Cataract and Refractive Surgery 
(ASCRS), the most frequent agents of infectious keratitis after LASIK are Gram 
positive bacteria and nontuberculous mycobacteria (NTM), in particular 
Staphylococcus spp. and Mycobacterium chelonae, respectively (Solomon, 
Donnenfeld et al. 2011). Other fungi and bacteria, such as Candida, Fusarium, 
Aspergillus, Streptococcus, Pseudomonas, and Nocardia, have also been reported in 
LASIK-associated corneal infections (Holmes, Bond et al. 2002; Lifshitz, Levy et al. 
2005; Feizi, Jadidi et al. 2007; Chen, Tsai et al. 2009; Garg, Chaurasia et al. 2010; 
Sharma, Jindal et al. 2012; Homa, Shobana et al. 2013). 
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In this work we described the environment and microbiological investigation of 
an ophthalmological surgical facility after the occurrence of an outbreak of infections 
by NTM following LASIK.  
 
MATERIAL AND METHODS 
 
Outbreak characterization 
Between December 2011 and February 2012, eight patients (15 eyes) 
developed keratitis after laser in situ keratomileusis (LASIK) performed in a single 
clinic in the state of Sao Paulo, Brazil. Samples from seven of the eight patients were 
obtained with a Kimura spatula either by direct scrapping of the cornea or by lifting 
the flap. Specimens were submitted to the Central Clinical Laboratory, Hospital Sao 
Paulo, Federal University of Sao Paulo (UNIFESP), Brazil and were evaluated by 
direct microscopy (Gram, Giemsa and Ziehl Neelsen staining) and cultivated on 
defibrinated sheep blood, chocolate, Sabouraud dextrose agar plates, thioglycolate 
broth and Löwenstein-Jensen slants (Probac do Brasil, São Paulo, Brazil).  Blood 
and chocolate agar plates were incubated at 37°C for 1 to 7 days in ambient 
atmosphere and 5% CO2. Löwenstein-Jensen and Sabouraud agar were incubated 
at 30°C and ambient temperature, respectively, for up to 30 days. Cultures were 
examined daily for evaluation of growth. Aerobic bacteria were identified by using the 
Phoenix automated system (Becton and Dickson). Nontuberculous mycobacteria 
were identified as described later in this section.  
 
Microbiological investigation of the surgical facility 
Following the outbreak, in April 2012 an environmental investigation of the 
surgical facility was performed. Samples of tap water, water from the reservoir of the 
bench top distiller equipment, from the portable steamer used to clean the 
microkeratome and from the STATIM 2000 Cassette Autoclave (Scican, Canonsburg, 
PA, USA) were collected. Imprints of microkeratome rings and other recently used 
surgical instruments were performed on Middlebrook 7H10-OADC (oleic acid-
albumin-dextrose-catalase) (Becton, Dickinson and Company, BD, Franklin Lakes, 
NJ, USA) agar plates. Samples of antiseptic solutions, microkeratome blades and 
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cannulas were inoculated directly into Middlebrook 7H9-OADC liquid medium 
(Becton Dickinson and Co) without previous decontamination (Table 1). 
All samples were collected in sterile flasks. Water samples were sent to the 
mycobacterial laboratory at the Department of Biological Sciences, Federal University 
of Sao Paulo (UNIFESP), where volumes higher than 100 mL were concentrated by 
vacuum filtration through 0.45 µm pore size nylon membranes (EMD Millipore, 
Billerica, MA, USA) and samples with lower volumes were concentrated by 
centrifugation at 3,000 g for 20 min. Concentrated samples were split in two. One half 
was sent to the Central Laboratory at Hospital São Paulo and cultured on 
defibrinated sheep blood agar, chocolate agar, and Sabouraud dextrose agar plates 
as described above. Aerobic bacteria were identified by using the Phoenix automated 
system (Becton and Dickson) and yeast isolates were identified by the API® ID 32C 
(bioMérieux). The second half of the samples was decontaminated with 0.05% 
cetylpyridinium chloride (CPC) (LabSynth do Brasil, Diadema, Brazil) and inoculated 
on Löwenstein-Jensen slants, Middlebrook 7H10-OADC plates and Middlebrook 
7H10-OADC-PANTA (BD and Co) plates (PANTA final concentration: 40 U/ml 
polymyxin, 4 µg/ml amphotericin B, 16 µg/ml nalidixic acid, 4 µg/ml trimethoprim and 
4 µg/ml azlocillin). Duplicate plates were incubated at 30°C and 37°C. Cultures were 
observed on a daily base until colonies were observed for a maximum of 60 days 
(Neumann, Schulze-Robbecke et al. 1997; Radomski, Cambau et al. 2010). 
 
Identification of Nontuberculous Mycobacteria 
All recovered colonies were initially visualized by microscopy after Ziehl-
Neelsen staining. Acid-fast bacilli (AFB) colonies were then identified by evaluation of 
phenotypic characteristics (growth rate and pigment production) and by PCR-
Restriction-Enzyme Analysis (PRA-hsp65) according to the protocol described by 
Chimara et al. (Chimara, Ferrazoli et al. 2008). Briefly, a 441-bp fragment of the 
hsp65 gene was amplified with primers TB11 (5´ACCAACGATGGTGTGTCCAT) and 
TB12 (5´CTTGTCGAACCGCATACCCT). Amplicons were digested separately with 
BstEII (Promega) and HaeIII (Invitrogen). Digestion products were visualized after 
electrophoresis in 3% agarose gels and digestion fragment sizes were estimated by 
visual analysis and using the BioNumerics v. 7.5 program (Applied Maths, Sint-
Martens-Latem, Belgium). The obtained digestion patterns were compared to those 
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present at the PRASITE database (http://app.chuv.ch/prasite/index.html). Final 
identification of AFB isolates was obtained by DNA sequencing of hsp65 and rpoB 
genes, 16S rRNA and the 16S-23S internal transcribed spacer (ITS). The primer 
pairs used for amplification and sequencing of these targets are depicted in Table 2. 
The sequences were edited using the BioEdit program (v. 7.1.9) and compared to 
sequences deposited in the GenBank database using the basic local alignment tool 
(BLAST) (URL: http://www.ncbi.nlm.nih.gov/BLAST). The obtained sequences were 
deposited in GenBank under accession numbers KT779779 to KT779786. 
 
Table 2. Primers used for amplification and sequencing  of 16S rRNA, rpoB, hsp65 and 
the 16S-23S internal transcribed spacer (ITS). 
Genes  Primers Reference 
16S rRNA 
16S-27F (5'-AGAGTTTGATCCTGGCTC AG-3') (Harmsen, Dostal et al. 2003) 
(Adekambi and Drancourt 2004b) 800F (5'-CAGGATTAGATACCCTGGTAG-3') 
16S-907R (5'-CGTCAATTCCTTTGAGT TT-3') (Harmsen, Dostal et al. 2003) 
16S-1492 (5'-ACGGCTACCTTGTTACG ACT T-3') (Gomila, Ramirez et al. 2007) 
23S1R (5'-CCCAAAGCCTATATATTCAGC-3') (Matsumoto, Chimara et al. 2012) 
rpoB 
MYCOF1 (5'-TCCGATGAGGTGCTGGCAGA-3') 
(Macheras, Roux et al. 2011) 
MYCOR2 (5'-ACTTGATGGTCAACAGCT CC-3') 
hsp65 
hsp667F- (5'-GGCCAAGACAATTGCGTACG-3') 
(Selvaraju, Khan et al. 2005) 
hsp667R- (5'-GGA GCTGACCAGCAGGATG-3') 
ITS 
Sp1 (5'-ACCTCCTTTCTAAGGAGCACC-3') (Roth, Reischl et al. 2000) 
23S1R (5'-CCCAAAGCCTATATATTCAGC-3') (Matsumoto, Chimara et al. 2012) 
 
 
Molecular typing by pulsed-field gel electrophoresis (PFGE) 
 
Mycobacteria obtained from patients and from environmental sources were 
typed by PFGE, as described by Matsumoto et al. (Matsumoto, Chimara et al. 2011). 
Briefly, single colonies were cultivated in Mueller Hinton broth (Oxoid, Hampshire, 
UK) supplemented with 0.05% of Tween 80. Plugs of bacterial cells were prepared in 
1% low-melt preparative agarose (Bio Rad Laboratories, Hercules, CA, USA). DNA 
was isolated and digested with 30 U DraI (Promega, Madison, WI, USA) at 37oC 
overight. Plugs were loaded into 1% Pulsed Field Certified Agarose (Bio Rad) in 0.5X 
TBE buffer (45 mM Tris-HCl, 45 mM boric acid and 1 mM EDTA). Electrophoresis 
was carried out in a CHEF-DR III System (Bio Rad) at 14°C for 21 h at 6V/cm, with a 
switch time of 1.6 to 21.3 s. Lambda Ladder PFG Marker (New England Biolabs, 
Ipswich, MA, USA) was used as the molecular standard. PFGE gel images were 
analyzed and dendrograms of PFGE patterns were produced with the BioNumerics v. 
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7.5 program (Applied Maths) using the band-based Dice UPGMA method based on 
1.5% optimization and position tolerance. 
 
Antimicrobial susceptibility testing 
 
The minimal inhibitory concentration (MIC) for amicacin (AMK), ciprofloxacin 
(CIP), clarithromycin (CLR), doxycycline (DXC), cefoxitin (CTX), tobramycin (TOB) 
minocycline (MIN), moxifloxacin (MOX), gatifloxacin (GAT), linezolid (LIN), imipenen 
(IMI) and trimethoprim-sulfamethoxazole (SXT) was determined by the broth 
microdilution method according to the guidelines of the Clinical and Laboratory 
Standards Institute (CLSI 2011). Mycobacterium chelonae isolates from two patients 
and from the distilled water of the surgical facility were cultivated in cation-adjusted 
Mueller-Hinton broth (Oxoid) for 3 to 5 days at 30ºC. Bacterial suspensions were 
adjusted to 0.5 McFarland standard and diluted to achieve a final inoculum of 
approximately 5x105 CFU/mL. The following drug concentrations were tested: CLR, 
IMI and TOB: 0.5 to 64 g/ml; CIP, DXC, GAT, MOX and MIN: 0.25 to 32 g/ml; AMK 
and CTX: 4-512 g/ml, STX: 0.25/4.5 to 32/608. Quality control was performed by 
testing Staphylococcus aureus ATCC 29213 strain. 
 
RESULTS 
 
The initial microbiologic investigation of the patients’ isolates revealed that M. 
chelonae was the causative agent in four patients. Coagulase negative staphylococci 
were isolated from eye samples of three patients and Serratia from one and were 
considered to be contaminants as only few colonies were detected. 
At the surgical facility, samples of tap water and distilled water from the 
storage tank and from the reservoir of the portable steamer contained acid-fast 
bacilli. Distilled water samples also contained Gram-negative bacteria and yeasts. 
Cultures of the imprints from the microkeratome rings and other surgical instruments, 
which were rinsed with distilled water after surgical procedures, yielded Gram-
negative bacteria growth (Table 1). 
ANNEX 2 
 
Table 1: Samples from the surgical facility analyzed in this work. 
 1 
Environmental 
samples 
volume 
or 
quantity 
processing culture AFB*** non-AFB identification 
tap water 500 mL 
vacuum 
filtration (0.45 
µm pore 
membranes ) 
* 
2 
colonies 
- 
Mycobacterium 
mucogenicum 
** - - - 
water distilled in 
the same day 
500 mL 
vacuum 
filtration (0.45 
µm pore 
membranes ) 
* 
5 
colonies 
- 
Mycobacterium 
chelonae 
** - 
red 
colony 
Methylbacterium 
extorquens 
distilled water 
(reservoir of the 
portable 
steamer) 
8 mL 
centrifugation 
at 3,000 g for 
20 min 
* 
2 
colonies 
- 
Mycobacterium 
chelonae 
** - 
different 
colonies 
Burkholderia cepacia, 
Burkholderia gladioli 
and Candida 
guilhermondis 
distilled water 
(cassette 
autoclave) 
10 mL 
centrifugation 
at 3,000 g for 
20 min 
* - - - 
** - 
different 
colonies 
Burkholderia cepacia, 
Sphingomonas 
paucimobilis and 
Candida guilhermondis 
microkeratome 
rings 
imprints - 
7H10-
OADC 
- 
different 
colonies 
Kingella kingae and 
Methylobacterium 
extorquens 
other surgical 
instruments 
imprints - 
7H10-
OADC 
- 
different 
colonies 
Pseudomonas 
oryzihabitans 
microkeratome 
blades 
recently 
used 
- 
7H9-
OADC 
- - - 
cannulas 
recently 
used 
- 
7H9-
OADC 
- - - 
Cetrimide 
solution (open 
for 15 days) 
3 mL - 
7H9-
OADC 
- - - 
Povidine iodine 
solution (open 
for 15 days) 
0.6 mL - 
7H9-
OADC 
- - - 
 
* Lowenstein-Jensen, 7H10-OADC, 7H10-OADC-Panta (after decontamination with cetylpiridinium chloride) 
**defibrinated sheep blood agar, chocolate agar, and Sabouraud dextrose agar plates 
*** AFB: Acid-Fast Bacilli 
 
 
All isolated mycobacteria were non-pigmented rapid growers. Isolates from the 
distilled water and from the portable steamer containers were identified as M. 
chelonae and the isolate from tap water was identified as Mycobacterium 
mucogenicum. One of the patients’ isolates and one isolate from the distilled water 
tank were identified by sequencing. The corresponding sequences of hsp65 and 
rpoB genes, 16S rRNA and ITS of both isolates showed 100% similarity and showed 
highest similarities with the corresponding sequences of M. chelonae type strain 
deposited in the GenBank by BLAST analysis (Table 3).  
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Table 3. Percent similarity of the sequences obtained with the isolate from the distilled 
water and the corresponding sequences of the species of the M. chelonae-M. abscessus 
complex.  
Gene M. chelonae-M. abscessus type strain 
GenBank 
accession number 
% similarity 
hsp65 
(401 pb) 
M. abscessus CIP 104536
T
 AY458075 93,02% 
M. chelonae CIP 104535
T
 AY458074 99,75% 
M. abscessus subsp. bolletii CIP 108541
T
 AY859675 92,52% 
M. franklinii DSM 45524
T
 KM392059 95,84% 
M. immunogenum CIP 106684
T
 AY458081 95,01% 
M. massiliense CCUG 48898 AY596465 92,77% 
M. salmoniphilum ATCC 13758
T
 DQ866777 96,01% 
rpoB 
(711 pb) 
M. abscessus CIP 104536
T
 AY147164 93,53% 
M. chelonae CIP 104535
T
 AY147163 99,86% 
M. abscessus subsp. bolletii CIP 108541
T
 AY859692 95,50% 
M. franklinii DSM 45524
T
 KM392056 94,97% 
M. immunogenum CIP 106684
T
 AY262739 97,19% 
M. massiliense CCUG 48898 AY593981.2 95,78% 
M. salmoniphilum ATCC 13758
T
 KM392056 96,62% 
ITS 
(215 pb) 
M. abscessus CIP 104536
T
 AY593976 90,23% 
M. chelonae ATCC 35752
T
 AY498739 98,60% 
M. abscessus subsp. bolletii CCUG 50184
T
 GU143888.2 90,23% 
M. franklinii DSM 45524
T
 HQ153093 93,49% 
M. immunogenum CIP 106684
T
 AY593977 86,67% 
M. massiliense CCUG 48898 AY593978 89,81% 
M. salmoniphilum ATCC 13758
T
 DQ866768 94,42% 
16S 
(1384 pb) 
M. abscessus CIP 104536
T
 AY457071 99,93% 
M. chelonae CIP 104535
T
 AY457072 100,00% 
M. abscessus subsp. bolletii CIP 108541
T
 AY859681 99,93% 
M. franklinii DSM 45524
T
 HQ153090 99,78% 
M. immunogenum DSM 45595
T
 HE654001 99,35% 
M. massiliense CCUG 48898 NR_043002 99,93% 
M. salmoniphilum ATCC 13758
T
 NR_043989 99,42% 
 
Gram negative bacteria isolated at the laser facility included Burkholderia 
cepacia, Burkholderia gladioli, Sphingomonas paucimobilis, Methylbacterium 
extorquens, Pseudomonas oryzihabitants and Kingella kingae. Candida 
guilhermondis was isolated from the portable steamer and from water collected from 
the STATIM autoclave reservoir (Table 1). 
 M. chelonae isolates obtained from four patients and from the distilled water 
storage tank (5 colonies) and the portable steamer reservoir (2 colonies) showed 
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indistinguishable PFGE patterns, which were different from the PFGE pattern of the 
M. mucogenicum isolate (Figure 1). 
 
 
 
Figure 1: Pulsed field gel electrophoresis patterns 
of isolates from patients and environmental isolates 
collected at the surgical facility. 1 - 4: patient's 
isolates (M. chelonae); 5: isolate from the distilled 
water tank (M. chelonae); 6: isolate from the 
portable steamer (M. chelonae); 7: tap water isolate 
(M. mucogenicum); at right: molecular markers (kb)  
 
The antimicrobial susceptibility profile determined by broth microdilution with 
two patients’ isolates and one isolate from the distilled water reservoir are displayed 
in Table 4. The isolates were highly resistant to antibiotics most commonly used for 
treatment of NTM infections. Among fluoroquinolones, which are frequently used for 
prophylaxis and treatment of ocular infections, isolates were either intermediate or 
resistant to ciprofloxacin, moxifloxacin (MIC ranging from 2 to 16 μg/ml) and 
gatifloxacin (MIC >16 μg/ml). Isolates demonstrated high-level resistance to 
doxycycline (MIC >32 μg/ml), cefoxitin (MIC ≥ 256 μg/ml) and 
trimethoprim/sulfamethoxazole (MIC 8/152 μg/ml). Aminoglycosides were not fully 
active against the isolates, with MIC raging from 4 to 8 μg/ml for tobramycin 
(intermediate and resistant) and from 8 to 32 μg/ml for amikacin (MIC 8 μg/ml 
susceptible, but close to the breakpoint and 32 μg/ml intermediate). Isolates were 
susceptible only to linezolid, with MIC values close to the breakpoint (8 μg/ml), and 
clarithromycin (MIC ≤0.5 μg/ml), which was the antimicrobial agent showing the 
highest in vitro activity against these M. chelonae isolates.  
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Table 4: Antimicrobial susceptibility of one isolate from distilled water from the clinic 
and two patients.  
 
water from the distilled 
water tank 
Patient 1 Patient 2 
 
MIC 
(μg/ml) 
susceptibility
a
 
MIC 
(μg/ml) 
susceptibility 
MIC 
(μg/ml) 
susceptibility 
AMK 32 I 32 I 8 S 
CIP 8 R 16 R 2 I 
CLR ≤0.5 S ≤0.5 S <0.5 S 
DXC >32 R >32 R >64 R 
CTX 512 R 512 R 256 R 
TOB 4 I 8 R 4 I 
MIN 8 NA 8 NA 32 NA 
MOX 2 I 8 R 16 R 
GAT ND
b
 - >16 NA >16 NA 
LIN ND - 8 S 8 S 
IMI ND - 32 R 32 R 
SXT ND - 8/152 R 8/152 R 
a
 interpretation of MIC results according to CLSI guidelines. S: susceptible; I: intermediate; R: resistant; NA: not 
available 
b
 ND: not done 
 
DISCUSSION 
 
Using a combination of microbiological and molecular typing methods, we 
demonstrated the presence of a unique strain of M. chelonae causing an outbreak of 
infectious keratitis following LASIK surgery that was associated with a common 
environmental source of contamination, the distilled water used in the 
ophthalmological facility where the surgeries were performed.  
The first case of post-LASIK keratitis caused by M. chelonae was described in 
1998 and it was an unilateral infection after simultaneous bilateral surgery (Reviglio, 
Rodriguez et al. 1998). The authors described the use of the same microkeratome 
blade in both eyes operated simultaneously and suggested that bacterial inoculation 
occurred intraoperatively following the corneal incision. Since then, reports of 
sporadic cases and outbreaks of post-LASIK NTM keratitis have increased in the 
literature(Chang, Jain et al. 2004).  
Environmental investigation to identify the source of post-LASIK keratitis has 
been rarely reported and frequently fails to determine the origins and clonal 
relatedness of contaminating organisms with the causative agent. Some publications 
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suggest that the infection could be caused by the contaminated microkeratome, but 
this hypothesis has not been fully confirmed (Reviglio, Rodriguez et al. 1998; Garg, 
Bansal et al. 2001). In an outbreak of infections after LASIK caused by M. chelonae 
reported in Southern California, the masks created from a soft contact lens were 
used in hyperopic LASIK and were determined as the source of infection, but 
mycobacteria were not detected in additional lenses from the same lot. A thorough 
environmental investigation failed to identify the source of infection, but cultures were 
performed more than three weeks after recognition of the outbreak (Chandra, Torres 
et al. 2001). 
The study of an outbreak of post-LASIK M. chelonae infections in São Paulo, 
Brazil, in 2000 revealed that samples from the air-conditioning system and water from 
the portable steamer contained the same strain of M. chelonae isolated from the 
patients, but the investigation was not specifically directed at finding possible sources 
of contamination (Freitas, Alvarenga et al. 2003).  
In a subsequent outbreak that occurred in Brazil, an environmental 
investigation was carried out one month after an outbreak after LASIK caused by 
Mycobacterium immunogenum and affecting five patients. Samples of tap water, 
antiseptic and anesthetic solutions, nonsurgical soap, commercial distilled water, 
water from a bench-top autoclave and from the air-conditioning system drain were 
collected, decontaminated and cultivated on Middlebrook 7H10 agar. None of the 
environmental cultures yielded mycobacteria (Sampaio, Junior et al. 2006).  
In one outbreak reported, a definite source was identified. The five confirmed 
cases were caused by Mycobacterium szulgai and the same species was isolated 
from the ice machine’s drain. Isolates from patients and from the ice machine 
showed indistinguishable PFGE patterns, confirming the contamination from ice that 
was used to chill syringes of saline solution used for intraoperative lavage (Holmes, 
Bond et al. 2002).  
There are multiple possible sources of keratitis including the patient’s 
conjunctival and lid microbiota, the microkeratome or other surgical instruments and 
postoperative inoculation by the patient. Contaminated water is frequently considered 
as the most likely source, but rarely confirmed in outbreak reports. Failure to use 
appropriate aseptic techniques has been considered as a contributing factor (Chang, 
Jain et al. 2004). The use of the same microkeratome blade in both eyes operated 
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simultaneously is a common practice, but it is unclear whether the lack of blade 
change between eyes in a simultaneous bilateral LASIK surgery would increase the 
risks of infection. A case of M. chelonae bilateral keratitis has been documented in 
which the surgeon refers to having used the same set of instruments and the same 
microkeratome blade on both eyes, emphasizing the contamination by instruments 
during surgery in bilateral occurrences (Garg, Bansal et al. 2001). Others have 
suggested, by observing the tissue patterns of infection evolution on the corneal 
stroma in a patient that underwent LASIK, that M. chelonae contamination of the 
microkeratome was the cause the postoperative development of keratitis 
(Kouyoumdjian, Forstot et al. 2001).   
NTM are present in different natural and artificial ecosystems as lakes, rivers, 
soil and potable water supply systems. Human beings are surrounded by these 
opportunistic pathogens (Falkinham 2009). Several publications have indicated that 
infections caused by NTM may originate from contaminated water (Conger, 
O'Connell et al. 2004; Brown-Elliott and Wallace Jr. 2012a). NTM not only survive but 
also multiply in water distribution systems (Falkinham 2002; Le Dantec, Duguet et al. 
2002b). Le Dantec et al. demonstrated that M. aurum and M. gordonae isolated from 
water delivery systems are 100 and 330 times more resistant to chlorine than 
Escherichia coli, respectively (Le Dantec, Duguet et al. 2002a). The elimination of 
microorganisms after water chlorination reduces competition and favors growth of 
chlorine-resistant bacteria, as those belonging to genus Mycobacterium (Falkinham, 
Norton et al. 2001; Le Dantec, Duguet et al. 2002a). Biofilms containing NTM may 
play a role in resistance against disinfection and sterilization procedures and favor 
the occurrence of outbreaks like the one studied here (Falkinham 2013). 
In this study, results of microbiological investigation of specimens from 
patients and from environmental samples, collected two months after the detection of 
the last case, confirmed that the strain of M. chelonae isolated from distilled water 
samples caused infections in four patients. The environmental and clinical isolates 
were genetically identical by DNA sequencing and by macrorestriction profile of 
whole cell DNA content examined by PFGE. Environmental and clinical isolates were 
highly resistant to the antimicrobial agents tested. Levels of resistance as determined 
by individual MICs for each drugs were similar, except for moxifloxacin for which the 
MIC value was 4-fold and 8-fold higher with patients’ isolates than with the water 
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isolate. This is likely to be the result of previous exposure to fourth-generation 
fluoroquinolones which were administered prophylactically after surgery and which 
were also empirically administered when the patients presented with symptoms of 
infection. Interestingly, gatifloxacin MIC values of the two patients’ isolates were high 
(>16 μg/ml), but all outbreak patients were treated with drops containing gatifloxacin 
and responded well, ending with 20/20 vision. 
In the surgical facility evaluated in this study, tap water was distilled on a daily 
base in a bench distiller, stored in a non-sterile tank and used to rinse instruments 
and to fill the portable steamer and autoclave reservoirs. Therefore, tap water could 
have been the original source of this M. chelonae strain, which persisted in biofilms in 
the storage tank together with other biofilm-forming microorganisms, as the Gram-
negative bacteria and yeasts that were isolated from the same distilled water 
samples. The investigation revealed the presence of M. mucogenicum in the tap 
water sample, indicating that NTM could be present in the water delivery system of 
the clinic.  
However, the presence of potential infection agents in distilled water cannot 
explain all aspects of the occurrence of this outbreak. Infections caused by the other 
isolated organisms were never detected in this clinic. One hundred and seventy two 
surgeries were performed in this particular surgical facility during the cluster period. A 
total of 15 surgeons used the laser facility from December 2011 to February 2012. 
One surgeon operated 7 out of the 8 patients that developed infection. All those 7 
infections were bilateral. Statistical analysis showed a statistically significant risk of 
developing mycobacterial infection when this particular surgeon was included in the 
analysis (data not shown). Therefore it is possible that technical differences among 
the surgeons may play an important role in the occurrence of post-LASIK infections. 
The only patient that was operated by a second surgeon was also the only patient 
that had unilateral infection. 
In conclusion, the use of tap water distilled locally represents a great risk of 
infection in ophthalmologic surgical facilities and should never be used to rinse 
surgical instruments even through the steamer equipment. Special care should be 
taken to ensure that the water supply, air filters, and sterilizing facilities in the laser 
center are free of contamination to reduce the probability of outbreaks. Finally, 
optimization of technical aspects of the surgical procedure is of utmost importance.  
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